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Riassunto Tesi 
I danni da alchilazione a carico del DNA sono potenzialmente pericolosi per l’integrità e la 
stabilità del genoma. In particolare, l’alchilazione a carico dell’ossigeno in posizione 6 della 
guanina, se non riparata, porta alla transizione nel DNA dalla coppia G:C alla coppia A:T durante la 
fase di replicazione [Pegg et al., 1991]. A tale scopo, l’evoluzione ha selezionato un enzima capace 
di riparare direttamente questo tipo di danno: l’O6-alchilguanina-DNA-alchiltransferasi (AGT, 
OGT, MGMT). Questa proteina ubiquitaria trasferisce irreversibilmente il gruppo alchilico dal 
DNA a una cisteina catalitica: la proteina alchilata è quindi riconosciuta non più funzionante dai 
sistemi di degradazione cellulari [Pegg, 2011]. 
Sebbene di ridotte dimensioni, le AGT sono costituite da due domini collegati da una regione 
non strutturata (connecting loop): analisi di struttura primaria e terziaria delle AGT da vari 
organismi mostrano una elevata identità del dominio C-terminale, coinvolto nel legame al DNA e 
nella reazione di catalisi, laddove il dominio N-terminale, meno conservato, sembrerebbe coinvolto 
nella regolazione, nella cooperatività di legame al DNA e nella generale stabilità della proteina. La 
più studiata in letteratura è quella umana (hAGT), perché la sua inaspettata over-espressione in 
alcuni tipi di neoplasie porta alla resistenza al trattamento chemioterapico a base di agenti alchilanti. 
Dopo numerosi studi è stato identificato uno degli inibitori più potenti: l’O6-benzil-guanina (O6BG) 
e suoi derivati, che, usato in combinazione con i trattamenti chemioterapici, ne ripristinano 
l’efficacia. Nonostante l’enorme caratterizzazione biochimica e strutturale su questa classe di 
proteine, alcuni dettagli dell’attività delle AGT non sono ancora chiari. In particolare, si suppone 
che l’alchilazione causi dei cambiamenti conformazionali che rendono le AGT instabili e 
identificabili dai sistemi di degradazione [Kanugula et al., 1998]. Tuttavia, tali cambiamenti non 
sono stati così evidenti da essere identificati nelle strutture 3D della hAGT nella forma alchilata 
[Daniels et al., 2000; Daniels et al., 2004]. 
In questo studio, abbiamo rivolto la nostra attenzione all’OGT dell’archeobatterio 
ipertermoacidofilo S. solfataricus (SsOGT). Quest’organismo, vivendo a una temperatura intorno ai 
75-80 °C e a estremi di pH pari a 2-4, è un utile modello per lo studio dei sistemi di riparo del 
DNA. Come atteso, la SsOGT si è mostrata molto stabile in svariate condizioni di reazione, 
rendendo possibile un’ampia caratterizzazione biochimica, attraverso un nuovo e semplice saggio di 
attività che utilizza derivati fluorescenti dell’inibitore O6BG [Perugino et al., 2012]. La proteina, 
essendo irreversibilmente modificata in seguito alla reazione 1:1 col substrato, viene marcata con un 
gruppo fluorescente, e l’intensità può essere misurata con i metodi convenzionali di gel imaging. 
Questo nuovo metodo ha permesso di caratterizzare in toto questa OGT, evidenziandone la stabilità 
in svariate condizioni chimico-fisiche non permissive per la maggior parte delle proteine mesofile.  
Attraverso esperimenti di termostabilità sulle proteine purificate, abbiamo potuto costatare e 
confermare una maggiore instabilità della forma metilata rispetto a quella libera alle temperature 
fisiologiche dell’organismo d’origine (> 70 °C), esattamente come avviene per tutte le AGT. 
Inoltre, mutanti della cisteina catalitica che “simulano” trasferimenti di gruppi alchilici ingombranti 
al sito attivo (C119L e C119F) sono risultanti ancor più instabili, suggerendo che l’instabilità 
generale della proteina è direttamente proporzionale all’ingombro sterico dei gruppi alchilici nel 
sito attivo. Tuttavia, la SsOGT è più stabile e versatile dell’omologo mesofilo umano alle 
temperature di quest’ultimo, rendendo possibile cristallizzarla nelle varie forme (SsOGT libera, in 
complesso con il DNA, e alchilata) e quindi poter analizzare gli eventuali cambiamenti 
conformazionali ipotizzati. 
Dalla superimposizione della struttura della SsOGT in forma libera con quella metilata sono stati 
evidenziati due cambiamenti conformazionali importanti che coinvolgono soprattutto il C-
terminale. Il primo coinvolge un’interazione tra un’arginina in posizione 133 (R133) sul dominio C-
terminale e un residuo di aspartato in posizione 27 (D27) sul dominio N-terminale: nella forma 
metilata la R133 si allontana sensibilmente dal D27. Siccome la distanza nella forma libera tra 
questi due residui è compatibile con un’interazione ionica, abbiamo ipotizzando che la perdita di 
questa interazione possa compromettere la stabilità generale della proteina. Attraverso la 
mutagenesi sito-diretta, abbiamo sostituito il residuo D27 con un’alanina o una lisina, in modo da 
eliminare la carica negativa o introdurne una positiva, stabilendo un’interazione di tipo repulsivo. 
Questi mutanti si sono rivelati estremamente instabili, confermando il ruolo di questa interazione 
nella stabilità generale della proteina. Inoltre, i saggi d’attività condotti su questi mutanti hanno 
chiarito il ruolo dell’interazione D27-R133 anche nella corretta comunicazione tra i domini durante 
il processo di riparazione [Perugino et al., 2015]. Il secondo cambiamento conformazionale 
identificato è a carico del cosiddetto “K48 network”, che coinvolge una rete di 5 residui 
amminoacidici (E44, K48, N59, R61 e E62) con al centro la lisina in posizione 48: dal confronto 
delle strutture tridimensionali delle tre forme della proteina (libera, legata al DNA e metilata) è stato 
osservato che questo network perde la propria interazione nelle forme legata al DNA e nella forma 
metilata. L’analisi biochimica ha dimostrato che la perturbazione del K48 network, tramite 
mutagenesi sito diretta, riguarda principalmente la stabilità della SsOGT, e non la sua attività di 
riparazione del DNA [Morrone et al., 2017]. Questi risultati permettono di proporre un modello che 
mette in relazione i cambiamenti conformazionali e l’attività di riparazione della SsOGT sul DNA 
alchilato. L'attività e la stabilità ottimali della SsOGT richiedono un preciso coordinamento tra i due 
domini; infatti, numerose interazioni intramolecolari si trovano proprio all'interfaccia tra questi. Le 
due interazioni scoperte giocano un ruolo importante nella stabilità, e nell’attività catalitica. Queste 
interazioni agiscono letteralmente come "serrature" presenti in uno stato chiuso nella forma libera: 
se entrambe le serrature si trovano nello stato “aperto” come nel caso della forma alchilata, si ha la 
perdita totale d’interazione tra i domini N e C-terminale, innescando la destabilizzazione e la 
degradazione della SsOGT [Morrone et al., 2016]. 
La reazione irreversibile dell’AGT con l’inibitore O6BG porta al legame covalente del gruppo 
benzilico al sito attivo della proteina, liberando la guanina. Sfruttando questa peculiare reazione, nel 
2003 il gruppo del Prof. Johnsson ha sviluppato una versione dell’hAGT (definita SNAP-tag) 
incapace di legare il DNA, per utilizzarla come protein-tag nelle proteine di fusione per la 
marcatura covalente e specifica di proteine [Juillerat et al., 2003]. Infatti, coniugando gruppi 
chimici d’interesse alla porzione benzilica dell’O6BG, è possibile marcare indirettamente una 
proteina d’interesse con quel gruppo chimico, sfruttando l’attività della SNAP-tag. Ad esempio, uno 
di questi derivati è la SNAP-Vista Green™, in cui al gruppo benzilico dell’O6BG è stata coniugata 
la fluoresceina. Tuttavia, la SNAP-tag technology presenta una limitazione: essendo derivata 
dall’hAGT mesofila, molte condizioni estreme di reazione sono poco applicabili. In questo 
contesto, si può proporre un mutante della SsOGT (SsOGT-H5) che, sebbene simile alla SNAP-tag 
in termini d’attività e incapace di legare il DNA, tuttavia risulta simile alla relativa proteina WT, 
riguardo la stabilità agli agenti denaturanti chimici e fisici. Per valutare l’espressione eterologa del 
gene H5 in condizioni di alta temperatura, è stato scelto l’organismo modello termofilo Thermus 
thermophilus HB27, privo di alcuna attività AGT endogena: dopo SDS-PAGE degli estratti cellulari 
e il saggio d’attività, la banda fluorescente corrispondente all’altezza attesa era presente solo nelle 
cellule trasformate con il plasmide recante il gene di H5, dimostrando che la proteina è espressa 
eterologamente e funzionalmente attiva ad alte temperature [Vettone et al., 2016]. Il mutante H5 è 
stato valutato anche come protein-tag, fondendo il gene di H5 a quello della termostabile beta-
glicosidasi di S. solfataricus (Ss-βGly). Il saggio fluorescente per H5 e il calcolo delle costanti 
cinetiche dell’attività enzimatica della Ss-βGly chimerica comparabili a quelli della sola Ss-βGly, 
dimostrano che ciascuna proteina della fusione è attiva e non interferisce in alcun modo con 
l’attività dell’altra. Ma il principale vantaggio di questo tag termostabile consiste nella purificazione 
attraverso un trattamento al calore dell’estratto, che permette di eliminare così buona parte delle 
proteine contaminanti di E. coli, procedura non possibile con le protein-tag convenzionali mesofile. 
Tutto ciò conferma che H5 è un ottimo candidato per ampliare la SNAP-tag technology anche in 
condizioni di reazione estreme [Vettone et al., 2016]. 
Un successivo capitolo di questa tesi riguarda lo studio in vivo delle AGT del nematode 
ermafrodito Caenorhabditis elegans. Questo sistema modello presenta due geni, codificanti la 
CeAGT-1 e la CeAGT-2: la prima sembra essere simile alle classiche AGT a livello di struttura 
primaria; la seconda invece è un’AGT in cui è presente il solo dominio C-terminale catalitico, fuso 
a un dominio histone-like. Data la peculiarità strutturale della CeAGT-2, ci siamo chiesti quale 
fosse il suo ruolo in vivo. In particolare, abbiamo caratterizzato i fenotipi del solo ceppo mutante 
disponibile della CeAgt-2. La maggiore sensibilità del ceppo CeAGT-2 all'agente alchilante MMS 
(metil-metan-sulfonato) rispetto al WT, conferma che la CeAGT-2 svolge un ruolo chiave nella 
risposta ai danni agli agenti alchilanti. Tuttavia, abbiamo sorprendentemente osservato in questo 
ceppo delle alterazioni rispetto al WT in condizioni fisiologiche, che hanno riguardato 
principalmente: i) una minore deposizione (circa il 20%), ii) una maggiore letalità embrionale e iii) 
una significativa presenza di fenotipi aberranti. Essendo questi fenotipi associati a mutazioni in geni 
coinvolti nella meiosi e nella formazione e/o produzione dei gameti, abbiamo quindi analizzato il 
ruolo della CeAGT-2 durante la meiosi. In particolare, abbiamo focalizzato l’attenzione sulla 
presenza della proteina Rad-51 sui tagli del DNA durante la ricombinazione meiotica, eseguendo un 
immunolocalizzazione sui nuclei della gonade del nematode. Nel ceppo CeAGT-2 si riscontra una 
maggiore persistenza e un maggior numero di foci per nucleo durante la fase di pachitene, 
suggerendo quindi un aumento fisiologico nel ceppo mutante di errori meiotici durante la 
formazione dei gameti femminili. Inoltre, l’analisi del numero di corpi apoptotici nel ceppo mutante 
ha rilevato anche un numero maggiore di questi rispetto al WT [Gartner et al., 2008], indicando 
ancora un difetto nella selezione delle cellule destinate all'apoptosi. I risultati ottenuti nel complesso 
attribuiscono un ruolo chiave della CeAGT-2 nelle vie metaboliche legate alla riparazione del DNA 
e allo sviluppo meiotico. Sono in corso vari esperimenti d’incroci genetici tra il ceppo CeAGT-2 e 
geni coinvolti nello sviluppo, allo scopo di chiarire più approfonditamente il ruolo di questo gene in 
vivo. 
 
 
 
 
 
 
 
 
 
 
 
 
Summary Thesis 
 
The alkylation damage on DNA is potentially dangerous to the integrity and stability of the 
genome. In particular, the alkylation on the oxygen at position 6 of guanine, if not repaired, leads to 
transition from the G: C pair to the A: T pair during the replication phase [Pegg et al., 1991]. For 
this purpose, evolution has selected an enzyme capable of directly repairing this type of damage: the 
O6-alkylguanine-DNA-alkyltransferase (AGT, OGT, MGMT). This ubiquitous protein irreversibly 
transfers the alkyl group from DNA to a catalytic cysteine and the alkylated protein, not active 
longer, is recognized by cellular degradation systems [Pegg, 2011]. 
Although small in size, AGTs consist of two domains linked by an unstructured region 
(connecting loop): primary and tertiary structure analysis of AGTs from various organisms show a 
high identity of C-terminal domain involved in DNA binding and in the catalysis reaction, whereas 
the less conserved N-terminal domain appears to be involved in regulation, binding 
cooperativeness, and overall protein stability. The most studied in the literature is human AGT 
(hAGT), because it unexpectedly involved in the resistance of some types of cancers to alkylating 
agents-based chemotherapy. After strong efforts, one of the most potent inhibitor was identified: the 
O6-benzyl guanine (O6BG) and relative derivatives, whose activity toward the protein restored the 
efficacy of the chemotherapy treatments. Despite the enormous biochemical and structural 
characterization of this protein class, some details of the activity of AGT are still unclear. In 
particular, degradation upon alkylation seemed to lead to conformational changes that make protein 
unstable and identifiable by degradation systems [Kanugula et al., 1998]. However, the 3D 
structures of hAGT in the alkyl form did not show evident conformational changes [Daniels et al., 
2000; Daniels et al., 2004]. 
In this study, we focused our attention on the OGT of the hyper-thermoacidophilus archaea 
Sulfolobus solfataricus (SsOGT). This organism, living at the temperature around 75-80 °C and an 
extreme pH of 2-4, is a useful model to study DNA repair systems. Because of its nature, SsOGT is 
very stable in various reaction conditions, making it possible a wide biochemical characterization 
[Perugino et al., 2012]. We developed a new simple activity assay using fluorescence derivatives of 
the O6BG inhibitor: the protein is irreversibly modified by the 1:1 reaction with the substrate, 
labelling with a fluorescent probe, and the intensity can be measured by conventional gel imaging 
methods. This new method, evolved and optimised in this thesis, further allowed the fully 
characterization of SsOGT, highlighting stability in various chemical-physical conditions that are 
not permissible for most mesophilic proteins. 
Through thermostability experiments on purified proteins, we could observe and confirm a 
greater instability of the methylated form than the free form at their physiological temperatures (> 
70 °C), as for other AGTs. In addition, catalytic cysteine mutants that "simulate" transfers of bulky 
alkyl groups to the active site (C119L and C119F) are even unstable, suggesting that the overall 
instability of the protein is directly proportional to the size of the groups which occupy the active 
site. However, SsOGT is more stable and versatile than the hAGT at lower temperatures, allowing 
the crystallization in various forms (free, complex with DNA and alkylated form) and thus 
analysing all the eventual conformational changes.  
From the superimposition of the structure of the SsOGT in free form to the methylated form, we 
identified two significant conformational changes: the first involves an arginine residue in position 
133 (R133) on the C-terminal domain and an aspartate residue in position 27 (D27) on the N-
terminal domain. In the methylated form R133 moves away from D27: since the distance in the free 
form between these two residues could be compatible with an ionic interaction, we assumed that the 
loss of this interaction could compromise the overall protein stability. Through site-directed 
mutagenesis, we replaced the D27 with an alanine or a lysine, in order to eliminate the negative 
charge or to introduce a positive one, respectively. The great instability and low activity of D27A 
and D27K mutants confirmed the role of D27-R133 interaction not only in the protein stability of 
SsOGT, but also in proper communication between domains during the DNA repair process 
[Perugino et al., 2015]. The second conformational change identified has been termed K48 network, 
which involves five amino acid residues (E44, K48, N59, R61 and E62), in a network in which the 
K48 could have the main role. Comparing the three-dimensional structures of the three protein 
forms (free, bound to DNA and methylated form), it has been observed that this network loses its 
interaction during the binding to DNA and in the methylated form. Biochemical analysis of K48 
mutants has shown that the perturbation of the K48 network mainly affects the stability of SsOGT, 
but not the DNA repair activity [Morrone et al., 2017]. These results delineated a proposed model 
that correlates conformational changes and repair activity of SsOGT on alkylated DNA. The 
optimum activity of SsOGT and its stability require precise coordination between the two domains. 
The two discovered interactions play an important role in stability and catalytic activity, acting as 
closed "locks" in the free form. If the locks are in their "open" state upon alkylation, there is a total 
loss of interactions between the N-terminal and C-terminal domains, triggering the destabilization 
and degradation of the SsOGT [Morrone et al., 2016]. 
The irreversible reaction of AGT with the O6BG inhibitor leads to the covalent bond of the 
benzyl group to the active site of the protein. In 2003, Prof. Johnsson’s group developed an 
engineered version of the hAGT (defined SNAP-tag) unable to bind DNA. SNAP-tag can be used in 
fusion proteins for covalent and specific protein labelling [Juillerat et al., 2003]. By derivatization 
of chemical groups of interest with the benzyl group of the O6BG, it is possible to label indirectly a 
protein of interest with a desired chemical group. For instance, one of these derivatives is the SNAP-
Vista Green™, in which a fluorescein moiety is conjugated to the benzyl group of O6BG. However, 
because of the mesophilic nature of the relative hAGT, the SNAP-tag technology is limited at 
mesophilic conditions, making extreme reaction conditions not applicable. In this context, we 
proposed a mutant of the SsOGT (SsOGT-H5). Similar to SNAP-tag, this mutant is unable to bind 
the DNA and possesses the same catalytic activity, but preserves the stability to the chemical and 
physical denaturing agents, as the relative WT protein. In order to test the heterologous expression 
of the H5 gene in the thermophilic model, we used Thermus thermophilus HB27 strain, which lacks 
of any AGT activity. By using the fluorescent substrate SNAP-Vista Green™, we identified a 
fluorescent band corresponding to the expected molecular weight. This signal, being present only in 
cells transformed with the plasmid harbouring the H5 gene, confirmed that the protein is expressed 
and correctly folded at high temperatures [Vettone et al., 2016]. The H5 mutant was also evaluated 
as a protein-tag, combining the H5 gene with the thermostable beta-glycosidase from S. solfataricus 
(SsβGly). The fluorescent assay and the calculation of the kinetic constants of the enzymatic 
activity of H5-SsβGly fusion, comparable to that of the SsβGly alone, demonstrated that the each 
moiety of the fusion protein does not interfere with the activity of the other one. It is very important 
to underline that the whole fusion can be treated at high temperature, in order to eliminate the most 
of E. coli proteins, during the purification phases. This is not applicable by using conventional 
mesophilic protein-tag. All this results led us to propose H5 as an excellent alternative for extending 
SNAP-tag technology even under extreme reaction conditions [Vettone et al., 2016]. 
A further chapter of this thesis concerns the in vivo study of the AGT of the hermaphrodite 
nematode Caenorhabditis elegans. It coding two genes for CeAGT-1 and CeAGT-2: the first seems 
to be similar to the classical AGTs at the primary structure level; in the second only the catalytic C-
terminal domain is present, fused to a histone-like domain. Due to the peculiar structure of CeAGT-
2, we wonder its role in vivo. In particular, we have characterized the phenotypes of the only mutant 
strain of CeAGT-2 available. The hypersensitivity of CeAGT-2 strain to the MMS confirmed, as in 
other organisms, that this protein plays a key role in the response to damage to alkylating agents. 
Surprisingly, by following the phenotypic analysis of the CeAGT-2 strain, we observed alterations 
with respect to the WT strain at physiological conditions: i) a lower deposition (about 20%); ii) 
major embryonic lethality and iii) significant presence of aberrant phenotypes. Because these 
phenotypes are often associated with mutations in genes involved in meiosis and in the formation 
and/or production of gametes, we analysed the role of CeAGT-2 during meiosis. In particular, we 
focused attention on the presence of Rad-51 protein on DNA cuttings during meiotic recombination, 
by immunolocalization on nematode gonad nuclei. The high endurance and major number of foci 
observed during the CeAGT-2 strain in the pachytene phase indicated meiotic defects during the 
formation of female gametes. Finally, we measured a higher number of germ cells undergoing to 
apoptosis in the mutant, respect to the physiological number in the WT [Gartner et al., 2008], 
suggesting again a defect in the selection of cells destined for apoptosis. Overall results showed a 
key role of CeAGT-2 in metabolic pathways related to DNA repair and meiotic development. 
Several genetic-crossing experiments between the CeAGT-2 strain and the genes involved in worm 
development are in progress, in order to further clarify the role of this gene in vivo. 
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1. Introduction 
 
 
1.1 Genomic integrity and its repair 
 
The maintenance of genome integrity is essential for organism survival and for the 
heritage of genes set to offspring. The dynamic state of DNA and its relative transactions, like 
replication (copying of DNA prior to each cell division), recombination (exchanges between 
different DNA molecules in a cell) and so on, expose it continually to a myriad of types of 
damage, forcing the cells to set ingenious mechanisms for tolerating and repairing these 
damages. Genomic instability by DNA damage, aberrant DNA replication or uncoordinated 
cell division, as well as hydrolytic loss of DNA bases, base oxidations, non-enzymatic 
methylations and other chemical alterations, as well as because of multiple reactions with 
exogenous (environmental) and endogenous (intracellular) reactive species (see figure 1), if 
left unrepaired, may interfere with DNA metabolism, resulting in the accumulation of 
mutations and disturbance in cellular processes [Lindahl, 1993; Friedberg, 2003]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic representation of the main types of damage, repair mechanisms and 
consequences of cellular response (from [Hoeijmakers, 2001]). 
 
 
 
There are several strategies that allow the cell to survive the various types of damage. First 
of all, the genome has a mutation tolerance due to gene redundancy, semi-conservative 
replication and translesion DNA synthesis, that involves the replication machinery bypassing 
sites of damage, allowing normal DNA replication and gene expression to proceed 
downstream of the unrepaired damage [Goodman, 2002]. Biological responsiveness to genetic 
insult embraces more than tolerance of DNA damage. The cells have evolved complex 
signalling pathways to arrest the progression of the cell cycle in the presence of DNA 
damage, thereby increasing operate time for repair and tolerance mechanisms [Zhou et al., 
2000]. When the gravity of genomic damage is too large to be effectively met by the various 
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responses, cells are able to initiate programmed cell death (apoptosis), eliminating itself from 
the population that otherwise could suffer serious pathological consequences (Figure 1) 
[Nowsheen et al., 2012]. 
The exposure of the cell to DNA damaging agents results in the transcriptional 
upregulation of a large number of genes involved in different processes. The pathways of the 
DNA repair embraces, not only the direct repair of some types of damage (about we will 
discuss later in more detail), but also multiple distinct mechanisms for excising damaged 
bases that are termed nucleotide excision repair (NER), base excision repair (BER) and 
mismatch repair (MMR) (figure 2). The principle of all three mechanisms of repair involves 
splicing out the damaged region and inserting new bases to fill the gap, followed by ligation 
of the backbone [Fagbemia et al., 2011]. The process of NER is biochemically complicated, 
involves as many as 30 distinct proteins, in human cells, that function as a large complex 
called the nucleotide excision repairosome. This 'repair machine' facilitates the excision of 
damaged nucleotides by generating incisions in the flanking regions and removing a fragment 
about 30 nucleotides in length. Damaged bases that are not recognized by the NER machines 
are corrected by BER, whereby the bases are excised from the genome as free bases by a 
different set of repair enzymes. In MMR, incorrect bases incorporated as a result of errors 
during DNA replication are excised as single nucleotides by yet a third group of repair 
proteins (see figure 2). Both NER and BER transpire by somewhat different mechanisms 
depending on whether the DNA damage is located in regions of the genome that are active 
gene expression (transcription-coupled repair) or are transcriptionally silent (global genome 
repair) [Yoshimoto et al., 2012]. 
In addition to the various modes of excision repair that evolved to cope with damaged 
bases or mistakes during replication, the cell frequently can encounter breakage of one or both 
chains of the DNA duplex. Reactive oxygen molecules, cross-linking agent and ionizing 
radiation are prevalent sources of such damage. Double strand breaks (DSB) must be repaired 
to maintain genomic integrity becuase sever the chromosomes, interrupting genetic 
information, and are lethal unless repaired. Several mechanisms for the repair of DSB have 
been elucidated. One of these involves swapping equivalent regions of DNA between 
homologous chromosomes, a process called recombination. This type of exchange occurs 
naturally during meiosis, the special type of cell division that generates the germ cells. It can 
also be used to repair a damaged site on a DNA strand by using information located on the 
undamaged homologous chromosome. This process requires an extensive region of sequence 
homology between the damaged and template strands. Multiple proteins are required for DSB 
repair by recombination and deficiencies in this repair mechanism can cause cancer. An 
alternative mechanism for the repair of DSBs, called non-homologous end joining, also 
requires a multi-protein complex, and essentially joins broken chromosome ends in a manner 
that does not depend on sequence homology and may not be error free (see figure 1) [Kelley 
et al., 2014]. A summary and schematic representation of the arguments above discussed until 
now is shown in Figure 1. 
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Figure 2: Schematic representation of the reaction mechanism of NER, BER and MMR. 
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1.2 Direct DNA repair by alkylation damages 
 
Direct DNA repair mainly repair changes made by intracellular and extracellular chemical 
compounds, which can lead to the formation of covalent bonds with the bases or the backbone 
of the DNA. The alkylating agents are one group of chemicals compounds that can lead to 
DNA damage. They comprise a group of mutagens and carcinogens that can modify DNA by 
alkylation, some are not only widespread in the environment but are also produced 
intracellularly as subproducts of normal metabolism. Alkylation of bases can arrest 
replication, interrupt transcription, or blocking the activation of cell-cycle checkpoints or 
apoptosis. In mammals they could be involved in carcinogenesis, neurodegenerative disease 
and aging [Singer et al., 1976]. 
Alkylating agents can introduce methyl or ethyl groups at all of the available nitrogen and 
oxygen atoms in DNA bases, producing a number of lesions (figure 3). The alkylation 
susceptibility of each site on the bases or backbone varies depending of the compound. The 
majority of evidence indicates that among the 11 identified base modifications two, N3-
methyladenin (N3mA) and O6-methylguanine (O6mG), are mainly responsible for the 
biological effects of alkylation agents [Singer et al., 1976]. Contribution of various lesions 
depends on the type of agent, its reaction mechanism and the secondary structure of the DNA 
target. Based on the reaction mechanism used, alkylating agents can be divided into two 
subgroups. The SN1 reagents, such as N-methyl-N-nitrosourea (MNU) and N-methyl-N’-
nitro-N-nitrosoguanidine (MNNG) use a monomolecular mechanism, while the SN2 ones, that 
include methyl methanesulfonate (MMS), act by a bimolecular mechanism. The SN1 type 
agents introduce alkyl adducts both at N and O atoms; in the case of the SN2 subgroup, N-
alkylation prevails, a summary of the possible alkylation site is shown in Figure 3. The major 
base modifications introduced in doubled stranded DNA by methylating agents are: N7-
methylguanin (N7mG), N3mA, O6mG, while N1-methyladenin (N1mA), N3-methylcytosine 
(N3mC), N7-methyladenin (N7mA) and O4-methylthymine (O4mT) represent minor 
modifications. In single stranded DNA, N1mA and N3mC are more frequent than in double 
strand DNA. The most mutagenic adduct introduced into DNA by methylating agents is 
O6mG. This modification mispairs during DNA replication with thymine leading to GC→AT 
transition, which could be fixed in the genome [Falnes et al., 2003]. The repair of DNA 
alkylation damage can be accomplished by some repair systems as BER, NER and MMR, but 
also directly by methyl transferase or oxidation demethylases. What mechanisms are most 
involved in the repair after exposure to alkylating agents is not yet clear: in principle it is 
assumed that the alkyltransferases and the MMR system are involved in O-alkylation repair, 
while BER and oxidative demethylases repair the N-alkylation [Chaney et al., 1996]. 
The most common strategy used by nature to directly repair alkylation damage is to 
irreversibly transfer the alkyl groups to nucleophilic Cys residues in repair proteins. O6-
Alkylguanine and O4-alkylthymine are repaired in such a manner by the sacrificial protein O6-
alkylguanine-DNA alkyltransferase (AGT or MGMT). The AGT are evolutionary conserved 
DNA repair proteins that represent the main cellular mechanism responsible for alkylguanine 
repair [Pegg, 2011].  
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Figure 3: Possible Sites Base Alkylation. Green arrows indicate most frequent alkylation 
sites; red arrows indicate sites that are most frequently alkylated by SN1 type mechanisms; 
yellow arrows indicate alkylated sites by SN2 type mechanisms. 
 
 
 
1.3 The Alkylguanine-DNA-alkyltransferases 
 
The first AGT to be identified and characterized is the E. coli Ada protein [Olsson et al., 
1980], followed by the human AGT (hAGT) described by the Pegg’s Group in 1991 [Pegg et 
al., 1991]. Then, AGT from two important model organisms as Drosophila melanogaster 
[Kooistra et al., 1999] and Caenorhabditis elegans, were characterised [Kanugula et al., 
2001]. It is important to note that it has been found both in thermophilic bacteria and 
hyperthermophilic Archaea, such as Aquifex aeolicus and Archaeoglobus fulgidus, 
respectively: however, they have been poor characterized because of their low solubility when 
expressed heterologously in E. coli [Kanugula et al., 2003]. Although AGTs are widespread 
proteins, however, no AGT gene was found in plants, the Schizosaccharomyces pombe yeast, 
Deinococcus radiodurans and Thermus thermophilus. 
From the analysis of the primary sequence, a very low homology of the N-terminal 
domain is evident, which also adds to functional diversification, whereas the high 
conservation of the C-terminal domain is expected for the presence of the main motifs, 
including the consensus sequence active site PCHRV, important for performing its proper 
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function. In the figure 4, it is highlighted the high homology of sequence that characterizes C-
terminal domain and how this has been preserved during the course of evolution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Alignment of aminoacid sequences of C-terminal domains from AGT of different 
species. The AGT sequences are from Homo sapiens (Hs), Mus musculus (Mm), Rattus 
norvegicus (Rn), Oryctolagus cuniculus (Oc), Escherichia coli (Ec), Salmonella typhimurium 
(St), Aeropyrum Pernix (Ap), Methanococcus jannaschii (Mj), and Sulfolobus solfataricus 
(Ss). Highly conserved amino acids are shown in red. Similar amino acids or identical to 
human protein are indicated in blue (from [Pegg, 2011]). 
 
 
 
1.3.1 The AGT 3D structure 
 
The three-dimensional structure of these small proteins consists of two domains connected 
by a loop, as reported for the hAGT (figure 5) [Daniels et al., 2000a]. The highly structurally 
conserved C-terminal domain contains the active site pocket that localizes the catalytic 
cysteine within the PCHRV consensus sequence, adjacent to the DNA-binding Helix-Turn-
Helix (HTH) motif. The poorly functionally characterized N-terminal domain displays a low 
degree of primary sequence and structural conservation between different species. The hAGT 
contains 207 amino acids (mw = ca. 22.0 kDa) with Cys145 as the reactive cysteine. Several 
X-ray crystallographic structures of unreacted AGT from human have revealed two-domain 
α/β fold. 
The hAGT N-terminal domain (approximately residues 1-85) does not show significant 
primary structural homology between other AGTs [Daniels et al., 2000a]: this domain 
contains a Zn2+ ion, which is not present in any of the bacterial structures, but is completely 
conserved among the known mammalian sequences. This suggests that the zinc site may be a 
structural role in higher eukaryotes [Daniels et al., 2000b], binding the Cys5, Cys24, His29, 
and His85 residues with tetrahedral coordination of the N-terminal domain, and stabilizing the 
interface between the N- and C-terminal domains [Rasimas et al., 2003a]. 
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Figure 5: Three-dimensional structure of hAGT::DNA complex (PDB ID: 1T38) (adapted 
from [Daniels et al., 2000]). 
 
 
 
The topology of the C-terminal domain is absolutely conserved in all known AGT 
structures. This domain (approximately residues 86-207 in hAGT) contains the conserved 
active-site motif (PCHRV), the O6-alkylguanine binding channel, and the HTH motif. The 
latter element is very common in DNA-binding protein families, including DNA repair 
proteins [Daniels et al., 2004]. Prior to the hAGT–DNA complex structures, HTH motifs of 
DNA repair proteins were thought to interact with the DNA major groove for sequence-
specific recognition. Surprisingly, structural data revealed that the HTH motif of human AGT 
promotes non-classical minor groove DNA binding. The small and hydrophobic nature of the 
recognition helix residues allows this helix to pack closely with the DNA minor groove, 
minimizes sequence-specific interactions, and may also be advantageous for DNA repair and 
nucleotide flipping [Wibley et al., 2000]. The hAGT–DNA complex structures, shown in 
figure 5, confirmed that to gain access to alkylated guanines, hAGT rotates the target base out 
from the DNA base stack into its active site pocket [Daniels et al., 2004, Duguid et al., 2005]. 
DNA binding does not cause evident structural change to the protein itself. However, it does 
result in significant structural changes to the DNA, causing bend roughly 15° away from the 
protein [Daniels et al., 2004, Duguid et al., 2005]. These changes may help to flip-out the 
damaged base from the DNA helix and to promote hAGT cooperative binding to facilitate 
damage recognition. Crystal structures of hAGT in complex with DNA suggest a mechanism 
for 3’ phosphate rotation that induces nucleotide flipping, involving conserved residues 
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Tyr114 and Arg128 [Daniels et al., 2004]. This residue, located at the beginning of the 
recognition helix of the HTH motif (figure 5), is called “arginine finger”, because it 
intercalates via the minor groove between the bases on either side of the substrate guanine 
[Daniels et al., 2004], and interacts via a charged hydrogen bond with the orphaned cytosine 
(previously base paired to the flipped-out guanine) to stabilize the extrahelical DNA 
conformation (figure 5). It may also be involved in scanning for damaged bases by playing an 
active role in pushing out bases. Mutations at Arg128 revealed that the length of this side 
chain is directly proportional to the alkyl transfer rate for methylated DNA, but not for 
binding to the latter [Daniels et al., 2000b]. 
hAGT binds to single- and double-stranded DNA in a highly cooperative manner 
[Rasimas et al., 2003b]. It has been proposed that hAGT detects DNA lesions by searching 
for weakened and/or distorted base pairs rather than for the present of adduct [Duguid et al., 
2005]. This promotes directional bias in repair and helps the search for damaged bases 
through localization of multiple hAGT molecules. Infact the protein repairs O6mG lesions at 
the 5’ end of DNA faster than at the 3’ end in single stranded oligonucleotides with lesions 
near both ends. The 3’-to-5’ kinetic scanning bias, along with the cooperative DNA binding, 
suggest efficient hAGT binding at the 5’ side of a another DNA-binding hAGT molecule 
[Tessmer et al., 2012]. These complexes contain overlapping protein molecules where there is 
little contact between the n protein and proteins n+1 and n+2, but the N-terminal surface of 
the n protein is positioned to contact the C-terminal surface of protein n+3. Such binding 
could facilitate rapid directional scanning and the efficient repair of lesions [Adams et al., 
2009]. 
The active site and HTH motif are stabilizes by a extremely conserved “Asn-hinge” 
(Asn137 in hAGT) [Daniels et al., 2000a] (figure 5). While the C-terminal domain of AGT 
contains the known necessary residues for DNA binding and alkyl transfer, the function of the 
N-terminal domain is still not clear. In an attempt to better understand the role of the N-
terminal domain, the two domains of hAGT have been separately expressed and purified: 
interestingly, the C-terminal domain alone is not active in the absence of the N-terminal [Fang 
et al., 2005]. These data suggest an important structural role for the N-terminal domain, in 
orienting the C-terminal domain for proper catalysis. Notably, two active AGT homologs, 
CeAGT-2 from Caenorhabditis elegans [Kanugula et al., 2001] and AGTendoV from 
Ferroplasma acidarmanus [Kanugula et al., 2005], lack the N-terminal domain. Indeed, 
CeAGT-2 and AGTendoV each possess a long C-terminal extension protruding from the 
AGT domain that is similar to histone 1C and endonuclease V, respectively. These C-terminal 
extensions may be important for proper catalytic orientation of the active sites in these 
homologs. 
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1.3.2 The activity of AGTs 
1.3.2.1 Recognition of lesion and DNA interaction 
 
One of the still obscure but interesting point is how AGTs recognize the lesion of a single 
DNA base between thousands and thousands of nucleotides. Three mechanisms have been 
proposed for this purpose: i) AGT migrates along the DNA and detects lesions by actively 
extruding each base on its active site; this scenario would be very expensive in terms of 
energy and reaction rates (Figure 6a); ii) AGT selectively detects intra-helical lesions 
resulting from non-canonical Watson-Crick couplings, "sensing" the resulting distortion and 
thus extruding only the damaged base (Figure 6b); iii) AGT captures a spontaneously extra-
helical lesion due to the inability of the damaged base to form a stable joint with the base of 
the complementary filament, thus limiting the capture of the base damaged by this passive 
extrusion (Figure 6c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Three possible models to explain the AGT base recognition mechanism. A) In this 
model, the protein actively flip-out each base in the task of the active site, until it finds the 
lesion. B) Model proposed for damage detection by sensing weak sites or helix distortions due 
to non-canonical pairs. C) The DNA repair protein passively acquires a transiently extra-
helical lesion (from [Yang et al., 2009]). 
 
 
 
Distinguishing between three scenarios described is not an easy work, because the direct 
methods of testing AGT do not good to discriminate between the various hypotheses. One of 
the few reported attempts aimed to solve the problem has been to use an EMSA assay 
combined with cross-linking substrates, consisting in appropriate oligonucleotides, in which 
there is a modified cytosine that after reaction covalently binding the protein to the substrate. 
To differentiate between different scenarios, the modified cytosine is coupled with the 
different oligonucleotides with different bases, so that different effects on the double filament 
can be analyzed. The results of this elaborated experiment suggest that while E. coli AGT (C-
Ada) recognizes and captures extra-helical lesions, hAGT actively activates the flipping-out 
of the injured base, being able to sense the distortion caused by incorrect coupling [Duguid et 
al., 2003]. However, kinetic and fluorescence experiments demonstrate that the latter 
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selectively pivoted the pair with unstable clinging [Zang et al., 2005] and it was recently 
proposed that hAGT detects DNA lesions for weakening or distortion in the double helix, 
rather than for the actual presence of the intake [Duguid et al., 2005]. 
 
 
1.3.2.2 The peculiar “suicide” reaction mechanism of AGTs 
 
After nucleotide disposal in the active site, the transfer of the alkyl group to the catalytic 
cysteine occurs (figure 7). This residue remains irreversibly alkylated and the enzyme, upon 
completion of its task, leaving the double filament and releasing the repaired guanine, which 
falls into its usual intra-helical configuration. The selectivity for the nucleotide is due to 
hydrogen bonds and geometric constraints in the active site. The extra-helical base is inserted 
into a hydrophobic tasc, which is defined by the side chain of Met134 and a loop present on 
the active site [Vora et al., 1998]. The conformation of the active site places the Cys145 
thiolate almost in front of the alkyl group in O6. A Glu-His-water-Cys hydrogen bond 
network may increase reactivity of Cys145 in AGT, this hydrogen bond network is conserved 
in AGTs, the consensus sequence PCHRV [Daniels et al., 2000a; 2000b]. 
The AGT hydrogen bond network also places its His146 side chain in a hydrophobic 
environment. It is thought that high reactivity of Cys145 is due to generation of a thiolate 
anion via proton transfer through the network. According to this mechanism for the 
dealkylation reaction, His146 acts as a water-mediated base, while Cys145 acts as the 
nucleophile. These interactions create a suitable environment for nucleophilic attack by the 
anionic thiolate on the carbon of the methyl group (figure 7) [Daniels et al., 2000a; 2000b]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Reaction mechanism of AGTs. The alkyl group at the O6-position of guanine is 
removed in a one step reaction, by the irreversible transfer of the alkylic group onto a catalytic 
internal cystein (adapted from [Mishina, 2006], [Pegg, 2011] and [Perugino et al., 2016]). 
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1.3.2.3 The fate of hAGT after alkylation 
 
All AGTs are degradated upon alkylation. The molecular mechanisms to the base the AGT 
unfolding and degradation, which follow the alkylation of protein, are unclear. The 
conformational changes and modification of intramolecular interactions are likely to be 
associated to each step of the reaction cycle. Data on structure and properties of modified 
hAGT are limited; this is due to the fact that the intrinsic instability of alkylated AGT is an 
important limitation to structural and biochemical studies [Brunk et al., 2013]. Once 
alkylated, tha hAGT is unstable and is rapidly degraded via the ubiquitin/proteasomal system 
[Srivenugopal et al., 1996, Xu-Welliver et al., 2002]. The alkylation induce conformation 
modifications that cause distortion of the DNA binding surface, facilitating the dissociation 
from DNA and the degradation is need to continue repair since the alkylated form interfere 
with repair by active hAGT molecules [Edara et al., 1999] The cause of ubiquitination is 
unknown, it has been postulated that the signal for this degradation is the disruption of a salt 
bridge between Asn137 and the carbonyl oxygen of Met134 due to steric clash of the new S-
alkylcysteine [Daniels et al., 2000b]. Crystal structures of the alkylated form of hAGT show a 
shift in the position of the guanine-binding loop 0.5-1.5 Å away from the protein core when 
compared to the native structure. Alkylation of hAGT at Cys145 leads to a sterically driven 
movement of a helical region that contains Met134 and Arg128 and an opening of the Asn137 
hinge. These changes presumably reveal the sites for ubiquitination [Daniels et al., 2000b]. 
Recently, two glycine residues (G131 and G132) were proposed to be implicated in the 
balance between stability and instability of hAGT, stabilizing the protein in the native form 
and triggering its destabilization upon alkylation, through a still unclear mechanism [Brunk et 
al., 2013]. It is important to emphasize that the 3D structures of modified hAGT were 
obtained from native hAGT crystals flash-frozen upon soaking in solutions containing the 
alkyl adduct and not directly from the modified forms, due that of their strong instability upon 
alkylation [Daniels et al., 2000b]. However, the modified 3D structures showed that C145 
alkylation induces subtle conformational changes at the active site, but these 3D structures 
might not reflect the physiological conformation of the alkylated hAGT, adopted in solution, 
and it is likely that protein movements are restricted in crystals [Daniels et al., 2000b]. 
 
 
 
1.4 The role of hAGT in chemotherapy 
 
The importance of human AGT rises because in some types of tumor high levels of 
protein expression were highlighted, often associated with resistance to alkylating agents. For 
this reason, the human AGT has received attention as a potential target for the development of 
treatments to be integrated into current chemotherapy protocols based on such drugs 
[Sabharwal et al., 2006]. As previously mentioned, many chemotherapeutic drugs used for 
their cytotoxic effects are based on alkylating agents [Chaney et al., 1996]. For example, the 
active intermediate of temozolomide (TMZ) [Tentori et al., 2009] interacts with DNA and 
generats a broad spectrum of methylated adducts, including N7mG N3mA and O6mG. The 
O6mG lesion, although produced in low percentage (~ 8%), is generally considered to be the 
most toxic and mutagenic among those produced by methylating agents. The cytotoxicity is 
highly influenced, in human cells, by the enzymatic levels of hAGT. The number of O6-
methyl-adducts repaired depends on the number of hAGT molecules present in the cell and 
from the ex-novo enzyme synthesis rate. When the cell expresses low concentrations of 
hAGT, the O6mG adducts are not repaired and the cell starts the cell death or apoptosis 
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program [Tentori et al., 1997]. Indeed, if the methyl adducts in the O6 position of guanine is 
not removed by hAGT, O6mG forms altered interactions with cytosine or thymine, this 
resulting in activation of the MMR. It, while acknowledging this mismatch, is unable to 
complete the repair because it can removes the cytosine or thymine, but not methylated 
guanine. The DNA polymerase can’t find the complementary base at O6mG, causing repeated 
activation of MMR. This futile and cyclic activation of MMR causes single and double 
filament breaks, stopping growth with consequent induction of the apoptotic process, this 
cycle is interrupted if high levels of hAGT are present in the tumor cell, reducing the efficacy 
of alkylating drugs [Horton et al., 2009]. It has been reported that high levels of hAGT are 
present in neoplastic cells that make tumors less sensitive to methylating agents. 
The antagonistic action between the effect of alkylating chemotherapies and the protection 
of hAGT is one of the main reasons because cancer cells have resistance to these types of 
drugs. For this reason, some studies suggest that the resistance to chemotherapy may be 
reduced by the inhibition of this class of methyltransferases. For this purpose, several 
approaches have been proposed, among which the most effective has been the combined use 
of alkylating chemotherapeutic agents and inhibitors pseudo-substrates of hAGT 
[McElhinney et al., 2003]. Instead, it has been found that the protein is strongly inhibited by 
O6-benzyl-guanine (O6BG), because the benzyl group is more stabilized on the active site 
[Dolan et al., 1990]. This compound mimics the damaged guanine on the DNA and reacts 
with the protein by covalent transfer of the benzyl group to the active site-cysteine, causing an 
irreversible inactivation of the enzyme. At therapeutic levels, O6BG is not toxic alone, but 
efficiently renders the tumor cells 2- to 14-fold more sensitive to alkylating agents. This 
establishes the potential therapeutic effect of O6BG as an enhancer of these drugs. It was 
proposed that the strongly inhibitory action of this compound could be greater if presented to 
the enzyme in the form of small oligonucleotides, using the ability of the protein to bind to 
nucleic acids. Oligonucleotides that containing more O6BG are potent inhibitors and they are 
a valid alternative to the use of free modified guanines to improve the activity of alkylating 
chemotherapeutic drug in the treatment of some classes of tumors [Luu et al., 2002]. 
 
 
 
1.5 Methods to measure the activity of AGTs 
 
High interest in AGTs is not only in the deepening of critical biological processes, such as 
DNA repair, but also for the development of new and simple, intuitive and economical assay 
to optimize inhibitory molecules of therapeutic interest in the treatment of tumors. Various 
assays for measuring AGT activity are reported in the literature. The first methods developed 
were based on the use of oligonucleotides in which the O6-alkylguanine group was labeled 
with radioactive isotopes (3H or 14C). Later with proteinase K it was done a proteolytic 
digestion of proteins and after an automatic amino acid analyzer were measured S-
methylcysteine levels in lysate [Olsson et al., 1980]. A very similar radioactive assay, but 
simpler and quicker, was just put on. In this procedure the terminal oligonucleotide was 
labeled with the radioactive phosphorus isotope and a modified guanine was inserted in a 
DNA sequence for a methylation-sensitive restriction enzyme. In this way, it was possible to 
investigate in which tumor and/or physiological tissue was removed the methyl and so to 
identify where the activity was present [Wu et al., 1987]. A similar, but improved procedure, 
was used by the Ciaramella’s group to identify for the first time the activity of the OGT of 
Sulfolobus solfataricus (SsOGT): this assay has the advantage of analyzing digested fragment 
directly by electrophoresis on polyacrylamide gels [Perugino et al., 2012]. In figure 8 is 
shown the experiment that demonstrated the alkyltrasferase activity of SsOGT. This method 
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was then made more precise, but less simple to done, by subsequent separation of digested 
oligonucleotides by HPLC. The separation allowed knowing the concentration of active AGT 
after measurement of the radioactivity of the peak corresponding to the digested fragment 
[Klein et al.., 1992]. Similarly, the Luu’s group developed analysis of hAGT reaction 
products in 2002, based on HPLC separation. This assay investigated the degree of inhibition 
of oligonucleotides having O6mG or O6BG in different positions which ranged from end 3 'to 
end 5' and whether they could be used as chemotherapeutic agents. IC50 values were obtained 
by quantifying the active protein remaining after radioactive DNA reaction. [Luu et al., 2002]. 
All of these asseys allowed for direct measurements of protein activity, however, the use of 
radioactive materials and chromatographic separations, although reliable and accurate, are 
long, laborious and unsafe methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Radioactive assay for SsOGT. In this experiment, set up by the Ciaramella’s group, the 
SsOGT alchyltrasferase activity was addressed. Left panel, the schematic rappresentation of 
experiment; on the right pannel the electrophoresis on polyacrylamide gels is reported (from [Perugino 
et al., 2012]). 
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1.6 Biotechnological uses of AGTs 
 
The specific labeling of proteins in living cells with synthetic probes is an important 
approach to study protein function. One way to achieve such a labeling is through expression 
of the protein of interest as a fusion protein with an additional polypeptide, called tag, which 
mediates the labeling. For example, these tags allow to simplify and optimize purification 
methods (affinity tags), simplify and optimize detection procedures (by using specific 
antibodies) and allow following the proteins in vivo [Johnsson et al., 2003]. Factors that affect 
the feasibility and attractiveness of such an approach are: i) the size of the tag; ii) the 
specificity and speed of the labelling; iii) the availability of a broad range of different probes 
and iv) properties of the tag that affect the function of the fusion protein, such as tag-
dependent localization or stability. However, most of them do not satisfy all features listed 
first, for example the Aequora victoria green fluorescent protein (GFP) [Tsien, 1998] have 
some disadvantages like: relative big dimensions, insensibility to all possible changes of the 
cellular environment in terms of pH, hydrophobicity and ionic concentrations, incompatibility 
in all applications concerning anaerobic conditions and, although few examples of 
thermostable GFP variants were applied in thermophilic microorganisms [Cava et al., 2008], 
the general use of most protein-tags is restricted only in mesophiles and in mild reaction 
conditions. 
The unusual covalent linkage established between the AGT protein and its substrates has 
been exploited for biological applications, ranging from the specific quantification of hAGT 
to using in fusion proteins, for in vivo fluorescent labeling. All of the uses are made possible 
due to the high tolerance of hAGT toward transfer of various large alkyl-groups on the O6-
position of guanine, without neglecting the advantage of their small protein size. The hAGT 
has been exploited for other applications completely removed from its DNA repairing 
function. In 2003, Kai Johnsson’s group has pioneered the use of hAGT fusion proteins as in 
vitro and in vivo biotechnology tools, which led to the commercialization of these hAGT 
variants, namely SNAP-tag™ and CLIP-tag™ (New England Biolabs) [Juillerat et al., 2003]. 
Evolved hAGT variants possess high reactivity for transferring large alkyl groups on the O6-
position of guanine free base to the reactive Cys residue of the protein [Juillerat et al., 2003]. 
Thus, bifunctional small molecules which contain O6BG conjugated through the benzyl group 
to a probe molecule can be prepared as good substrates for the hAGT mutants [Damoiseaux et 
al., 2001]. The SNAP-tag™ can be fused with other proteins of interest: expressing the fusion 
protein inside cells followed by incubation with the bifunctional molecule leads to in vivo 
labeling of the fusion protein with the probe (figure 9) [Keppler et al., 2003]. Fluorescent 
probes have been used to determine the location of the target protein [Keppler et al., 2004]. 
The same concept has been used for in vitro immobilization of fusion proteins as well. In this 
case the alkyl group of O6-alkylguanine is a tether attached to a surface. Transfer of the alkyl 
group to hAGT anchors the fusion proteins to that surface [Kindermann et al., 2003]. This 
offers a mild condition for fixing a wide range of proteins on a surface for evaluating their 
functions. However, being originated by the hAGT, a serious limitation of using these 
mesophilic tags is, the application to extremophilic organisms and/or to harsh reaction 
conditions.  
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Figure 9: The SNAP-tag™ technology. SNAP-tag™ is an engineered version of hAGT, for 
the specific in vivo and/or in vitro labelling of fusion proteins with small molecules of interest 
(indicated with a blue square) conjugated with the O6BG moiety (adapted from [Keppler et 
al., 2003]). 
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1.7 The Sulfolobus solfataricus OGT (SsOGT) 
 
Among thermophilic archaea, the Sulfolobus solfataricus OGT (SsOGT) has been 
extensively characterized by the fact that, contrary to previous homologues, the 
heterologously expressed E. coli protein is soluble, very stable and easy to purify [Perugino et 
al., 2012]. 
In Sulfolobus solfataricus the open reading frame (ORF) n. SSO2487 encodes for a 
protein of 151 amino acids, of a total molecular mass of 17 kDa expressed heterologously in 
E. coli, widely characterized and classified as O6-alkylguanine-DNA-alkyltransferase 
[Perugino et al., 2012]. As expected, alignments of sequences of SsOGT with hAGT and 
homologous to other thermophilic organisms show a high sequence identity mainly in the C-
terminal portion involved in catalytic activity and DNA binding. 
SsOGT has a high thermal stability at 80 °C and the enzyme has a maximum activity at 80 
°C, but it is important to note that it is active even at lower temperatures, as low as 25 °C. It is 
able to work under various reaction conditions such as pH extremes (5.0 - 8.0), high ionic 
strength (up to 2M NaCl) and in the presence of detergents such as Tween 20 (0.5%), Triton 
X-100 (1.0%) and Sarcosyl (0.5%) [Perugino et al., 2012]. In addition, it can also function in 
the presence of EDTA, confirming the lack of any structural zinc ion [Perugino et al., 2012]. 
The biochemical characterization of SsOGT was carried out through the development of 
an innovative assay, based on the use of a commercial fluorescein derivative of the O6BG 
inhibitor (SNAP-Vista Green™) (figure 10a). Given the irreversible reaction of the protein, 
the stoichiometric ratio between protein and inhibitor is 1:1: so the amount of covalently 
bound probe (measured by fluorimetric techniques) is a direct measure of protein activity, and 
the complex can be analyzed under denaturing conditions. This made possible to calculate the 
kinetic constants for this complex (figure 10b) [Perugino et al., 2012]. By following this 
approach, it was also possible measure the activity of SsOGT on its natural substrate 
(methylated DNA), using the latter as non-fluorescent competitor of the SNAP-Vista Green™: 
the measured fluorescence reduction was a function of concentration of the competitor (figure 
10c). The affinity for methylated DNA was determined through the rules of the classical 
competitive inhibition [Perugino et al., 2012]. This new assay has also been used for the 
biochemical characterization of Mycobacterium tuberculosis (MtOGT) and relative mutants 
[Miggiano et al., 2013]. A schematic rappresentation of this set of experiment on SsOGT is 
reported in figure 10, describing a general method to measure the activity of all O6BG-
sensitive AGTs. 
In SsOGT highly conserved residues are involved in the repair of damaged DNA, such as 
residues forming the helix recognition and the role of Arg102 and Tyr90 in extrusion of the 
damaged base. The role of HTH in binding to DNA and the role of Arg102 in flipping-out 
have been confirmed by EMSA assays with SsOGT mutants. Indeed, H5 mutant, containing 
five mutations in HTH (S100A, R102A, G105K, M106T, K110E), shows a complete loss of 
binding to DNA, but mantaining its activity on free synthetic substrates [Perugino et al., 
2012]. The mutant R102A, lacking the "arginine finger", shows a reduced binding activity at 
the double helix, confirming its involvement in the flipping-out of the damaged base. These 
experiments also showed a cooperative manner in protein binding DNA [Perugino et al., 
2012]. Interesting results were obtained from the in vivo study of SsOGT. Although in 
Sulfolobus cells the levels of its mRNA increase following treatment with the alkylating 
agent, the Western Blot data using an α-SsOGT antibody show a decrease in intracellular 
protein, proportionally to time and at doses of treatment with the alkylating agent [Perugino et 
al., 2012]. This experimental evidence show that SsOGT after alkylation, such as hAGT and 
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other examples of eukaryotic organisms, is irreversibly inactivated and then subjected to 
degradation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: The new fluorimetric assay for AGTs. A) In vitro labelling of SsOGT with 
commercially SNAP™ substrates, which are O6BG-derivatives (in black) with different types 
of fluorophores. After the reaction with SsOGT, it is possible to follow the labeling for gel 
imaging; B) The direct activity assay: fluorescence intensity data give a direct value of the 
amount of covalently modified protein (in pmol) and allow to calculate kinetic constants for 
the SsOGT reaction. k1= rate of covalent linkage. KS= dissociation constant for the free 
enzyme and free substrate during the first collision step, before covalent modification. C) The 
competition assay: using the natural and non-fluorescent substrate (methylated DNA) together 
with SNAP-Vista Green™, it is possible to calculate the KDNA inhibitory constant: all the 
linearized plots reached a similar intercept, but showing a rising slope with increasing 
concentration of ds-UPm, confirming that both substates compete for the same active site. 
(adapted from [Perugino et al., 2012]). 
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2. Purpose of the thesis 
 
DNA alkyltransferases are conserved proteins that catalyze repair of alkylation damage by 
a mechanism involving the transfer of the alkylic group from O6mG to a cysteine residue in 
their own active site. AGTs are called suicide proteins because the alkylated form of the 
protein is irreversibly inactivated. In human cells, alkylated AGT is rapidly directed to the 
degradation ubiquitin pathway due to alkylation-induced conformational change that turns the 
protein into a proteolysis-sensitive form. Although AGT protects from mutagenic and 
carcinogenic effects of alkylating agents, in humans, it also plays a role in the onset of 
resistance to alkylating agents used in the treatment of several cancer types. Inhibition of 
human AGT is a potential strategy to improve the efficacy of anticancer alkylation 
chemotherapies but for this purpose is necessary know as much as possible on its mechanism 
of action. For this reason, biochemical and structural investigations on AGT and relative 
mutants, mimicking changes occurring in vivo, could provide new insights on the meccanisms 
of protein binding to DNA and its stability after alkylation.  
In my present work, I show biochemical, structural and mutational analysis of two AGTs, 
from Sulfolobus solfataricus (SsOGT) and Mycobacterium tuberculosis (MtOGT). 
SsOGT is intrinsically stable at high temperatures and to common denaturing agents 
[Perugino et al., 2012]: for these reasons, it resulted a convenient model to unravel structure 
modifications after upon alkylation. Like the modified hAGT (obtained only by soaking 
protein crystals in substrate solutions [Daniels et al., 2000b]) the methylated form of SsOGT 
was unstable at its physiological temperatures (> 70 °C) and precipitates in solution; however, 
the Sulfolobus AGT resulted soluble and stable at mesophilic temperatures (as high as 40 °C). 
This great stability allows deep analysis of the protein in its post-reaction form. In this way, 
the structure could mantain the physiological conformations upon protein alkylation, and tries 
to unravel those conformational changes, which were not possible to observe in hAGT since 
the movements are forced by the crystalline grind.  
Furthermore, the identification and the characterization of this thermophilic AGT 
[Perugino et al., 2012] could be a candidate to extend the SNAP-tag™ technology to extreme 
environments. To this aim, we consider the SsOGT-H5 mutant, because it lacks of any DNA 
binding activity and a marked catalytic efficiency with the fluorescent BG-derivatives. 
Furthermore, likely its relative wt enzyme, it displays a marked stability to wide range of 
temperatures, pH, ionic strength and to common denaturing agents [Perugino et al., 2012]. 
The MtOGT encodes for a sequence (adaB; Rv1316c) part of an adaptive response operon 
and associated with the virulence of Mycobacterium tuberculosis strains. The amino acid 
sequence of this protein is very similar to hAGT and shares with this latter its mesophilic 
characteristics. In addition, certain AGT variants are associated with the virulence of 
Mycobacterium tuberculosis species and it is interesting that a number of multidrug-resistant 
strains are characterized by possess mutated OGT that carrying an amino acid substitution of 
N- terminal domain. It has been suggested that a defective alkylated-DNA repair could have 
played a role in the balance between genomic stability preservation and adaptability to host 
during the evolutionary history of the pathogen [Miggiano et al., 2013]. 
From resolution of the 3D structure of MtOGT complexed with a modified DNA 
molecule, we can reveal similar or peculiar traits when compared with the equivalent structure 
of hAGT. The crystal structure of the complex could show features of the protein–protein and 
protein-DNA interactions occurring during alkylated DNA binding. Finally, biochemical and 
structural characterization of protein and relative variants at the N- and the C-terminal 
domains could highlight how this protein contributes to protect the bacterial GC-rich genome 
against the mutagenic lesion of O6mG in DNA. 
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ABSTRACT
Alkylated DNA-protein alkyltransferases repair alky-
lated DNA bases, which are among the most com-
mon DNA lesions, and are evolutionary conserved,
from prokaryotes to higher eukaryotes. The human
ortholog, hAGT, is involved in resistance to alky-
lating chemotherapy drugs. We report here on the
alkylated DNA-protein alkyltransferase, SsOGT, from
an archaeal species living at high temperature, a
condition that enhances the harmful effect of DNA
alkylation. The exceptionally high stability of SsOGT
gave us the unique opportunity to perform struc-
tural and biochemical analysis of a protein of this
class in its post-reaction form. This analysis, along
with those performed on SsOGT in its ligand-free and
DNA-bound forms, provides insights in the structure-
function relationships of the protein before, during
and after DNA repair, suggesting a molecular basis
for DNA recognition, catalytic activity and protein
post-reaction fate, and giving hints on the mecha-
nism of alkylation-induced inactivation of this class
of proteins.
INTRODUCTION
Alkylated DNA-protein alkyltransferases (AGTs, MGMTs
or OGTs, EC 2.1.1.63) are conserved proteins that repair
alkylation damage in DNA, manly at position O6 of gua-
nines. They use a peculiar single-step mechanism in which
the direct repair of the alkylated base is coupled with irre-
versible alkylation of the catalytic cysteine in the protein ac-
tive site. The trans-alkylated protein is permanently inacti-
vated and prone to degradation both in vivo and in vitro (1–
4). Most knowledge these proteins comes from classic stud-
ies on Ada-C and OGT of Escherichia coli, as well as the
human hAGT (1–4). In light of the observation that hAGT
over-expression in tumor cells is frequently associated with
resistance to alkylating agents, hAGThas received attention
as a potential target for the development of treatments to be
integrated into current chemotherapy protocols based on
such drugs (5).
The current understanding of the AGTsmolecular mech-
anism responsible for alkylated DNA recognition and re-
pair is mainly based on the 3D structures of hAGT and
its complex with double-stranded (ds) DNA molecules (6–
9). The protein contacts the DNA minor groove through
the helix-turn-helix (HTH) motif of its C-terminal domain.
By adopting an extra-helical conformation stabilized by an
‘arginine finger’ (R128) of the HTH, the damaged base is
deeply inserted in the protein active site, and the alkyl moi-
ety is then transferred to the catalytic cysteine (C145). Data
on structure and properties of alkylated AGTs are limited,
because alkylation greatly destabilizes their folding; as for
3D structures, the only available are those of the methylated
(hAGTm) and benzylated (hAGTb), which were obtained
from native hAGT crystals flash frozen upon soaking in
solutions containing O6-methyl- (O6-MG) and O6-benzyl-
guanine (O6-BG), respectively (7). The hAGTm and hAGTb
structures showed that C145 alkylation induces subtle con-
formational changes at the active site; however, these struc-
tures might not reflect the physiological conformation of
the alkylated hAGT, since in the crystalline state the pro-
tein could not accurately display the conformation adopted
in solution. Indeed, it is likely that protein movements are
restricted in crystals, and larger rearrangements may lead to
crystal decay (7).
Alkylation-induced instability of AGTs is interesting
from both a biological andmechanistic point of view. AGTs
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degradation is an important process in the organisms’ re-
sponse to alkylation damage; in human cells, hAGT physi-
cally associates and undergoes repair-mediated degradation
with the BRCA2/FancD1 protein (10). Germlinemutations
of Brca2 are associated with cancer prone syndromes and
Fanconi anemia, and absence of a functional BRCA2 pro-
tein induces increased cell sensitivity to DNA crosslinking
agents (10); thus, hAGTactivity and degradationmight also
affect other DNA repair pathways. The relation between
active site modification and protein unfolding/degradation
has been difficult to study due to the instability of alkylated
AGT forms. In vivo, conformational changes might expose
residues, which are target for ubiquitination, thus triggering
the protein degradation; on the other hand, alkylated hAGT
is also intrinsically unstable in vitro (7,11). It has been sug-
gested that alkylation-induced conformation modifications
induce distortion of the DNA binding surface, facilitat-
ing the dissociation of alkylated hAGT from DNA, while
destabilizing the protein native fold (7,12,13). Recently, two
glycine residues (G131 and G132) were proposed to be im-
plicated in the balance between stability and instability of
hAGT, stabilizing the protein in the native form and trig-
gering its destabilization upon alkylation, through a still un-
clear mechanism (14).
AGTs are present in organisms from the three living do-
mains (Eucarya, Bacteria, Archaea). In thermophilic bac-
teria and archaea, living at >80◦C, alkylation damage is a
serious harm since alkylated bases are unstable at high tem-
perature and induce DNA ruptures (15,16). We have previ-
ously reported on OGT from the archaeon Sulfolobus sol-
fataricus (SsOGT), a protein with outstanding stability at
high temperature, which, upon alkylation, becomes unsta-
ble and undergoes degradation in vivo, suggesting that it fol-
lows the same fate as hAGT (17,18).
We present here a biochemical, structural andmutational
analysis of SsOGT. The crystal structure of the ligand-free
protein and its complex with anO6-MG containing dsDNA
revealed overall similarities with the corresponding struc-
tures of hAGT, but also peculiarities, which were found
to have functional significance. Moreover, in contrast to
the corresponding hAGTm, the methylated form of SsOGT
(SsOGTm) was soluble and relatively stable, thus allowing
in-deep analysis of the protein in its post-reaction form.
Structural and biochemical analysis of SsOGTm, as well
as of a mutant mimicking the presence of a bulkier adduct
in the active site (C119L), suggested a possible mechanism
of alkylation-induced SsOGT unfolding and degradation.
Based on our data, we suggest a general model for themech-
anism of post-reaction AGTs destabilization.
MATERIALS AND METHODS
DNA mutagenesis and protein purification
Site-directed mutants were obtained by using the oligonu-
cleotide ‘mut’ and ‘rev’ pairs (Supplementary Table S1)
and the GeneTailorTM Site-Directed Mutagenesis System
(Invitrogen); the template was the S. solfataricus ogt gene
cloned in the pQE31TM vector (17). N-terminally His-
tagged proteins were expressed in theE. coliABLE-C strain
and purified as described (17).
Fluorescent assays for O6-alkyl-guanine alkyltransferase ac-
tivity
SsOGT activity was determined by a fluorescent assay, by
using the SNAP-Vista GreenTM (BG-VG) substrate un-
der the standard reaction conditions as previously reported
(17,19). After SDS-PAGE, fluorescent protein bands were
visualized by gel imaging using the VersaDoc 4000TM sys-
tem (Bio-Rad). The fluorescence intensity of each band was
corrected for the amount of protein loaded by Coomassie
Blue staining. Determination of pseudo-first-order reaction
rate values was carried out under standard conditions, tak-
ing protein aliquots at different times. Second-order rate
constants were then obtained by dividing values by the sub-
strate concentration (17,20).
Direct DNA repair activity
The efficiency of repair of ds oligonucleotides containing
a single O6-MG was determined by incubation of fixed
amounts of protein (5 !M) for different timespans at
25◦C in the presence of increasing concentrations of the
ds-Fwdm26 oligonucleotide. Then, 10 !M of BG-VG was
added, incubation was prolonged for 2 h and samples an-
alyzed by SDS–PAGE. Gel imaging and Coomassie correc-
tion was performed as described above.
Competition assay with non-fluorescent O6-methyl-guanine
containing DNA
The efficiency of repair of ds oligonucleotides containing
a single O6-MG was determined by using the half maxi-
mal inhibitory concentration (IC50) method, where IC50 is
the concentration of methylated DNA needed to reduce by
50% the fluorescence intensity of the SsOGT band in reac-
tions containing fixed concentrations of the fluorescent BG-
VGmolecule (Supplementary Figure S1A). Reactions were
incubated at fixed temperatures with increasing concentra-
tions (0–10 !M) of the appropriate methylated oligonu-
cleotide. Gel imaging and Coomassie correction were per-
formed as described above; corrected data of fluorescence
intensity were fitted with the IC50 equation. For competitive
inhibition, the affinity of the inhibitor (KDNA) is related to
the IC50 value by the adapted Cheng-Prusoff Equation (1)
(21):
KDNA = IC50
/
[1+ ([VG]/KVG)] (1)
where KDNA is the binding affinity of the inhibitor, IC50 is
the functional strength of the inhibitor, [VG] and KVG are
the VG concentration and the concentration of the BG-VG
substrate at which enzyme activity is half maximal, respec-
tively (17).
Electrophoretic mobility shift assay
A tetramethylrhodamine labeled dsDNA probe was pre-
pared by annealing the oligonucleotides A+ and D−, as re-
ported (Supplementary Table S1; 17). Different amounts of
protein (0.0–25.0 !M) were incubated at 37◦C for 10 min
with the probe (0.2 !M), in a total volume of 10.0 !l, as
described (17). After loading the sample on an 8% poly-
acrylamide native gel run in 1X TBE (90.0 mM Tris-HCl,
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90.0 mM boric acid, 2.0 mM EDTA, pH 8.3), signals were
measured by gel imaging, using a green LED/605 band-
pass filter as excitation/emission parameters, respectively.
For DNA binding assay with unlabeled dsDNA oligonu-
cleotides containing O6-MG, samples were prepared as de-
scribed above, except that, after electrophoresis, gels were
stained with ethidium bromide (10 mg/ml) for 15 min at
RT.
Protein stability assays
Thermal stability was determined by two different methods.
(i) temperature-induced aggregation: 30 !l aliquots of 5.0
!M (0.1 mg/ml) of each protein were incubated for 20 min
at different temperatures in PBS 1X buffer, centrifuged for
20 min at 16 000 × g, and 20 !l of supernatant were imme-
diately loaded on 15% SDS-PAGE. The relative intensity
of Comassie-stained SsOGT bands were plotted as a func-
tion of temperature, considering as 100% the intensity of
each protein band incubated at 25◦C. Reported data are the
mean ± SD of three independent experiments; (ii) Differ-
ential Scan Fluorimetry (adapting the protocol described in
22): each protein (25 !M; 0.5 mg/ml) was incubated in PBS
1X buffer and SYPRO Orange dye 1X, in a total volume
of 30 !l. Samples were heated from 20 to 95◦C in a Real-
Time Light Cycler (Bio-Rad, Milan, Italy). Thermal stabil-
ity scans were performed at 0.2◦C/min (5 min/cycle with an
increase of 1◦C/cycle). Data were normalized to the maxi-
mum fluorescence value within each scan. Relative fluores-
cence intensities were plotted as a function of temperature;
the obtained sigmoidal curve describes a two-state transi-
tion, where the Tm value represents the inflection point of
the transition curve, as described by the Boltzmann Equa-
tion (2),
y = LL+ (UL− LL)
1+ exp (Tm−xa ) (2)
where the values of minimum and maximum fluorescent in-
tensities are LL and UL, respectively, and a represents the
slope of the curve within Tm (22). Data are the mean ± SD
of three independent experiments.
Data analysis
Corrected datawere fitted to appropriate equations by using
GraFit 5.0 Data Analysis Software (Erithacus Software) or
Prism Software Package (GraphPad Software) (23).
Preparation of SsOGTm
20 ml of 10 !M of the SsOGT wt protein were incu-
bated at 25◦C for 24 h in the presence of O6-MG (10
mM, protein:inhibitor ratio 1:1000). To test the efficiency
of methylation, an aliquot containing 50 pmols (1.0 !g)
of SsOGT from the methylation reaction was incubated
with an equimolar amount of BG-VG at 70◦C for 30 min
and subsequently subjected to SDS-PAGE and fluorescence
imaging: no fluorescent signal was detected, confirming the
complete methylation of the protein. Unreacted inhibitor
was removed using aHiTrapDesaltingTM (GE, Healthcare)
column pre-equilibrated in PBS 1X.
Preparation of SsOGT-C119A::dsDNAm complex
To obtain the modified dsDNA molecule used
in co-crystallization experiment (dsDNAm), the
O6-methylguanine-containing oligonucleotide (5′-
GCCATG[O6-MG]CTAGTA-3′, Primm, Milan, Italy)
was annealed to the complementary oligonucleotide
5′-TACTAGCCATGGC-3′ (Eurofins MWG Operon).
The resulting sample was mixed with the C119A protein
solution (7 mg/ml in 20 mM phosphate buffer, pH 7.3 and
150 mM NaCl) at a protein:DNA molar ratio of 1:1.2, and
incubated 1 h at room temperature before crystallization
trials.
Crystallization and data collection
Initial crystallization conditions for wild type, C119L and
SsOGTm proteins and for the C119A::dsDNAm complex
were identified by means of a robot-assisted (Oryx4; Dou-
glas Instruments), sitting-drop-based spare-matrix strategy
using screen kits from Hampton Research and Qiagen.
Wild-type SsOGT crystals grew at 4◦C in 4 !l drops ob-
tained by mixing equal volumes of 9 mg/ml purified pro-
tein solution and precipitant 0.35 M potassium nitrate and
1.6 M ammonium sulfate in a final droplet volume of 1 !l.
A single crystal was cryo-protected in precipitant solution
containing 15% glycerol, mounted in a cryo-loop, and flash-
frozen in liquid nitrogen at 100 K for further X-ray diffrac-
tion analysis. Single crystal diffracted at 1.85 A˚ of resolution
at the ID23 synchrotron radiation (" = 0.87 A˚) (European
SynchrotronRadiation Facility [ESRF],Grenoble, France).
The diffraction data were indexed with XDS program (24),
whose indexing score assigned crystal to the trigonal space-
group R3 with the cell dimension a = 94.72 A˚ b = 94.72
A˚ c = 76.70 A˚. Crystals of C119L mutant (8 mg/ml) were
identified in the initial crystallization trials in the condition
containing 4 M sodium formate as reservoir solution in a
protein to reservoir ratio of 1:1, in a final droplet volume
of 1 !l. Single crystal suitable for X-ray diffraction was ma-
nipulated as previously describe for wild-type protein and it
diffracted at 2.6 A˚ of resolution at 100K at the ID23 beam
line (" = 1.89 A˚) (ESRF, Grenoble, France). Indexing pro-
cess with XDS program assigned the crystal to the cubic
I432 space-group with the dimension a= b= c= 140.56 A˚.
SsOGTm, obtained as described above, was concentrated to
7 mg/ml. Well-shaped single crystals grew in a 1 !l droplet
containing equal volumes of protein and reservoir solution
(0.1 M Bis-Tris pH 5.5, 0.1 M ammonium acetate, 17% w/v
PEG 17000). Data collection was performed at BM30 syn-
croton radiation (" = 0.979 A˚) (ESRF, Grenoble, France),
under cryogenic condition using 15% glycerol as cryo pro-
tectant in reservoir solution. The best crystal diffracted at
2.8 A˚ of resolution and it was assigned to the orthorhombic
space group P212121 with the cell dimensions a = 48.49 A˚
b = 50.22 A˚ c = 142.02 A˚, containing 2 molecule for asym-
metric unit, with a Matthews parameter and a solvent frac-
tion of 2.28 A˚3 Da−1 and 45.98%, respectively. C119A::O6-
MG-DNA single crystals grew in approximately 1 week in
a 1 !l droplet of equal volume of protein-DNA complex
solution and reservoir solution composed by 0.2 M Na/K
tartrate 20% (w/v) PEG 3350. Diffraction experiments were
conducted at 100 K using synchrotron radiation ("= 0.972
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A˚) at the ID29 (ESRF, Grenoble, France). Data collection
was performed up to 2.7 A˚ of resolution. Indexing score
withXDS assigned crystal to the orthorhombic space group
P212121 with the cell dimensions a = 41.76 A˚ b = 65.88
A˚ c = 97.52 A˚. For all data sets described above, further
data manipulations were carried out using COMBAT and
SCALA from the CCP4 program suite (25). The data statis-
tics of the solved structures are summarized in Table 1.
Structure determination, model building and refinement
The initial phases for wild-type SsOGT, C119Lmutant and
SsOGTm structures were generated by molecular replace-
ment with the program PHASER (26) of the PHENIX soft-
ware suite (27) using Sulfolobus tokodaii OGT structure
(PDB ID code:1WRJ) as the search model. The starting
search model for C119A::O6-MeG-DNA complex struc-
ture consisted of Sulfolobus tokodaiiOGT structure and the
double stranded, methylated DNAmolecule as crystallized
in complex with hAGT (PDB ID code: 1T38) for the protein
and DNA component, respectively. Initial model building
was performed using AUTOBUILD of the PHENIX suite
(28) followed by manual model building with the program
COOT (29). Solvent molecules were added by ARP/wARP
SOLVENT program from CCP4 program suite followed by
structure refinement that was done with PHENIX (27). In
the refined SsOGTm structure we noticed a large difference
between Rwork and Rfree values. We deeply investigated all
possible space groups suggested by the XDS analysis, and
acceptable statistics could only be obtained by processing
data in the space group P212121. Similarly an unambiguous
solution of molecular replacement could only be found in
P212121 space group. All figures illustrating structural anal-
yses were generated with PyMol (http://www.pymol.org/)
(30).
Protein structure accession numbers
The atomic coordinates and structure factors of the SsOGT
wild type, C119L mutant, SsOGTm and C119A::dsDNAm
have been deposited in the Protein Data Bank (http://www.
rcsb.org) under the accession codes 4ZYE, 4ZYH, 4ZYG,
and 4ZYD, respectively
RESULTS
Structure-function analysis of free SsOGT
The crystal structure of SsOGT was solved at 1.8 A˚ resolu-
tion (Table 1). As observed for all AGTs structures present
in the Protein Data Base (6–9,19,31–34), SsOGT folds in
two domains joined by a long connecting loop (a.a. 54–69)
(Figure 1A). The N-terminal domain (a.a. 1–53) consists of
an anti-parallel #-sheet, connected to a conserved $-helix
(H1) by a random-coiled region, which is stabilized at its
N-side by a disulphide bridge established between the C29
and C31. The C-terminal domain (a.a 70–151) houses the
functional elements required for DNA binding and repair:
(i) the catalytic C119 residue within the conserved PCHR
signature; (ii) the helix-turn-helixmotif (HTH), which binds
theDNAminor groove and holds the arginine finger (R102)
that participates to the modified base flipping out from the
DNA base stacking; (iii) the ‘asparagine hinge’ that, to-
gether with the helix H4 of the HTH, defines one wall of
the ligand-binding pocket; and (iv) the active site loop on
the H4-facing side of the active site (Figure 1A). Previously,
we demonstrated that mutation of the R102 residue reduces
DNA binding efficiency, whereas mutation of five residues
in theHTHmotif abolishes the protein ability to form stable
complexes with DNA, although both mutants are normally
proficient in the trans-alkylation reaction (17).
An interesting feature, not previously reported for other
AGTs, is the C29-C31 S-S bridge of the N-terminal do-
main. To test its role in the SsOGT activity and stability,
we produced the C29A mutant, which resulted as active
as the wild-type protein in repair of a O6-MG-containing
ds oligonucleotide at 50◦C (Supplementary Figure S1B).
In contrast, the C29A mutant was significantly less ther-
mostable than the wild-type (Figure 1B): incubation at in-
creasing temperatures showed that, whereas the wild-type
protein remained 100% soluble after 20 min at 70◦C, the
C29A protein aggregated above 60◦C. Quantitative analysis
by Differential Scanning Fluorimetry (DSF) allowed calcu-
lation of a Tm of 80◦C for SsOGT and 60◦C for C29A (Fig-
ure 1C). Thus, the S-S bond is not involved in DNA repair
activity, but is an important structural element contributing
to the impressive thermal stability of SsOGT.
Alkyltransferase-like proteins (ATLs) share structural
similarity with AGTs, but are catalytically inactive and are
believed to act as DNA damage sensors (35). Although the
general fold is shared by hAGT and Schyzosaccharomyces
pombe ATL1, important differences were found in the cat-
alytic loop and Asn hinge, resulting in larger size of the
lesion-binding pocket in ATL1, which might account for
its broad lesion recognition range (36). Superimposition of
SsOGT, ATL1 and hAGT structures showed the same dif-
ferences, confirming the higher similarity of SsOGT with
hAGT as comparedwithATL1 (Supplementary Figure S2).
Structure-function analysis of dsDNA-bound SsOGT
Different strategies have been adopted to trap the AGT-
alkylated dsDNA complex and solve its structure: the wild-
type hAGT has been crystallized crosslinked to oligonu-
cleotides containing alkylated guanine analogues (8,9), and
the hAGT C145S inactive mutant was co-crystallized with
a more physiologic, O6-MG-containing, 13 base pair long
oligonucleotide (dsDNAm) (8). These DNA-bound hAGT
structures were found essentially superposable to each other
and to ligand-free hAGT, suggesting that binding to DNA
does not affect the protein overall structure (8,9).
To solve the SsOGT DNA-bound crystal structure, we
obtained the C119A mutant, carrying a substitution of the
catalytic C119 to prevent protein alkylation and subsequent
dissociation from the repaired DNA substrate (data not
shown). The crystal structure of the C119A::dsDNAm (Fig-
ure 2A) was solved at 2.7 A˚ resolution (Table 1), revealing
that a single SsOGT monomer is able to occlude 4 base-
pairs (bp) on dsDNA substrate, paralleling what observed
for DNA-bound hAGT (37–39). The crystal structure of
the ligand-free protein and of the C119A::dsDNAm com-
plex can be superposed with a 0.3 A˚ average root-mean-
square deviation (r.m.s.d.) of C$ positions. Assuming that
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Figure 1. Structure–function of SsOGT. (A) Cartoon representations of the crystal structure of wild-type ligand-free SsOGT. Secondary structure elements
and functional domains/motifs are indicated; residues commented through the text appears as sticks. (B) Thermal stability of the C29A mutant. The
indicated proteins (0.1 mg/ml, 5 !M) were incubated for 20 min at the indicated temperatures; after incubation, samples were centrifuged for 20 min
at 16 000 × g and supernatants were analyzed by SDS-PAGE (left); the relative intensity of the Coomassie-stained bands were plotted as a function of
temperature (right), considering as 100% the reference value at 25◦C for each protein; shown is the mean ± SD from three independent experiments. (C)
Differential Scanning Fluorimetry (DSF). The relative fluorescence intensity values of each protein as a function of temperature were measured and used
to obtain the Tm values. Data were obtained from three independent experiments.
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Figure 2. Structure-function of SsOGT-DNA complex. (A) Cartoon representations of the crystal structure of the C119A mutant in complex with
dsDNAm. (B) Detail of the interaction of superposed C119A (yellow) and hAGT (green) (PDB ID: 1T38) with the O6-MG ds DNA at the 3′ side of
the lesion; (C) left, detail of the C119A::ds DNAm2 interactions at the 5′ side of the lesion; right, detail of the hAGT::ds DNAm2 interactions at the 5′
side of the lesion; in both images the damaged DNA strand is colored as the corresponding protein chain. (D) Structure-based models of C119A::ds
oligonucleotides carrying the lesion in different positions (see Supplementary Table S1).
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Table 1. Data collection, phasing, and refinement statistics
SsOGT SsOGTm SsOGT-C119L C119A::dsDNAm
Data collection
Space Group R3 P212121 I432 P212121
Unit cell (A˚) a = b = 94.72 a = 48.49 a = b = c = 140.56 a = 41.76
b = 50.22 b = 65.88
c = 76.70 c = 142.02 c = 97.52
$ = # = % = 90◦ $ = # = % = 90◦ $ = # = % = 90◦ $ = # = % = 90◦
Wavelength (A˚) 0.873 0.979 1.89 0.972
Resolution (A˚) 1.8 2.8 2.6 2.7
Total reflections 83580 35418 78410 41645
Unique reflections 21897 8764 7600 7960
Mean(I)/sd(I) 11.4 (2.43) a 10.1 (3.1) a 25.6 (5.3) a 10.62 (1.7) a
Completeness (%) 99.9 (99.8) a 97.5 (98.7) a 99.9 (100) a 98.5 (90.9) a
Multiplicity 3.8 (3.7) a 4.0 (4.1) a 10.3 (10.3) a 5.2 (5.2) a
Rmerge (%) 6.7 12.9 7.3 8.1
Rmeas (%) 7.8 14.8 7.7 9.0
Refinement
Rfactor/Rfree (%) 16.0/18.2 19.0/29.0 17.5/24.2 21.3/27.1
Protein/DNA Atoms 1204 2380 1175 1707
Ligand atoms 24 - - -
Water molecules 211 12 45 6
R.m.s.d. bonds (A˚) 0.007 0.010 0.009 0.012
R.m.s.d. angles (◦) 0.98 1.27 1.31 1.29
Average B (A˚2)
Protein 25.3 17.9 35.3 63.8
Solvent 38.9 11.0 39.4 49.6
aValues in parentheses refer to the highest resolution shell.
the structure of the C119A::dsDNAm complex is similar to
that of the physiologic complex formed by the wild-type
protein, our analysis indicates that DNA binding does not
substantially alter the protein architecture, as also shown
for hAGT (8).
The C119A::dsDNAm crystal structure was largely, but
not completely, similar to that described for hAGT in com-
plex with the same dsDNAm substrate. The interaction net-
work established by both proteins with the region of the
modified strand at the 3′ side of themethylated base appears
conserved. Indeed, in the C119A::dsDNAm complex the
phoshodiester bond between bases +1 and +2 downstream
of O6-MG is clamped between the positive dipole momen-
tum at the N-side of the H3 helix of the HTH domain and
the backbone nitrogen of E125, at a mean 3.0 A˚ distance
(Figure 2B). From this analysis we predict that at least 2
bases downstream to the O6-MG are needed to establish
correct interactions, as shown for hAGT (40). In contrast,
the protein-dsDNA interactions at the 5′ end of the O6-
MG base appear less tight in the C119A::dsDNAm struc-
ture compared to the human counterpart. Indeed, we found
important differences in structure-based models of SsOGT
and hAGT in complex with a dsDNAm2, an oligonucleotide
carrying the O6-MG lesion located one base from the 5′
end of the damaged strand (Supplementary Table S1). In
the C119A::dsDNAm2 complex, the phosphodiester bond
joining the last two bases at the 3′ end of the complemen-
tary intact strand is not engaged in contacts with the pro-
tein (Figure 2C, left panel), while it appears kept in place
by the side chain of N123 in an equivalent model of the
hAGT::dsDNAm2 complex (Figure 2C, right panel).
hAGT-catalyzed repair of dsDNA molecules containing
a singleO6-alkylguanine is directionally biased, as alkylated
bases at positions near the 3′ end of the modified strand
are repaired less efficiently than those located in the mid-
dle or at the 5′ end (40). We reasoned that, if this behav-
ior reflects the protein-DNA complex architecture, SsOGT
might show a different bias toward the position of the le-
sion. To test this hypothesis we modified our previously de-
veloped competitive kinetic assay forO6-BG sensitiveAGTs
activity (17,19). Briefly, AGTproteins become covalently la-
beled when incubated with the fluorescent competitive in-
hibitor SNAP-Vista GreenTM (hereafter BG-VG); the flu-
orescence intensity of the protein bands is a direct mea-
sure of the protein trans-alkylation activity. Moreover, the
fluorescence intensity obtained in competition assays with
BG-VG and unlabeled alkylated DNA is an indirect mea-
sure of the efficiency of DNA repair (17). This method
was successfully applied to determination of kinetic con-
stants for DNA trans-alkylation reaction and DNA repair
activity by SsOGT and Mycobacterium tubercolosis OGT
(17,19). We have modified this assay to allow determination
of DNA repair activity by SsOGT by measuring the pro-
tein fluorescence intensity in competition assays performed
in the presence of fixed amounts of BG-VG and increas-
ing amounts of ds oligonucleotides containing a single O6-
MG. This method allows rapid determination of an IC50,
which can be converted to KDNA, giving an indirect mea-
sure of the efficiency of O6-MG repair by SsOGT (Sup-
plementary Figure S1A). The method was validated by de-
termining the KDNA of SsOGT for the ds-UPm oligonu-
cleotide (Supplementary Table S1), which was compara-
ble to the value previously reported (17) (Supplementary
Figure S1A). We thus applied this method to determine
the efficiency of repair by SsOGT of 41 bp dsDNA sub-
strates, each containing a single O6-MG at different posi-
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Table 2. Polarity of lesion recognition by SsOGT
tions along the molecule (Supplementary Table S1; see also
Figure 2D). The efficiency of repair was comparable when
the methylated base was located in the middle or within 3
bases from either the 5′ or the 3′ end. In contrast, the ef-
ficiency of repair was significantly reduced (about 6-fold)
when the damaged base was located one base from the 5′
end, and dropped dramatically (more then 50-fold) when
the lesion was located one base from the 3′ end (Table 2).
Solution binding and AFM studies clearly indicated that
hAGT binds both single- and double-stranded substrates in
a cooperative fashion (38,39,41–44); the wild-type SsOGT
also showed cooperative binding when analyzed in EMSA
assays with short oligonucleotides (17). The C119A protein
showed similar behavior and bound all methylated oligonu-
cleotides with comparable efficiency (Supplementary Fig-
ure S3), thus suggesting that the observed differences reflect
the efficiency ofO6-MG recognition and/or removal, rather
than of unspecific DNA binding.
These results show that SsOGT, like hAGT, is highly inef-
ficient in repairing lesions near the 3′ end of the molecule, in
line with the conserved network of interactions formed with
the DNA strand on the 3′ side of the lesion by both proteins
(Figure 2B). In contrast, whereas two bases from the 5′ end
of the molecule are sufficient for efficient repair by hAGT,
SsOGT requires at least 4 bases betweenO6-MG and the 5′
end for optimal activity (a situation illustrated by the cen-
tral miniature in Figure 2D); in this latter case, positively
charged residues of both helix H2 (e.g. R72 in Figure 2A)
and helix H4 could efficiently contact the sugar-phosphate
backbone of the complementary strand 3′ end, fully restor-
ing the protein-DNA association potential.
Effect of alkylation on SsOGT stability
Methylated and benzylated forms of hAGT are highly un-
stable (37), and soaking of hAGT crystals in O6-alkyl-
guanine substrates leads to crystals destabilization (7). Con-
sidering that SsOGT is extremely stable at high tempera-
ture, but is also active at room temperature (17), we won-
dered whether it might be alkylated and remain relatively
stable if kept at temperatures below its optimum. Consis-
tently with this assumption, we obtained a homogeneously
methylated protein form (SsOGTm) by incubating purified
SsOGT with O6-MG at room temperature. Since the ben-
zylated SsOGT form (SsOGTb) was not soluble, to test the
effect of the presence of larger adducts in the protein active
site, we constructed two site-directed mutants carrying sub-
stitutions of the catalytic C119 with an F or an L residue,
mimicking a benzylated or isopropylated protein, respec-
tively. Whereas the corresponding C145F and C145L mu-
tants of hAGT were extremely unstable when expressed in
E. coli cells (7), both SsOGT mutants resulted stable in the
same expression system and could be purified to homogene-
ity (data not shown).
When tested in EMSA analysis, SsOGTm and mutants
were able to bind dsDNA, although with slightly reduced
affinity as comparedwith the wild-type protein (Figure 3A),
in line with results reported for hAGT, whose dsDNA bind-
ing affinity decreases to little extent when the protein is alky-
lated in vitro (37). We then analyzed the stability of the mu-
tants and SsOGTm at different temperatures. Whereas, as
shown above, the wild-type protein was 100% soluble after
20 min incubation at 70◦C, complete aggregation was ob-
served for SsOGTm at 70◦C and for C119F at 50◦C (Fig-
ure 3B). DSF analysis demonstrated the instability of these
proteins, showing a Tm value of 60◦C for SsOGTm and ca.
45◦C for both the C119L and C119F mutants, compared
with the wild-type protein (Tm = 80◦C) (Figure 3C). Thus,
the presence of alkylated groups bound to the catalytic C119
leads to Tm destabilization, whose extent is dependent on
the size of the adduct in the active site.
Effect of alkylation on SsOGT structure
In order to elucidate the structural basis of the dramatic ef-
fect of alkylation on protein stability, we solved the crys-
tal structure of the SsOGTm and SsOGT-C119L proteins
at 2.8 and 2.6 A˚ resolution respectively, whereas we failed
to obtain suitable crystals of the C119F mutant, likely as a
consequence of its intrinsic instability.
The analysis of the optimally superposed crystal struc-
tures of the ligand-free and SsOGTm proteins revealed con-
formational changes that occur in discrete regions of the
molecule, upon the C119methylation (Figure 4A). The only
comparable structures available so far are those obtained by
alkylating hAGT after crystallization (7); similarly to what
observed in the human counterpart, in the SsOGTm struc-
ture we observed a 1.0 A˚ movement of the C-side of the
recognition helix H4 and following Asn-hinge, a conforma-
tional change responsible for amodest increase of the ligand
binding site size (Figure 4A). In addition, in the structure of
SsOGTm the distance between the C-side of the conserved
H2 helix and the H4 recognition helix is increased of ap-
proximately 3 A˚ with respect to the observed distance be-
tween the same structural elements in the ligand-free wild-
type protein. Similarly, the distance between the active site
loop and the H4 is increased of 1.9 A˚ in the SsOGTm struc-
ture. Alkylation of hAGT crystals induce shift of 0.5–1.5 A˚
C$ of the recognition helix away from the N-terminal do-
main (7).
An unbiased difference distance matrix plot of SsOGTm
versus SsOGT revealed that many interactions between
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Figure 3. Effect of active site alkylation on SsOGT activity and stability. (A) EMSA. Reactions (10.0 !l) containing increasing amounts of each indicated
protein (0–25.0 !M) were incubated with the TAMRA-labeled ds A+/A− oligonucleotide (0.2 !M; Supplementary Table S1) for 10 min at 37◦C. Native
polyacrylamide gels were analyzed by gel fluorescence imaging. The first lane of each gel is the no protein control. For quantification (right), the relative
intensity of each band was plotted as a function of the protein concentration (pmol); data are from three independent experiments. (B) Thermal stability.
Reactions were set and analyzed and quantified as described in the legend to Figure 1B. (C)DSF. Data were obtained from three independent experiments
as described in the legend to Figure 1C.
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Figure 4. Comparative analysis of structures of free and methyalted SsOGT. (A) Ribbon representation of the crystal structures of the two proteins upon
optimal overlaying. Each protein chain is uniformly colored following the legend on the right of the picture. The arrows indicate the movements described
in the text. An enlarged view of the D27 and R133 residues (drawn as sticks) appears in the inset on the left. (B)Distance difference matrix plot, obtained
by the computation of Needleman-Wunsch sequence alignment by using the CMView v1.1.1 freeware, choosing amino acid side chain contact type and 8
A˚ cutoff. (left panel) methylated versus native SsOGT; (right panel) methylated (PDB ID: 1EH7) versus native hAGT (PDB ID: 1EH6).
aminoacid residues were lost or gained, suggesting over-
all reshaping of the molecule upon methylation (Figure 4B,
left panel). Compared with analogous analysis performed
on alkylated versus free hAGT (Figure 4B, right panel),
many more interactions were affected upon SsOGTmethy-
lation, thus suggesting that crystallization of the protein in
its reacted form allow us to observe the repositioning of
higher number of residues than that observed in the hAGT
methylated in crystallized form. In both proteins most re-
arrangements occurred within the N- and C-terminal do-
main, respectively (Figure 4B, gray quarters) rather than
between domains (white quarters); however, in SsOGTm a
group of inter-domain interactions were lost in correspon-
dence of the R133 residue (Figure 4B). Interestingly, in the
SsOGT structure, the R133 residue at the C-side of the ac-
tive site loop of the C-terminal domain and the D27 residue
at the C-side of the third #-strand of theN-terminal domain
form an interaction at 2.6 A˚ distance (Figure 4A, inset). In
the SsOGTm structure the distance between the carboxylic
group of D27 and the guanidinium group of R133 is in-
creased by 0.6 A˚ and the R133 side chain is rotated by ca
60◦ with respect to its position in the unmodified protein on
the same plane, overall resulting in a 1.9 A˚ movement of the
active site loop toward the solvent (Figure 4A). Distance
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increase from the D27 residue and rotation of the R133
residue was also observed in the superposition of the C119L
structure with that of the wild type, although at lower extent
(Supplementary Figure S4, inset), suggesting again that the
modification of the D27–R133 interaction is a direct con-
sequence of the active site modification. This observation
prompted us to hypothesize that the C119 alkylation could
have a role in the conformational change of the active site
loop, which, in turn, might perturb the D27/R133 interac-
tion, or alter the interaction geometry, ultimately triggering
protein destabilization.
The active site expansion is not observed in the crystal
structure of the C119L mutant, which rather shows a 1 A˚
movement of the H2 helix toward the Asn hinge (Supple-
mentary Figure S4); therefore the C119L mutant is not as
informative as the SsOGTm protein with respect to the de-
scription of structural rearrangements taking place upon
trans-alkylation reaction.
Alkylation-induced structural changes affecting the connec-
tion between the two domains impair SsOGT stability and
activity
In order to directly test whether the D27/R133 interaction
plays a role in SsOGT stability, we prepared two mutants
carrying substitutions of the D27 residue, namely D27A
and D27K, whose positive charge should eventually en-
hance the mutation destabilizing effect. In thermal stabil-
ity assays, the D27A mutant was indeed destabilized with
respect to the wild type, showing complete aggregation at
70◦C; moreover, the D27K protein was dramatically less
stable and aggregated completely above 50◦C (Figure 5A);
the Tm determined by DSF was of 72◦C for D27A and
44.7◦C for D27K, respectively (Figure 5B). Thus, these data
confirmed our prediction that the interaction between D27
and R133 plays a crucial role in SsOGT stability.
We then characterized theD27AandD27Kactivity. Both
mutants were effective in dsDNA binding, although the
D27Kmutant showed slightly reduced binding efficiency as
compared with the wild-type and the D27A proteins (Fig-
ure 5C). In addition, mutated proteins were tested in their
DNA repair activity by using the fluorescent assay with
O6-MGcontaining ds oligonucleotides described in Supple-
mentary Figure S1. While the D27A mutant showed slight
reduction of repair efficiency, as compared with the wild-
type (IC50 of 2.26 ± 0.13 versus 1.23 ± 0.07 !M at 50◦C),
we could not calculate an IC50 value for the D27K protein
at either 50 or 25◦C, thus suggesting that the D27K pro-
tein is unable to repair DNA, or this activity is greatly im-
paired. A slow DNA repair activity by the D27K protein
could be detected in prolonged (6 h) incubation at 25◦C
with methylated oligonucleotides (Figure 5D; note that un-
der the same conditions the wild-type SsOGT completes
the reaction within few minutes; data not shown); thus, the
D27K protein is not completely inactive, yet its DNA re-
pair activity is strongly compromised. This result suggests
that the disruption of the D27–R133 interaction not only
affects the protein stability, but also its DNA repair activ-
ity even at low temperature, thus not as a consequence of
thermal induced denaturation. To understand the reason of
the D27 mutants DNA repair defect, we then determined
the efficiency of the alkyl-transfer reaction independently of
DNA binding and lesion recognition, using our previously
developed assay based on the use of the synthetic substrate
BG-VG (17). Interestingly, only marginal reduction of the
catalytic efficiency of the covalent modification reaction at
25◦Cwas observed for theD27Kmutant, and no significant
changes for the D27A, as compared with the wild-type pro-
tein (Figure 5E). Thus, the D27/R133 interaction does not
play an important role in the alky-transfer reaction from
free alkylated bases to the catalytic cysteine, while it greatly
affects the efficiency of de-methylation of O6-MG bases in
the context of dsDNA.
DISCUSSION
SsOGT proved to be a convenient model to unravel the
structure-function relations of AGTs. Indeed, the overall ar-
chitecture of the free and DNA-bound protein (this work),
as well as details of its reaction mechanisms (17) are con-
served between SsOGT and mesophilic counterparts. Most
important, the peculiar thermal stability of SsOGT allowed
us to obtain the protein in a post reaction form suitable to
both biochemical analysis and crystallization, overcoming
the restrictions to experimental manipulation imposed by
the extreme instability of alkylated hAGT forms.
One peculiar feature of SsOGT is the disulphide bond in
its N-terminal domain; this structural element is not found
in the corresponding domain of hAGT, which instead
contains a zinc atom coordinated by two cysteine and
two histidine residues (7). Previously, it was reported that
nitric oxide synthase undergoes a conformational change
with release of a Zn ion coordinated by four cysteines,
coupled to formation of a disulphide bond involving two
of such cysteines (45), thus suggesting that an exchange
between Zn ion coordination and S-S bond is in principle
possible. Although in the nitric oxide synthase this change
appears to have regulatory function, it might occur in
SsOGT as an artifact due to Zn depletion during purifi-
cation of the His-tagged protein through metal-chelating
columns, inducing formation of the S-S bond. However,
this is unlikely to be the case for two reasons: (i) the S-S
bond is also present in the OGT protein from the strictly
related Sulfolobus tokodai species, showing 68% aminoacid
sequence identity with SsOGT; although no functional
data are available for this protein, its crystal structure
(PDB entry 1WRJ) was obtained from the protein without
any tag (http://www.ebi.ac.uk/thornton-srv/databases/
cgi-bin/pdbsum/GetPage.pl?pdbcode=1wrj&template=
header records.html&r=getheader); (ii) the SsOGT struc-
ture does not reveal any possible canonical tetrad for
Zn coordination around the C29-C31 residues. Thus, the
S-S bond appears to be a structural peculiarity of the
thermophilic protein, and we showed that its disruption
significantly destabilizes SsOGT; it is possible that the
N-terminal domain is involved in protein activity, as previ-
ously suggested (19,46), as well as in the overall stability of
AGTs, although by means of different structural elements
in different proteins.
The efficiency of DNA repair by SsOGT is highly depen-
dent on the O6-MG position, and its optimal activity re-
quires at least three bases at both sides of the lesion, consis-
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Figure 5. Effect of D27 residue mutations on SsOGT stability and activity. (A) Thermal stability (see legend to Figure 1B; mean ± SD from three inde-
pendent experiments). (B)DSF. (see legend to Figure 1C; data from three independent experiments). (C) EMSAs were performed and quantified as in the
legend to Figure 3A. The first lane of each gel is the no protein control. (D)Direct DNA repair activity of SsOGT D27K mutant. The protein (5 !M) was
incubated for 6 h at 25◦C in the presence of increasing amounts of the ds-Fwdm26 oligonucleotide, as indicated. Then, 10 !M of BG-VG was added and
the incubation was prolonged for 2 h. The histogram reports the reduction of the fluorescence intensity of the protein band (shown in the gel labeled F)
depending on the methylated oligonucleotide concentration in pre-incubation before BG-VG labeling. Equal amounts of protein were loaded in each lane,
as shown by the Coomassie staining of the gel (C). (E) Trans-alkylation activity of D27 mutants. Second-order rate constants were obtained incubating
the proteins at 25◦C with BG-VG for increasing time spans; data were fitted as previously reported (17).
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Figure 6. (A) Details of the D27–R133 interaction during the reaction cycle and its methylation-induced modification. (B) Model of the conformation
modification induced by alkylation-induced perturbation of inter-domain interactions.
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tent with the contacts between the protein and both DNA
strands in crystal structure. Interestingly, whereas contacts
formed with the DNA strand at the 3′ side of the lesion are
important for both hAGT and SsOGT, those formed with
bases at the 5′ side seem more important for the latter. One
possible explanation for this difference is that SsOGT needs
to form stronger contacts at both sides of the DNA sub-
strate to assist stabilization of the DNA-protein complex at
higher temperatures, and/or hold the bound DNA in a cor-
rect ds conformation, counteracting thermal denaturation
and facilitating lesion removal.
Alkylation-induced instability of hAGTs is a well known
process whosemolecularmechanism is, however, poorly un-
derstood, mainly due to the instability of alkylated hAGT
and its C145F and C145L mutants (7,37). Thanks to the
relative stability of SsOGTm, and of C119L and C119F
mutants at mild temperatures, we could obtain direct and
quantitative data on the protein stability in correlation with
the active site status, as well as insights in the structural
modifications occurring upon methylation in solution, thus
in conditions more physiological than those in which the
structures of alkylated hATG could be obtained (7). In-
deed, although structural rearrangements were observed
upon alkylation of hAGT crystals, Daniels and coworkers
predicted that such rearrangements would be even larger in
solution (7). Consistently, we found extensive remodeling
of interactions between aminoacid residues upon methy-
lation and larger movements in the backbone structure of
SsOGTm, as compared with alkylated hAGT. These data
support the correlation between active site alkylation, con-
formational changes and protein unfolding (7). Our data are
also in line with the observation that alkylated SsOGT un-
dergoes degradation after treatment of S. solfataricus cells
with alkylating agents (17): at the physiological growth tem-
perature (75–80◦C) alkylated SsOGT is destabilized, which
might target the protein to degradation pathways, either
directly or after some still unidentified post-translational
modification.
Our structural and biochemical data show that the D27
residue of the N-terminal domain plays an important role
in both SsOGT activity and stability, through the forma-
tion of an interaction with the R133 residue of the catalytic
C-terminal domain (Figure 6A). Intriguingly, the remark-
able extent of D27K destabilization is strikingly similar to
that of the C119F and C119L mutants, showing that the
same effect on protein stability is obtained by acting on two
completely different residues. Moreover, the D27/R133 in-
teraction is important not only to maintain SsOGT folding
at high temperature, but also to allow its activity even at low
temperature. Exploiting our different assays, which allow
dissection of the SsOGT reaction, we showed that the D27–
R133 interaction is not involved in the trans-alkylation re-
action per se, whereas it is required for the protein to repair
efficiently the alkylated base in the DNA context. An at-
tractive hypothesis is that C119 alkylation-induced pertur-
bation of the D27–R133 interaction weakens the contacts
between the two domains, impairing optimal co-ordination
between the N- and C-terminal protein domains, which in
turnmight be crucial both forDNArepair andmaintenance
of the correct protein folding.
We could also obtain the first crystal structure of an
AGT mutant carrying a substitution of the catalytic cys-
teine with a leucine, mimicking an isopropylic group; the
hAGT corresponding mutant was extremely unstable (7).
The crystal structure of the C119L protein showed that the
conformational modifications occurring in this mutant at
the level of the D27–R133 interaction recall those occur-
ring in the methylated protein. However, it is also impor-
tant to note that not all the structural modifications ob-
served in SsOGTm are also present in the C119L protein,
thus suggesting that the bulky adduct in the active site in-
serted by mutation may not completely reproduce the effect
of the conformational changes triggered by alkylation. In-
deed, alkylation takes place in the correctly folded protein,
whereas the mutant accommodates the large adduct during
its folding, whichmight affect the protein conformation in a
different manner. These results suggest that structural and
functional data obtained with substitution mutants should
be carefully considered.
The inter-domainD27–R133 interaction is not conserved
in the structures of other AGTs, as a consequences of poor
sequence conservation at level of the N-terminal domain of
AGTs from different species. However, in the case of Ther-
mococcus kodakaraensis Tk-MGMT the two domains are
connected by an ion-pair network formed by the R50–E93–
R132 residues. Although no data are available on the effect
of alkylation on this interaction, mutation to alanine of the
E93 residue, located at the center of the network, destabi-
lized the protein (32,47). In hAGT, alkylation causes disrup-
tion of the active site hydrogen-bond network and perturbs
the hydrophobic packing between the N-hinge and the N-
terminal domain, which gives an important contribution to
the interface between the two protein domains (7). Upon
alkylation, movements of the HTH helix H6 and collision
of the N137 residue with the alkyl adduct disrupt three H-
bonds formed by the N137 residue. Most important, muta-
tion of N137 to alanine resulted in dramatic hAGT destabi-
lization (48). Thus, although in three AGTs the connection
between the two domains are provided by different struc-
tural elements, these observation suggest a common theme
for alkylation-induced destabilization through perturbation
of the connection between the two domains, triggering pro-
tein destabilization (Figure 6B).
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Background: Alkylated DNA-protein alkyltransferases (AGTs) are conserved proteins that repair alkylation dam-
age in DNA by using a single-stepmechanism leading to irreversible alkylation of the catalytic cysteine in the ac-
tive site. Trans-alkylation induces inactivation and destabilization of the protein, both in vitro and in vivo, likely
triggering conformational changes. A complete picture of structural rearrangements occurring during the reac-
tion cycle is missing, despite considerable interest raised by the peculiarity of AGT reaction, and the contribution
of a functional AGT in limiting the efﬁcacy of chemotherapy with alkylating drugs.
Methods: As a model for AGTs we have used a thermostable ortholog from the archaeon Sulfolobus solfataricus
(SsOGT), performing biochemical, structural, molecular dynamics and in silico analysis of ligand-free, DNA-
bound and mutated versions of the protein.
Results: Conformational changes occurring during lesion recognition and after the reaction, allowed us to identify
a novel interaction network contributing to SsOGT stability,which is perturbedwhen a bulky adduct between the
catalytic cysteine and the alkyl group is formed, a mandatory step toward the permanent protein alkylation.
Conclusions: Our data highlighted conformational changes and perturbation of intramolecular interaction occur-
ring during lesion recognition and catalysis, conﬁrming our previous hypothesis that coordination between the
N- and C-terminal domains of SsOGT is important for protein activity and stability.
General signiﬁcance: A general model of structural rearrangements occurring during the reaction cycle of AGTs is
proposed. If conﬁrmed, thismodelmight be a starting point to design strategies tomodulate AGT activity in ther-
apeutic settings.
© 2016 Elsevier B.V. All rights reserved.
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1. Introduction
Alkylated-DNA protein alkyltransferases (called AGT, OGT, or
MGMT, EC: 2.1.1.63) are specialized proteins that perform the direct re-
pair of alkylation damage in DNA, mainly acting at position O6 of gua-
nines. They use a peculiar one-step mechanism, in which a single
trans-alkylation reaction catalyses the transfer of the alkyl group from
DNA to a cysteine residue in the protein active site, restoring the correct
DNA structure with no need for other factors or energy source [1,2].
AGTs are evolutionary highly conserved, andorthologs fromhumans,
bacteria and archaea have been extensively studied [2,3]. In particular,
the human protein (hAGT) has raised considerable interest because its
activity antagonizes the effect of alkylating drugs widely used in chemo-
therapy, and its overexpression is frequently associated with resistance
to such drugs [2]. Moreover, certain AGT variants have been associated
with the virulence ofMycobacterium tuberculosis species [4,5].
Previous structural and biochemical studies elucidated details of
DNA binding, lesion recognition and repair by AGTs [4–13]. Invariably,
the protein architecture consists of a highly conserved C-terminal
(Cter) domain, containing both the DNA binding helix-turn-helix motif
and the catalytic site; and a N-terminal (Nter) domain, whose function
is less understood and has been suggested to assist the correct folding/
stability of the Cter domain [14] and contribute to optimal catalysis
[4,5]. Upon lesion recognition, the alkylated base is ﬂipped out from
the regular base stacking of the double helix, and inserted into the pro-
tein active site, allowing the transfer of the alkyl moiety to the catalytic
cysteine. The drawback of this elegant reaction is that once alkylated,
the protein is irreversibly inactivated and destabilized, both in vitro
Biochimica et Biophysica Acta 1861 (2017) 86–96
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and in vivo [15,16]. In human and yeast cells, the degradation of hAGT
occurs through the ubiquitin-proteasome pathway [16] and might
also affect other DNA repair pathways [17].
The molecular mechanisms underlying the AGT unfolding and deg-
radation, which follow the alkylation of the active site cysteine, are
only partially understood: conformational changes and modiﬁcation of
intramolecular interactions are likely to be associated to each step of
the reaction cycle. Evidence of some changes occurring after hAGT
methylation has been provided [18–20]; however, the intrinsic instabil-
ity of alkylated AGTs has been an important limitation to structural and
biochemical studies [19].
These limitations have been overcome by the availability of a
thermostable DNA alkyl-transferase from the archaeon Sulfolobus
solfataricus (SsOGT) [11], which proved to be a convenient model for
AGTs. In this hyperthermophilic microorganism, alkylating agents ac-
tion is potentiated by the high temperature of growth, resulting in an
apoptotic-like effect, characterized by DNA fragmentation and degrada-
tion of key proteins involved in genome stability [3,21–24]. SsOGT is
also degraded after treatment with lethal doses of alkylating agents,
thus recalling its fate in human cells [11]. Although alkylation reduces
the exceptional stability of SsOGT in vitro, the alkylated protein is stable
enough to allow structural and biochemical analysis at operational tem-
peratures [10,11]. We exploited this unique property to obtain direct
structural and biochemical information on SsOGT in its free, DNA-
bound andmethylated post-reaction form [10]. Importantly, in contrast
to the 3D structure of the methylated hAGT (obtained by soaking pro-
tein crystals in substrate solutions; [19]), the 3D structure of SsOGT
was obtained by crystallizing the protein previouslymethylated in solu-
tion and puriﬁed, which might better reﬂect the physiological confor-
mation of the alkylated protein, allowing free movements that could
otherwise be restricted in crystals.
The available SsOGT structures are useful tools as they open the pos-
sibility of understanding how alkylation triggers the protein unfolding
and describing the conformational changes associated to each step of
the reaction. So far, this analysis showed signiﬁcant changes occurring
upon SsOGT active site cysteine (C119) methylation in discrete regions
of the protein and allowed the identiﬁcation of one interaction whose
methylation-induced perturbation leads to protein destabilization [10]
(see also below).
In this paperwe report a further step forward, aswe analyse the con-
formational changes and intramolecular interactions, which are
perturbed during binding of SsOGT to methylated DNA, before the
transmethylation reaction is completed. Moreover, we solved the crys-
tal structure of the SsOGT-C119F mutant, gaining an indirect insight
into the possible conformation adopted by the protein upon the remov-
al of an aromatic and bulky adduct from the DNA. Taken as a whole, the
structural, biochemical and molecular dynamics studies of ligand-free,
methylated and mutated forms of SsOGT suggested a model for the
alkylation-induced unfolding and degradation of this protein, which is
of possible relevance also for other AGTs.
2. Materials and methods
2.1. Reagents
All chemicals were from Sigma, and synthetic oligonucleotides were
from EuroFins (Milan, Italy). E. coli ABLE C and JM109 strains, as well as
PfuDNA polymerase were purchased from Stratagene (La Jolla, CA). The
SNAP-Vista Green™ substrate (BG-VG) was from New England Biolabs
(Ipswich, MA), and SYPRO Orange™was from Thermo Fisher Scientiﬁc
(NYSE, TMO).
2.2. DNA site-directed mutagenesis and protein production
Starting from the S. solfataricus ogt gene cloned in the pQE31™ vec-
tor [11] used as template, mutants were obtained by applying the
GeneTailor™ Site-Directed Mutagenesis System (Invitrogen) method,
by using oligonucleotide pairs listed in the Supplementary Table S1.
All proteins were heterologously expressed in the E. coli ABLE-C or
JM109 strain and puriﬁed by afﬁnity chromatography and desalting
steps, as described [11].
2.3. Determination of the catalytic activity by ﬂuorescent assay
The catalytic activity was measured by using a ﬂuorescent assay
we previously set up and validated, based on the use of derivatives of
O6-benzyl-guanine (O6-BG),which is known to inhibit AGTs by covalent
transfer of the benzylic group to the active site cysteine. Our assay
employs a ﬂuorescein-conjugated derivative of O6-BG (SNAP-Vista
Green™, hereafter called BG-VG), which labels the protein covalently
and stoichiometrically [4,5,10,11,25]. For the catalytic constants deter-
mination, ﬁxed SsOGT and BG-VG concentrations were incubated for
different time spans; the ﬂuorescence intensity of the labelled protein
band in SDS-PAGE was quantiﬁed and used to calculate second-order
rate constants [11,26].
2.4. Determination of the DNA repair activity by the IC50 method
The efﬁciency of repair of AGTs depends on their ability to bindDNA,
recognize the lesion and repair it: all these functions have been analysed
by a unique competition assay according to the IC50 method, where a
dsDNA oligonucleotide containing a single O6-MG was used as a com-
petitor in the reaction of SsOGT with BG-VG. Finally, KDNA constants
were calculated from the obtained IC50 values [10,27].
2.5. Differential Scanning Fluorimetry (DSF) assay for the protein stability
determination
The stability against thermal denaturation was followed
spectroﬂuorimetrically as described [10], adapting the method pro-
posed by the group of Vedadi [28]. Because of the intrinsically high sta-
bility of SsOGT, thermal stability scans from 25.0 to 95.0 °C were
performed at a scan rate of 0.2 °C min−1 (5 min per cycle with an in-
crease of 1.0 °C per cycle). Normalized data of the ﬂuorescence intensi-
ties vs temperature from three independent experiments were ﬁtted
with the Boltzmann equation [10,28] allowing the determination of
the Tm values.
2.6. Crystallization and data collection
The puriﬁed SsOGT-C119F mutated variant was subjected to robot-
assisted crystallization trials (Oryx4; Douglas Instruments) using com-
mercial screens from Hampton Research (Crystal Screen, Crystal Screen
II, PegIon and PegIon II) and Qiagen (Classics Suite and Classics Suite II),
applying the vapor diffusion method in sitting drop. Protein crystals, in
the form of thin needles, grew to their maximum dimensions in three
weeks at 4 °C in drops obtained by mixing 0.5 μL of a 5.3 mg mL−1 pro-
tein solution and an equal volume of a precipitant solution containing
0.2 M ammonium phosphate monobasic and 20.0% W/V PEG 3350.
The single crystals were cryo-protected in precipitant solution contain-
ing 15.0% glycerol, mounted in cryo-loop, and ﬂash-frozen in liquid ni-
trogen at 100 K for subsequent X-ray diffraction analysis. Diffraction
datasets were collected at the ID29 beamline at the European Synchro-
tron Radiation Facility (ESRF, Grenoble, France) equippedwith a Pilatus
6M-F, at a wavelength of 1.008 Å. A data collectionwas performed up to
2.7 Å of resolution and the complete dataset was indexed with
IMOSFLMprogram [29], allowing to assign the crystal to the orthorhom-
bic space group P212121, with cell dimensions a= 52.86 Å b=85.85 Å
c = 98.46 Å, containing two molecules per asymmetric unit, with a
Matthews coefﬁcient and a solvent content of 2.94 Å3 Da−1 and
58.19%, respectively. Further data analyses were carried out using the
CCP4 suite programs COMBAT and SCALA [30].
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2.7. Structure determination, model building and reﬁnement
The initial phases for solving the structure of the SsOGT-C119F vari-
ant were generated by molecular replacement with the program
PHASER [31] of the PHENIX software suite [32,33], using the structure
of Sulfolobus solfataricus wild type OGT (PDB ID: 4ZYE) as the search
model. In this structure, the catalytic cysteine at position 119, the
water and the ligand molecules have been omitted. Model building
was performed with the program COOT [34] and crystallographic re-
ﬁnement was carried out with PHENIX [32]. Data converged to the
Rfactor and Rfree values of 0.172 and 0.237, respectively, with good
geometry.
2.8. Protein structure accession numbers
The atomic coordinates and structure factors of the SsOGT-C119F
mutated variant have been deposited in the Protein Data Bank (http://
www.rcsb.org) under the accession code ID: 5LLQ.
2.9. Molecular dynamics (MD)
Crystallographic structure of ligand-free SsOGT (PDB ID: 4ZYE) and
its mutants C119A (PDB ID: 4ZYD), C119L (PDB ID: 4ZYH) and C119F
(PDB ID: 5LLQ) were used for the initial coordinates of the MD simula-
tions. MD simulations were performed using GROMACS 5.1 software
[10.1016/j.softx.2015.06.001] with the GROMOS 54a7 force ﬁeld
[10.1007/s00249-011-0700-9] implemented in Intel Xeon Octa Core
processor with Linux environment. In our models, basic residues are
protonated and acidic residues are unprotonated. Systems were neu-
tralized and solvated in a periodic octahedric box containing a simple
point charge (SPC) water model [31]. Two series of simulations were
carried out: at a constant temperature of 353 K since SsOGT is a hyper-
thermophile enzyme, and at a constant temperature of 500 K to analyse
the protein unfolding. Before every MD simulation, the internal con-
straints were relaxed by energyminimization, followed by equilibration
(100 ps at constant temperature and 100 ps at constant pressure) under
position restraints of the carbon backbone atoms. During the MD runs,
covalent bonds in the protein were constrained using the LINCS algo-
rithm [10.1002/(SICI)1096-987X(199709)18:12b1463::AID-JCC4N
3.0.CO;2-H]. The SETTLE algorithm was used to constrain the geometry
of water molecules [10.1002/jcc.540130805]. Berendsen's coupling al-
gorithm was used to maintain the simulation under constant pressure
and temperature [10.1063/1.448118]. Van der Waals forces were treat-
ed using a cutoff of 1.0 nm. Longrange electrostatic forces (r.1.0 nm)
were treated using particle mesh implemented in the Verlet method
[10.1103/PhysRev.159.98]. Through the production runs, the trajectory
data were saved every 1 ps, and the total duration of the simulations
was 200 ns.
Root-mean-square deviations (RMSD) were calculated taking the
energy-minimized structure as a reference (Supplementary Fig. S1).
Principal components analysis (PCA) of the protein motion was deter-
mined from the diagonalization of the covariance matrix of the inter-
atomic ﬂuctuation [10.1002/prot.340170408]. Average conformations
were calculated from the variance-covariance matrix of all protein
atoms during the equilibrium time of the run. Tools from the
GROMACS package were used for the analysis of the data.
2.10. Data analysis
Prism Software Package (GraphPad Software) and GraFit 5.0 Data
Analysis Software (Erithacus Software) were used for corrected data
ﬁtting using appropriate equations.
Difference Distance Matrix Plots (DDMPs) were obtained by using
the CMView v1.1.1 freeware. All the structures used in this analysis
(free SsOGT; SsOGT-C119A mutant bound to DNA; methylated SsOGT)
were aligned by the computation of Needleman-Wunsch sequence
method, and choosing all types of amino acid contacts with a cut-off
of 8.0 Å.
All the ﬁgures illustrating structural analysis were generated by
Pymol freeware version 1.7 (Schrodinger, LLC., http://www.pymol.
org) using standard code for amino acid atoms colouring.
3. Results and discussion
3.1. SsOGT conformational modiﬁcations associated with O6-MG
recognition and binding
In order to describe the complete picture of conformational changes
occurring throughout the DNA repair reaction, we performed unbiased
DDMP analysis, by comparing the network of intramolecular interac-
tions observed in the available 3D structures of SsOGT. A preliminary
analysis previously performed on ligand-free vs SsOGTm structures
gave important hints on changes occurring upon protein methylation
([10]; see also below). We have now extended and further reﬁned
this analysis by comparing the free, DNA-bound and methylated
SsOGT (SsOGTm) structures, taking into account all intramolecular inter-
actions, including those formed by the atoms of the protein backbone
(Fig. 1).
The crystal structure of the SsOGT inactive mutant, C119A, in com-
plex with a methylated dsDNAm oligonucleotide showed that substrate
binding does not affect signiﬁcantly the protein overall structure [10];
however, structural changes in speciﬁc protein regions are expected to
occur, in order to accommodate the double helix as well as the methyl-
ated base, which adopts an extra-helical conﬁguration in the complex.
Indeed, the DDMP analysis comparing the free and DNA-bound protein
forms showed an extensive reshaping of themolecule, withmovements
involving a number of residues and leading to a lot of lost and gained in-
teractions when the protein contacts DNA and ﬂips out the O6-MG into
its active site (Fig. 1a). The DDMP analysis comparing the DNA-bound
and SsOGTm structures, which corresponds to the DNA-free protein in
its post-reaction form, showed an almost symmetrical pattern, with
most changes found in the DNA-bound structure no longer present
(compare Fig. 1b and a); those changes, which correspond mainly to
intra-domain interactions, are thus a consequence of the binding of
the natural substrate, as expected from the induced ﬁt model for a gen-
uine enzyme.
However, like all AGTs, SsOGT is not a true enzyme, and irreversible
methylation has dramatic consequences on its structure [10]; consis-
tently, DDMP analysis comparing the SsOGTm with the free and DNA-
bound structures showed multiple modiﬁed contacts (Fig. 1c). We ar-
gued that interdomain interactions should have amajor role in securing
the overall protein stability, and could be reasonable candidates to trig-
ger the protein destabilization; thus, we focused our attention on three
clusters of interactions occurring at the interface between the Nter and
Cter domains. Two such clusters were already identiﬁed in a previous
analysis [10]: in particular, cluster 1 corresponds to perturbation of
the interaction between the D27 residue in the Nter domain and the
R133 residue in the Cter domain, due to a ca. 60° clockwise rotation of
the latter (inset 1 in Fig. 1c; d); this modiﬁcation leads to strong desta-
bilization of the overall structure. The second cluster corresponds to a
loss of interactions caused by the ca. 3.0 Å movement of the C-side of
the conserved H2 helix away from the overall structure upon alkylation
(Fig. 1c, inset 2; Fig. 1d). Both modiﬁcations were found in the methyl-
ated protein, but not in the DNA-bound protein, thus suggesting that
they are a direct consequence of the active site alkylation (compare
DDMPs in Fig. 1b and c).
In addition, our current analysis highlighted another region where
conformational changes occur, in particular at the interface between
the Nter domain and the connecting loop (indicated in inset 3 of
Fig. 1c; d) which, in contrast to clusters 1 and 2, is common to both
DNA-bound and SsOGTm. This cluster is characterized by a number of
lost interactions at the level of a complex network involving the E44,
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K48, N59, R61 and E62 residues (hereafter called K48-network). In the
free SsOGT, these residues are close to each other (2.9 Å distance on av-
erage), consistent with an ionic/hydrogen bond network (Fig. 2 and
Table 1). In both the DNA-bound and methylated forms of the protein,
the E44 and K48 appear to ﬂip out, moving away from the body of the
protein (Fig. 2). The former loses its hydrogen-bond with the E62,
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whereas the conformational change of the K48 residue has a stronger
impact, perturbing its interactions with the N59, R61 and E62 (Fig. 2
and Table 1).
Taken together, these observations suggest that lesion recognition
and alkylation trigger distinct modiﬁcations of intramolecular interac-
tions in SsOGT: whereas the changes at the level of cluster 1 and 2
occur only upon irreversible trans-alkylation of the catalytic cysteine,
those observed in the K48-network might be a consequence of lesion
recognition/steric hindrance of the active site, since they are already
found in protein in complex with the methylated DNA and are retained
in the post-repair protein structure devoid of DNA. Importantly, all
three clusters occur at the interface between the two domains, suggest-
ing that the interdomain communication plays important role in multi-
ple steps of the reaction.
3.2. Structural analysis of the SsOGT-C119F mutated variant
To conﬁrm the hypothesis that the observed rearrangements of the
K48-network are linked to the presence of chemical groups in the active
site, we analysed the conﬁguration of this network in the C119Lmutant
(PDB ID: 4ZYH), in which a leucine residue replaces the catalytic cyste-
ine [10]. This mutant showed biochemical and structural features con-
sistent with the hypothesis that the L119 residue mimics an
“isopropylation” of the active site [10]. Similarly to what has been ob-
served in the crystal structure of the DNA-bound and SsOGTm, in the
C119Lmutant structure a displacement of the E44 residuewas observed
(Fig. 2); however, most distances among residues in the K48-network
were not signiﬁcantly affected (Fig. 2 and Table 1). The reasons for the
difference with respect to the SsOGTm structure are currently not
clear. We previously observed that the C119L protein 3D structure
does not completely overlap the SsOGTm structure [10], suggesting
that the C119L mutant might not be an optimal model of SsOGT alkyl-
ation. Therefore, we sought to obtain independent experimental
support to our hypothesis.
Wepreviously obtained theC119Fmutant that, by virtue of the pres-
ence of a phenylalanine residue substituting the catalytic cysteine in the
active site, mimics a “benzylated” form of the protein. Consistently, bio-
chemical analysis showed that, similarly to the C119L mutant, this pro-
tein is also greatly destabilized, and preliminary crystallization trials
failed [10]. Similar results were obtained with the C145F mutant of
hAGT, which was extremely unstable when heterologously expressed
in E. coli [19]. Nevertheless, new crystallization trials were successful
and allowed the resolution of the SsOGT-C119F structure at 2.7 Å
(Fig. 3 and Table 2). Interestingly, the structural analysis of SsOGT-
C119F revealed elements of novelty compared to the available AGT
structures that represent the protein at the different stages of the
alkyltransferase reaction [4,7–10,13,19,36–38]. It has been suggested
that alkylation of the active site could trigger movements of the con-
served recognition helix belonging to the HTH motif, explaining the
in vivo destabilization of the reacted form of the protein. However, a
comparative structural analysis performed on the ligand-free and
alkylated forms of the human enzyme did not reveal signiﬁcant shifts
of the correspondent recognition helix away from the Nter domain of
the protein [18,19]. By analysing the SsOGT-C119F structure, we directly
observed for the ﬁrst time a repositioning of the recognition helix H4,
probably induced by the need to make room for the alkyl adduct in
the active site pocket (i.e. the aromatic moiety of F119 side chain). Con-
comitantly, we observed a repositioning of the N111 of the highly
conserved Asn-hinge of the protein (Fig. 3, inset), a residue that is crucial
for protein stability; in fact, themutation to alanine of the equivalent as-
paragine residue (N137) in the human ortholog resulted in a dramatic
protein destabilization [35].
In this new conformation, N111 moves approximately 2.0 Å toward
the active site loop that constitutes part of the opposite wall of the cat-
alytic cavity, and establishes a hydrogen bondwith the hydroxyl moiety
of the S132 residue (Fig. 3). A partial movement of S132 was previously
observed in the crystal structure of SsOGTm andwas associatedwith the
loss of interaction between R133 and D27, triggering protein unfolding
[10]. Moreover, the structural analysis of SsOGT-C119F conﬁrms our hy-
pothesis that alkylation of the active site induces further amino acid re-
positioning that alters the protein stability. Indeed, the peculiar
arrangement of ionic bonds observed inside the K48-network of the
ligand-free protein in the SsOGT-C119F structure is destroyed at the
d
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Fig. 1. The stages of the SsOGT activity analysed by DDMP. Available structures were
compared in pairs, as indicated, leading to three distinct DDM plots (a, b and c). Clusters
of lost (in magenta) and gained (in green) interactions were numbered and described in
the text. Insets represent the position of the identiﬁed interactions of each
corresponding cluster on the free protein 3D structure. SsOGT, the DNA-bound and
SsOGTm were represented in cyan, yellow and magenta colour, respectively. (d) Overall
structure of the free SsOGT, where identiﬁed clusters are numbered as in (c) and
indicated in magenta. Amino acid atoms are coloured according the CPK convention
(carbon, in white or in the corresponding colour of each 3D structure; oxygen, in red;
nitrogen, in blue, sulphur, in yellow).
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same extent as in the methylated form of the protein (Fig. 2 and
Table 1). The extent of the movements detected in the K48-network as
a consequence of the active site modiﬁcation is summarized in Table 1.
As previously demonstrated, transalkylated AGTs are permanently
inactivated and prone to degradation both in vivo and in vitro [1,2,10–
12,19]. The opening of the tertiary structure that we observed in the
SsOGT-C119F mutant may represent the mechanism for protein
destabilization and its consequent degradation in vivo. Overall, the anal-
ysis of the SsOGT-C119F structure allowed us to better describe the con-
formational modiﬁcations that characterize the SsOGT protein,
following the entire alkyltransferase reaction.
The differences between the C119F and C119L structures at the level
of the K48-network are currently difﬁcult to interpret: for instance, al-
though the interactions formed by the K48 residue were similar in the
C119F and in the SsOGTm, but not in the C119L, the reverse was true
for the position of the E44 residue (Table 1; Figs. 2 and 3), showing
that neither mutant could faithfully recapitulate all conformational
changes triggered by physiological alkylation. These results should sug-
gest caution, in general, in the interpretation of structure-function data
obtained with synthetic mutant proteins. Indeed, post-translational
modiﬁcations of a native protein might affect the protein conformation
in a differentmanner as comparedwith amino acid substitutions, which
are incorporated in the protein structure co-translationally. In our case,
the availability of structural and biochemical data obtained from two in-
dependent mutants, along with the physiologically methylated protein,
helped to partially overcome these limitations.
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Fig. 2. TheK48-network in SsOGT. 3D structures are in transparent cartoon representation, in a colour code as in Fig. 1. TheK48-network residues are indicated and displayed in ball and stick
format. Yellow arrows illustrate themovement of side chains on the structure, during the stages of the SsOGT activity and in the cysteine 119mutants (C119L in grey, C119F in green). H1,
H5 and cl stand for Helix 1, Helix 5 and the connecting loop, respectively. Amino acid atoms are coloured as in Fig. 1.
Table 1
Comparison of the distances among the K48-network residues in all available SsOGT 3D
structures.
Entrya Interaction Distance (Å)
SsOGT DNA-bound SsOGTm C119L C119F
① E44 (Oε1) ⇔ E62 (Oε2) 2.63 8.74 7.50 8.11 6.57
② K48 (N) ⇔ E62 (Oε2) 3.02 5.33 4.82 3.12 4.60
③ K48 (N) ⇔ R61 (Oα) 3.05 6.67 6.39 3.21 5.01
④ K48 (N) ⇔ N59 (Oα) 2.87 5.08 6.73 3.06 3.80
a The encircled numbers refer to the distances graphically represented in Fig. 2.
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3.3. Molecular dynamics (MD) simulations
In order to obtain independent information on the role of SsOGT res-
idues in the protein stability, we followed the mobility of SsOGT resi-
dues by MD simulations. SsOGT wild type, C119A, C119L, and C119F
mutantswere simulated for 200 ns at 353 K (80.0 °C). To assess the sim-
ulation stability, somegeometrical properties such as the average values
of the radius of gyration (RG), the number of intra-protein hydrogen
bonds (HBintra) and the solvent-accessible surface area (SASA), both
apolar and polar, were monitored as a function of time; all these
properties indicated that the structures were stable during the entire
simulation (Table 3). Information about protein equilibration is provid-
ed by convergence of RMSD of the atomic position, with respect to the
initial structure, calculated as function of time. The comparison of
these values (Table 3) and the RMSD plots (Fig. S1b) indicated that
free SsOGT requires less time to equilibrate and its RMSD is the lowest.
The resulting average conformation for each simulation was used to
perform a second MD simulation for 200 ns at 500 K (227.0 °C, Supple-
mentary Table 2). Thus, theMD simulation at 353 Kwas used to analyse
the protein structure at physiological temperature, while the one at
500 K was used to interpret the effect of mutations on structural
changes.
In order to obtain further insights into the dynamics of SsOGT struc-
ture, the principal component analysis (PCA)was used to dissect out co-
operative inner motions. In free SsOGT (Fig. 4), at 353 K we observed
movements of a few residues; at 500 K the internal molecular motion
was obviously increased, especially in the Cter domain, with signiﬁcant
movements of residues in helices H3, H4 and H5. By contrast, the Nter
domain showed higher stability, which can be explained in terms of
rigid body-like behavior, since all its secondary structures moved to-
gether in the same direction, and the whole domain behaved like a sin-
gle object. In the SsOGT mutants (Fig. S1a), the motions in the MD
simulations performed at 353 K showed that overall molecular internal
motion increases: in particular, the K48-network region was more
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Fig. 3. Structural analysis of SsOGT-C119F. Cartoon representation of the crystal structure of the ligand-free form ofwild-type SsOGT (pdb: 4ZYE: in cyan) and of the C119Fmutated variant
(pdb: 5LLQ, in green), upon optimal superposition. A zoomed view of the conformational changes observed in the C119F variant active site appears in the inset on the right. The yellow
arrows indicate the relevant movements of the N111 residue and of the recognition helix H4, as described in the main text. For the colour code of amino acid atoms, refer to the
description in Fig. 1.
Table 2
Data collection, phasing, and reﬁnement statistics of the SsOGT-C119F
mutant.
Data collection
Space group P212121
Wavelength (Å) 1.008
Resolution (Å) 2.7
Total reﬂections 51,418
Unique reﬂections 12,411
Mean (I)/sd (I) 10.26 (3.35) a
Completeness (%) 96.5 (97.7) a
Multiplicity 4.1 (4.3) a
Rmerge (%) 10.2
Rmeas (%) 11.6
Reﬁnement
Rfactor/Rfree (%) 17.2/23.7
Protein atoms 2380
Ligand atoms 12
Water molecules 30
R.M.S.D. bonds (Å) 0.016
R.M.S.D. angles (°) 1.38
Average B (Å2)
Protein 32.40
Solvent 30.20
Ligands 47.40
Table 3
Selected structural properties of SsOGT structures at 353 K.
System RG
(nm)
HBintra Apolar
SASA
(nm2)
Polar
SASA
(nm2)
Cα RMSD
(nm)
RMSD
(nm)
SsOGT 1.53 ± 0.02 100 ± 6 42 ± 2 50 ± 2 0.13 ± 0.03 0.23 ± 0.04
C119A 1.56 ± 0.01 101 ± 6 37 ± 1 54 ± 1 0.16 ± 0.04 0.52 ± 0.17
C119L 1.54 ± 0.02 96 ± 6 37 ± 2 53 ± 2 0.14 ± 0.03 0.39 ± 0.19
C119F 1.56 ± 0.02 97 ± 5 38 ± 2 54 ± 2 0.15 ± 0.03 0.39 ± 0.16
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unstable in all mutant structures, as compared with the wild-type. The
dramatic effect of mutations on protein stability was evenmore evident
inMD simulations at 500 K (Supplementary Table 2). Themutant struc-
tures showed overall larger movements than wild type SsOGT: these
movements were mainly in the Cter domain of the protein, consistently
with our previous analysis which identiﬁed in this domain nuclei of de-
stabilization that could provide explanation of protein degradation
in vivo upon alkyltransferase reaction, i.e. destroyed interactions and
the displacement of conserved α-helixes (H2 and H4) [10]. In all mu-
tants, strong movements were also observed in the Nter domain,
which cannot be considered as rigid-body in these structures.
The above analysis conﬁrmed that SsOGT stability depends on chem-
ical modiﬁcation of the catalytic cysteine, and all the mutations that
mimic different adducts at the C119 residue have dramatic effects,
353 K
(80 °C)
500 K
(227 °C)
elbatsnuelbats
Nter
Cter
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K48
N59
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E62
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Fig. 4. PCA analysis of wild type SsOGTMD simulations. PCA analysis was performed to analyse the dynamics of residues during theMD simulations performed at 353 and 500 K. A colour
scale is used to indicate the stable (blue) and unstable (red) portions of the protein structures. Detail of K48-network region of bothMD simulation results is depicted. Amino acid atoms are
coloured as described in Fig. 1.
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decreasing the overall protein stability and enhancing residue move-
ments at high temperature. Increased movements were observed in
the two protein domains, aswell as at the level of the interdomain inter-
face, where the D27-R133 and K48-network interactions are perturbed.
3.4. Analysis of the functional role of the K48-network
In order to establish the role of the K48-network in SsOGT stability
and activity, we prepared three site-directedmutants carrying substitu-
tions of crucial residues in the network, namely E44L, K48A and K48L.
We analysed the catalytic and DNA repair activity of these mutants
by using the ﬂuorescence based assays previously developed [10,11].
The former was determined by measuring the efﬁciency of the alkyl-
transfer reactionwith the synthetic substrate BG-VG; at 25.0 °C, the cat-
alytic activity of mutants was not signiﬁcantly different from that of the
wild-type protein (Table 4). DNA repair activity assays were performed
by using a dsDNAm as a competitor of the ﬂuorescent substrate, thus
giving a measure of the overall protein activity [10,11]. As shown in
Table 4, whereas the efﬁciency of lesion repair by the E44L mutant
was similar to that of the wild-type SsOGT, both K48 mutants showed
a slight reduction of the repair efﬁciency (KDNA of 1.6 vs 0.8 μM at
50.0 °C).
In thermal stability assays, the E44L mutant showed the same resis-
tance to thermal denaturation as thewild type; instead, the K48A/L mu-
tants were signiﬁcantly destabilized, and aggregated above 65.0 °C (data
not shown). As expected, Tm values determined by DSF showed a reduc-
tion of ca. 8.0 and 10.0 °C for K48A andK48L, respectively (Table 4). Thus,
these data, consistently with the structural observations, demonstrated
that the integrity of the K48-network contributes signiﬁcantly to the pro-
tein stability; moreover, substitution of the E44 residue has minor im-
pact on protein stability with respect to the K48 residue, in agreement
with the central position and multiple intramolecular interactions
established by this latter residue within the network in the free protein.
In conclusion, our biochemical analysis demonstrated that perturba-
tion of the K48-network affects mainly SsOGT stability, and at lesser ex-
tent its DNA repair activity, consistent with the notion that AGT
alkylation has a minor effect on the DNA binding activity [10,39].
Taken together, these results support the hypothesis that the main
role of the K48-network is contributing to stabilizing connection be-
tween the Nter domain and the connecting loop.
4. Conclusions
Our combined structural, biochemical,mutational andmolecular dy-
namics analysis demonstrate that the K48-network, along with the pre-
viously identiﬁed D27-R133 interaction, contributes to maintain the
correct folding of SsOGT and is perturbed after lesion recognition.
Based on our previous and present data, we propose a model of the
conformational changes and fate of the SsOGT upon the repair of
alkylated DNA (Fig. 5). The optimal activity and stability of SsOGT re-
quire coordination between the Nter and Cter domains of the protein;
in fact, several intramolecular interactions are found at the interface
Table 4
Biochemical characterization of the activities and the stability of theK48-networkmutants,
in comparison with the wild type SsOGT.
Catalytic activity
BG-VG
(M−1 s−1)a
DNA repair
activity
KDNA (μM)b
Thermal
stability
Tm (°C)c Note
SsOGT 2730 ± 320 0.83 ± 0.02 80.0 ± 0.4 From ref. [10]
E44L 1960 ± 410 0.66 ± 0.13 80.7 ± 0.1 This study
K48A 3090 ± 240 1.61 ± 0.30 72.0 ± 0.3 This study
K48L 2880 ± 330 1.59 ± 0.23 70.4 ± 0.3 This study
a Second-order rate constants of the trans-alkylation activity at 25.0 °C on the ﬂuores-
cent substrate from three independent experiments, accordingly to the conditions previ-
ously reported [10] (see Materials and methods).
b Competition assaywith BG-VG andamethylated-dsDNAoligonucleotide for 10min at
50.0 °C. IC50 valueswere from three independent experiments; KDNA valueswere obtained
as shown in Materials and methods.
c Data obtained from three independent DSF experiments, as described inMaterials and
methods.
Fig. 5.Model of the conformational changes and fate of the SsOGT upon repair of alkylated DNA. The Nter and Cter domains of the free enzyme (in cyan; PDB ID: 4ZYE) are stabilized and
coordinated by the presence of two locks (coloured dots), namely the D27-R133 interaction [10] and the K48-network, respectively. SsOGT binds the DNA (in yellow, and in gray,
respectively; PDB ID: 4ZYD) and recognizes the damaged guanine (O6-MG, in orange ball and stick format), led to the opening only of the lock 2: this state could still allow the enzyme
to dissociate the DNA and restore the K48-network. Upon the alkylation of the catalytic cysteine (mC119), both the locks change to the open state, causing the irreversible
conformational changes in charge of the alkylated-enzyme (in magenta; PDB ID: 4ZYG), and subsequently its destabilization. All the important residues for the activity of SsOGT are
drawn as ball and stick, and coloured as described in Fig. 1.
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between the twodomains,which are likely to contribute to interdomain
communication. Our previous [10] and present work identiﬁed two
groups of interactions, namely the D27-R133 pair and the K48-network,
respectively, playing important role in protein stability, as well as in
communicating the state of active site. We suggest that these interac-
tions act as “locks”: in the ligand-free protein, both locks are in their
“closed state”, thus ensuring the correct folding of the protein for its op-
timal stability and ready to perform the reaction. Binding to DNA and
recognition of the damaged guanine lead to opening of lock 2 only
(through perturbation of the K48-network), destabilizing the link be-
tween the Nter domain and the connecting loop. We hypothesize that
this modiﬁcation is reversible as long as the active site remains unmod-
iﬁed: if the protein dissociates from DNAwithout performing the repair
reaction, the integrity of the K48-network is restored and the structural
stability of the protein is preserved (Fig. 5). However, once the DNA re-
pair reaction is completed, alkylation of the catalytic cysteine induces ir-
reversible conformational changes, ﬁxing the lock 1 (formed by the
D27-K133 ion pair) in its “open state” (Fig. 5). The loss of coordination
between the Nter and Cter domains triggers the SsOGT destabilization
and, subsequently, its degradation.
To the best of our knowledge our studies provided themost detailed
description of alkylation-induced conformational changes occurring in a
protein of this class. The unavailability of a similarly detailed analysis for
the human as well as other AGTs impairs extensive comparison of these
results. By analysing the available structures of humanAGT [7,13,19]we
notice that the region corresponding to that containing the K48-network
in SsOGT, is characterized by the presence of hydrophobic residues that
stabilize contacts between the α-helix belonging to the N-terminal do-
main and the random coiled loop connecting the two protein domains.
Although this hypothesis could not be tested directly, due to the insta-
bility of alkylated hAGT structures, these hydrophobic interactions
might play a role similar to the SsOGT K48-network. Thus, our model
might be extended to other AGTs, assuming that, whatever their nature,
interdomain communication and coordination play a key role in main-
taining proper folding and respond to alkylation triggering destabiliza-
tion and degradation.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2016.10.020.
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Mycobacterium tuberculosis O6-methylguanine-DNA methyl-
transferase (MtOGT) contributes to protect the bacterial GC-rich
genome against the pro-mutagenic potential of O6-methylated
guanine in DNA. Several strains of M. tuberculosis found
worldwide encode a point-mutated O6-methylguanine-DNA
methyltransferase (OGT) variant (MtOGT-R37L), which displays
an arginine-to-leucine substitution at position 37 of the poorly
functionally characterized N-terminal domain of the protein.
Although the impact of this mutation on the MtOGT activity
has not yet been proved in vivo, we previously demonstrated
that a recombinant MtOGT-R37L variant performs a suboptimal
alkylated-DNA repair in vitro, suggesting a direct role for
the Arg37-bearing region in catalysis. The crystal structure of
MtOGT complexed with modified DNA solved in the present
study reveals details of the protein–protein and protein–DNA
interactions occurring during alkylated-DNA binding, and the
protein capability also to host unmodified bases inside the active
site, in a fully extrahelical conformation. Our data provide the
first experimental picture at the atomic level of a possible mode
of assembling three adjacent MtOGT monomers on the same
monoalkylated dsDNA molecule, and disclose the conformational
flexibility of discrete regions of MtOGT, including the Arg37-
bearing random coil. This peculiar structural plasticity of MtOGT
could be instrumental to proper protein clustering at damaged
DNA sites, as well as to protein–DNA complexes disassembling
on repair.
Key words: co-operativity, crystal structure, DNA-bind-
ing protein, DNA repair, Mycobacterium tuberculosis,
O6-methylguanine-DNA methyltransferase.
INTRODUCTION
Mycobacterium tuberculosis displays a remarkable genetic
stability despite the continuous exposure to potentially
promutagenic and genotoxic stresses that could compromise the
pathogen’s capability of establishing a latent infection in
the human host and exiting from the dormant state at reactivation
[1,2]. Generated by the M. tuberculosis-infected macrophages
as part of the antimicrobial response, highly reactive oxygen and
nitrogen intermediates can directly damage several mycobacterial
targets, including DNA, and can trigger the endogenous synthesis
of potent DNA-alkylating metabolites [3–5].
As observed in other organisms, M. tuberculosis repairs
alkylated bases in DNA either by using multi-enzymatic systems
or through the action of single proteins [6,7], such as the
O6-methylguanine-DNA methyltransferase (OGT, EC 2.1.1.63).
Genes encoding O6-alkylguanine-DNA alkyltransferases (altern-
atively abbreviated as AGT or MGMT) have been identified
in the genome of the most diverse organisms, and numerous
studies aimed at the functional characterization of members
of this protein family have been published (reviewed by Pegg
[8,9]). These analyses reveal that alkyltransferases preferentially
repair O6-alkylated guanine in DNA, invariably performing the
stoichiometric transfer of the alkyl group from the modified base
to a conserved cysteine residue buried in their active site [10–
12]. Much less is known about the cellular fate of the inactivated
protein resulting from DNA repair, although it has been proposed
that the irreversible alkylation of the catalytic cysteine could
induce conformational changes, which might increase protein
instability in vitro and its propensity to degradation in vivo [13,14].
The M. tuberculosis OGT (MtOGT)-encoding gene is part of
the mycobacterial adaptive response operon [15], and evidence
was obtained pointing at MtOGT as a main player in protecting
the M. tuberculosis chromosome against the risk of G:C-to-A:T
transition mutations associated with O6-alkylated guanine in DNA
[3,6,16,17]. It is interesting that a number of geographically
widely distributed M. tuberculosis strains and multidrug-resistant
isolates are characterized by point-mutated OGTs carrying an
amino acid substitution at position 15 or 37 of the N-terminal
domain (T15S and R37L), and it has been proposed that a
defective alkylated-DNA repair could have played a role in
tuning the balance between genome stability preservation and
adaptability to the host during the evolutionary history of the
pathogen [18–20]. Although the functional consequences of
the presence of these MtOGT variants on the biology of the
corresponding strains have not yet been determined, we showed
that a recombinant MtOGT-R37L is significantly impaired in
alkylated-DNA damage reversal in vitro, displaying a 10-fold
lower affinity for methylated dsDNA (dsDNAmet) with respect to
the wild-type protein [21].
Parallel X-ray crystallography studies of the ligand-free form
of MtOGT showed that Arg37 belongs to a mainly random coiled
region (residues 28–47) of the N-terminal domain, the sequence
and overall structure of which significantly vary among OGTs
from different species [21]. Moreover, Arg37 maps away from the
protein active site and the DNA-binding motifs so far identified,
Abbreviations: AGT, O6-alkylguanine-DNA alkyltransferase; E1X-dsDNA, N1-O6-ethano-2′-deoxyxanthosine-containing dsDNA; hAGT, human AGT;
HTH, helix–turn–helix; MtOGT, Mycobacterium tuberculosis OGT; OGT, O6-methylguanine-DNA methyltransferase; VG, SNAP-VISTA Green reagent.
1 Correspondence may be addressed to either of these authors (email menico.rizzi@uniupo.it or franca.rossi@uniupo.it).
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based on structural analyses of the human orthologue O6-
alkylguanine-DNA alkyltransferase (hAGT) [22–25]. Finally, the
structural comparison of MtOGT and MtOGT-R37L showed that
the Arg37-to-Leu substitution produces a negligible impact on the
protein conformation in the absence of ligands [21], underlining
the need to obtain the structure of MtOGT in alternative substrate-
bound states in order to elucidate the molecular determinants of
the observed suboptimal catalysis performed by the MtOGT-R37L
variant.
In the present study we describe the crystal structure
of wild-type MtOGT complexed with a modified dsDNA
molecule, N1-O6-ethano-2′-deoxyxanthosine-containing dsDNA
(MtOGT::E1X-dsDNA), which reveals similar as well as peculiar
traits when compared with the equivalent structure of human AGT
[24]. Indeed, in the MtOGT::E1X-dsDNA structure, we directly
observed, for the first time, a possible mode of assembling three
adjacent protein chains on to the same damaged DNA duplex.
This allowed us to gain insight into the architecture of protein–
DNA complexes that could explain the co-operative DNA-binding
mechanism of MtOGT, which was suggested by EMSA-based
analyses [21] and the present study. It is interesting that, in the
MtOGT::E1X-dsDNA structure, the protein monomers that are
not engaged in binding the modified base are equally observed
to host an unmodified adenine in their active site, contributing
further information to the vision of a mechanistic model of the
alkylation damage detection process. Finally, discrete regions of
both the N- and the C-terminal domains of MtOGT display a
high level of structural plasticity, a specific MtOGT feature that
could be required for proper protein assembly at the alkylated
site during DNA repair, as also suggested by the biochemical
and structural characterization of additional MtOGT mutated
variants.
EXPERIMENTAL
Chemicals
All reagents were obtained from Sigma–Aldrich unless otherwise
specified.
Expression and purification of point-mutated MtOGT variants
The pET-MtOGT construct coding for the wild-type M. tuber-
culosis O6-methylguanine methyltransferase (ORF: Rv1316c)
[21] was used as the DNA template in PCR-based site-directed
mutagenesis experiments, using the QuikChange II site-
directed mutagenesis kit reagents (Stratagene) and the primer
pairs R37K fwd/R37K rev, R37E fwd/R37E rev, and Y139F
fwd/Y139F rev (see Supplementary Table S1). The region
encoding the corresponding point-mutated MtOGT variant in
each resulting expression construct (namely pET-MtOGT-R37K,
pET-MtOGT-R37E and pET-MtOGT-Y139F) was verified by
sequencing (Eurofins MWG Operon). The expression and
purification of the three new point-mutated versions of MtOGT
used in crystallization trials and activity assays were achieved
by adopting the same procedure used for the wild-type protein
[21]. All proteins are monomeric and display similar stability in
solution (results not shown).
Synthesis of the E1X-containing oligonucleotide
The E1X monomer [26] was prepared adopting the reaction
scheme illustrated in Supplementary Figure S1. The full procedure
used for the synthesis of the E1X-modified oligonucleotide
(ON473 in Supplementary Table S1 and Supplementary Figure
S2) appears in the Supplementary Methods section. The ON473
oligonucleotide was annealed to 1.2 molar equivalents of the
complementary strand (anti-ON473 in Supplementary Table S1)
in 20 mM Tris/HCl, pH 7.5, and 25 mM NaCl, resulting in the
E1X-dsDNA used in crystallization trials.
Crystallograpic studies
Crystallization
Wild-type MtOGT was purified as previously described [21],
with buffer exchanged against 20 mM Tris/HCl, pH 7.5, and
25 mM NaCl (PD10 column, GE Healthcare), mixed with E1X-
dsDNA in equimolar ratio, and incubated for 18 h at 4 ◦C. The
reaction mixture was concentrated (10-kDa molecular mass cut-
off, Vivaspin, Vivascience, Fisher Scientific) and loaded on to
a size-exclusion chromatography column (Superdex 200 10/300,
GE Healthcare). The MtOGT::E1X-dsDNA complexes eluted in
a broad peak corresponding to absorption maxima at wavelengths
280 nm and 260 nm; the corresponding fractions were pooled, and
concentrated up to 5 mg/ml as described above. Crystallization
conditions for the MtOGT::E1X-dsDNA complex were identified
by means of a robot-assisted (Oryx4, Douglas Instruments)
sitting-drop-based spare-matrix strategy using kits from Hampton
Research and Qiagen. The initially obtained needle clusters
were used as micro-seeds to inoculate 1 µl of freshly prepared
MtOGT::E1X-dsDNA complex mixed with an equal volume of
reservoir solution (0.2 M ammonium acetate, 22% PEG 3350
and 0.1 M Hepes, pH 7.5), and equilibrated in a hanging drop
against 800 µl of the reservoir solution at 4 ◦C. Single thin rod
crystals grew up to their maximum dimensions of 0.05 mm in
about 6 weeks. Crystals of the R37K or Y139F MtOGT variants
were grown using the hanging-drop vapour-diffusion method by
mixing 2µl of the corresponding protein solution at 5 mg/ml with
an equal volume of a reservoir solution containing 0.1 M Hepes,
pH 7.5, 4% PEG 8000, and either 4% or 8% ethylene glycol
(for MtOGT-R37K and MtOGT-Y139F, respectively); the drops
were equilibrated against 800 µl of the corresponding reservoir
solution at 4 ◦C until crystals reached their maximum dimensions
of 0.2 mm in about 2 weeks.
Data collection
All crystals used in diffraction experiments were directly taken
from the corresponding crystallization drop, rapidly equilibrated
in the specific reservoir solution containing 15% glycerol as
cryoprotectant, and flash-frozen under liquid nitrogen. Diffraction
experiments were conducted at 100 K using synchrotron
radiation at the ID-29 (MtOGT::E1X-dsDNA complex) or ID14-
EH4 (MtOGT-R37K and MtOGT-Y139F variants) beamlines
(European Synchrotron Radiation Facility, Grenoble, France).
Complete diffraction datasets were collected up to 3.0-,
2.3- and 2.6-Å resolution (1 Å=0.1 nm) for crystals of the
MtOGT::E1X-dsDNA complex, and the MtOGT-R37K and
the MtOGT-Y139F variants, respectively. For all data collections,
diffraction intensities were integrated and scaled by using the
CCP4 suite of programs [27].
Structure determination
Analysis of the MtOGT::E1X-dsDNA diffraction dataset assigned
the crystal to the orthorhombic space group P212121, with cell
c⃝ 2016 Authors; published by Portland Press Limited
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Table 1 Data collection, phasing and refinement statistics
Values in parentheses refer to the highest resolution shell.
MtOGT::E1X-dsDNA MtOGT-R37K MtOGT-Y139F
Data collection
Space group P212121 P21212 P21212
Wavelength (A˚) 0.972 0.979 0.99
Resolution (A˚) 3.0 2.3 2.6
Total reflections 62 363 50 946 17 965
Unique reflections 12907 8668 5719
Mean(I)/S.D.(I) 8.8 (1.6) 26.7 (8.5) 10.8 (2.4)
Completeness (%) 99.7 (99.9) 99.5 (100) 95.9 (100)
Multiplicity 4.8 (5.0) 5.9 (6.0) 3.1 (2.9)
Rmerge (%) 15.0 3.9 6.1
Rmeas (%) 16.9 4.3 7.3
Refinement
R factor/R free (%) 19.4/26.5 18.4/22.5 20.4/27.6
Protein/DNA atoms 4257 1257 1258
Ligand atoms 6 12 4
Water molecules 8 61 9
RMSD bonds (A˚) 0.011 0.009 0.014
RMSD angles (◦) 1.42 1.05 1.75
Average B (A˚2)
Protein 62.0 41.7 55.0
Solvent 27.2 40.9 50.8
dimensions a = 43.48 Å, b = 102.90 Å and c = 137.09 Å,
containing three protein chains and one dsDNA molecule per
asymmetrical unit, with a corresponding solvent content of
50%. The structure of the MtOGT::E1X-dsDNA complex was
solved by molecular replacement using the program Phaser [28].
The starting search model for the protein component was the
structure of MtOGT (PDB accession code 4BHB) [21], edited
to omit Tyr139 of the active-site loop and the C-terminal tail
(residues 156–165); the starting search model for the DNA
component was the E1X-dsDNA, as crystallized in complex
with hAGT (PDB accession code 1T39) [24], omitting bases
12–13 and 14–15 of the duplex. The resulting electron density
map was of good quality, allowing manual model rebuilding,
using the program Coot [29]. The programs PHENIX [30] and
Refmac [27] were used for crystallographic refinement and to add
water molecules. The structures of MtOGT-R37K and MtOGT-
Y139F were solved by molecular replacement using the program
Phaser [28] and the structure of wild-type MtOGT as the search
model (PDB accession code 4BHB) [21], omitting water/ligand
molecules and either Arg37 or Tyr139 respectively. In both cases,
the procedure yielded high-quality electron density maps. Manual
model building, crystallographic refinement and solvent addition
were performed as described above for the MtOGT::E1X-dsDNA
structure. The stereochemistry of the refined models has been
assessed using the program PROCHECK [31]. Data collection
and refinement statistics are summarized in Table 1. Structural
superimpositions were performed with the Superpose program
of the CCP4 suite [27]; figures were generated using PyMol
(http://www.pymol.org).
Deposition
The atomic co-ordinates and structural factors of the
MtOGT::E1X-dsDNA complex, MtOGT-R37K and MtOGT-
Y139F have been deposited in the Protein Data Bank
(http://www.rcsb.org) under PDB accession codes 4WX9, 4WXC
and 4WXD, respectively.
Biochemical analyses
To measure the alkyltransferase activity of the new MtOGT point-
mutated variants. MtOGT-R37K, MtOGT-R37E and MtOGT-
Y139F, competitive assays using the fluorescent SNAP-Vista
Green reagent (VG; New England Biolabs) were performed as
previously described [21,32]. Similarly, the EMSA-based analysis
of the three mutated variants of MtOGT was performed adopting
the same protocol used to characterize the wild-type protein and
its R37L and T15S mutated versions [21].
RESULTS
Overall structure of MtOGT complexed with E1X-dsDNA
In order to clarify the functional role of Arg37 in MtOGT-
mediated catalysis, we co-crystallized the wild-type protein in
the presence of the 13-bp-long E1X-dsDNA, thus choosing the
same experimental strategy first adopted by Daniels et al. [24]
to solve the structure of wild-type hAGT covalently bound to a
modified dsDNA (PDB code 1T39). Different from the equivalent
structure of the human enzyme, in the MtOGT::E1X-dsDNA
crystal structure, three protein chains (A, B and C) and one E1X-
dsDNA molecule are present in the asymmetrical unit, with chain
A binding the E1X base at position 7 of the modified strand (E1X7)
(Figure 1a). It is of interest that, by applying crystallographic
symmetry operators, a peculiar supramolecular assembly can be
observed in the MtOGT::E1X-dsDNA crystal lattice (Figure 1b).
By focusing on a unit consisting of chain A bound to the E1X7
base, and counting nitrogenous bases starting from the 5′-end of
each strand, a symmetry equivalent of chain C (‘C sym. mate’)
binds the deoxyadenosine residue at position 4 of the modified
strand (dA4), and a symmetry equivalent of chain B (‘B sym.
mate’) does the same with the deoxyadenosine residue at position
5 of the complementary strand (dA18). In all cases, the bound base
adopts a fully extrahelical conformation, and is deeply inserted
into the protein active site. Overall, the MtOGT::E1X-dsDNA
complex can be described as consisting of two co-oriented MtOGT
monomers sharing 1 bp of their 4-bp-long DNA-anchoring site
on the damaged strand and displaying a reciprocal ‘N-to-C’
domain arrangement (‘chain A’ and ‘C sym. mate’), whereas
the third chain (‘B sym. mate’), which binds the intact strand,
shows a ‘C-to-C’ domain arrangement with respect to chain A
(Figure 1c).
The association of each MtOGT chain on to the E1X-
dsDNA molecule is mainly stabilized by the strong protein–DNA
interactions established by the helix–turn–helix (HTH) motif and
a few conserved active site residues of each subunit, with the DNA
minor groove and the flipped base, respectively (see below). In
contrast, protein–protein interchain contacts are limited to a weak
interaction engaging the co-oriented monomers ‘chain A’ and
‘C sym. mate’ (Figure 1b, inset). However, it must be noticed
that, different from the crystal structures of wild-type MtOGT
and point-mutated variants of the protein in their ligand-free
forms [21] (and the present study), in the MtOGT::E1X-dsDNA
structure no electron density was visible for chain A residues 33–
35 (omitted from the final model), and a poor electron density
characterizes region 29–36 of the N-terminal domain random coil
in each chain. For this reason, we cannot assume, under physiolo-
gical conditions, that a higher number of contacts are established
between the MtOGT chain binding the alkylated base and the
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Figure 1 The overall structure of MtOGT complexed with modified DNA
(a) Cartoon representation of the asymmetrical unit content of the MtOGT::E1X-dsDNA crystal; the E1X-containing dsDNA is observed complexed with chain A, the C-terminal domain of which hosts
the modified base (E1X, red arrowhead). (b) Cartoon representation of three MtOGT chains assembled on to the same E1X-dsDNA molecule, resulting from applying crystal symmetry operators;
extrahelical bases are rendered as sticks and indicated by an arrowhead (inset: close-up view of the contact region between the co-oriented chains that bind bases of the modified DNA strand).
(c) Representation of the reciprocal arrangement of the protein chains and DNA duplex illustrated in (b); the broken arrow points to a scheme of the covalent adduct formed between the chain A
catalytic cysteine (Cys126) and the E1X base. The colour codes for protein domain and DNA strand identification appear at the bottom of the figure.
adjacent protein subunit locking the unmodified base at 4 bp
upstream to the lesion (‘chain A’ and ‘C sym. mate’ in Figure 1).
The structure of the MtOGT active site complexed with E1X-dsDNA
Ground-breaking X-ray crystallography-based studies on
recombinant versions of hAGT complexed with modified dsDNA,
containing either a physiologically relevant O6-methylguanine
residue [24] or base analogues carrying bulky substituting groups
[24,25], disclosed the molecular details of the protein association
with alkylated DNA. These results showed that hAGT invariably
binds the dsDNA substrate at the level of its minor groove, by
exploiting the conserved HTH motif of the protein C-terminal
domain. In this peculiar mode of protein–dsDNA assembly, the
modified nitrogenous base is flipped out from the regular base
stacking and clamped into the enzyme active-site pocket, thus
resulting in proper placement of the reactive cysteine (Cys145 in
hAGT) to catalyse the SN2-like dealkylation reaction [24,25].
The architecture of the substrate-binding site of the three
MtOGT chains building up the MtOGT::E1X-dsDNA crystal
structure is quite similar to the one described for the human
orthologue complexed with different dsDNA species (Figure 2a).
Inspection of the active site of MtOGT chain A reveals a
continuous density signal contouring the catalytic Cys126 and
the modified E1X7 base (Figure 2b). Other close protein–DNA
contacts involve: the strictly conserved ‘arginine finger’ (Arg109)
which, by invading the double helix from the minor groove
side, and stacking between the planes of the dG6 and dC8
bases, structurally compensates for the flipped-out E1X7 base; the
carboxamide group of Asn115, observed at a 2.9-Å mean distance
from the E1X7 O2 position; the hydroxy group of Tyr95, standing at
a 3.4-Å mean distance from both the N3 atom and the deoxyribose
moiety of the E1X7 base; the active-site loop residues Thr137 and
Gly140, the backbone oxygen and nitrogen atoms of which are
observed at a distance of 2.8 and 2.7 Å from E1X7 O4′ and
O6, respectively; and Tyr139 which contributes to narrowing of
the active site and increasing the aromatic nature of the ligand-
binding pocket. In addition, the positive charge at the N-side
of helix H3 and the main-chain nitrogen atom of Ala132 appear to
lock, from both sides, the sugar–phosphate backbone downstream
of the lesion (Figure 2c).
With the obvious exception of contacts involving E1X7-specific
positions, an almost identical bonding scheme is observable in the
active site of chains B and C – which host the symmetry equivalent
of the dA18 and dA4 unmodified bases, respectively (Figure 2d),
thus indicating that MtOGT can efficiently bind nitrogenous bases
independently of the presence of the alkyl adduct.
In principle, the insertion of an undamaged adenine residue into
the MtOGT ligand-binding pocket would not expose the DNA
substrate to an increased risk of chemical modifications. In fact,
the reactivity of the purine ring N1 and N6 positions, as they
were observed in the active site of the B and C chains of the
MtOGT::E1X7-dsDNA structure, does not appear significantly
enhanced by the nearby catalytic cysteine, nor by the presence
of the other residues co-ordinating the base (see Supplementary
Figure S3a).
Notably, one of the three protein chains (chain hAGT-B)
building up the crystal structure of hAGT in complex with a
dsDNA containing an N4-alkylcytosine base (PDB code 1YFH)
[25] binds the thymine base at the 3′-end of the modified strand.
However, different from what we observed in the active site
of the B and C monomers of the MtOGT::E1X-dsDNA structure,
the thymine base appears to be only partially inserted into
the hAGT-B ligand-binding pocket (see Supplementary Figure
S3b). We therefore speculated that MtOGT could perform lesion
searching through a non-selective base-flipping mechanism, with
the flipped-out base fully inserted into the active site. If this
assumption is correct, MtOGT could not adopt a gate-keeping
mechanism in discriminating between normal and damaged bases
in vivo, different from what was hypothesized for the human
counterpart [25,33].
MtOGT undergoes structural rearrangements on DNA binding
The structure of MtOGT complexed with E1X-dsDNA discloses
a further unique feature of the mycobacterial protein, i.e. its
conformational plasticity. In fact, the structural analyses of hAGT
[22–25] and Sulfolobus solfataricus OGT [36], at different stages
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Figure 2 Structural analysis of the MtOGT protein complexed with E1X-dsDNA
(a) Cartoon representation of the optimally superimposed structures of MtOGT (chain A) and hAGT (PDB code 1T39), each in complex with the E1X-dsDNA substrate; the E1X base is rendered as
sticks and coloured, applying the same colour codes used for the corresponding protein chain (shown on the top of the panel). (b) Close-up view of the active site of the MtOGT::E1X-dsDNA chain
A housing the modified base (E1X7), with σ A-weighted 2Fo−Fc electron density contoured at 1.0 σ ; the Cys126 thiol group is observed at a distance of 2.1 A˚ from E1X7, the C11 atom; the protein
backbone appears as a ribbon. (c) Close-up view of the MtOGT chain A active site complexed with E1X-dsDNA; secondary structural elements and functional motifs are indicated in italic (the colour
codes for protein domain/DNA strand identification appear in a). (d) Cartoon representation of the active site of optimally superimposed MtOGT::E1X-dsDNA chains A, B and C (average RMSDs are
0.671 and 0.456 A˚ for the couples B/A and C/A, respectively); DNA appears as a cartoon and coloured, applying the same colour codes used for the corresponding protein. Protein residues and DNA
bases mentioned throughout the text are rendered as sticks.
of the transalkylation reaction, suggest that the active site of the
human and archaeal proteins is largely pre-shaped to perform
the catalysis, without requiring heavy structural rearrangements.
On the contrary, the association of MtOGT with the E1X-
dsDNA substrate induces the repositioning of three solvent-
exposed protein regions: a random coiled segment (residues
29–39) of the N-terminal domain, part of the active-site loop
(residues 135–142) and the C-terminal tail (residues 156–165)
(Figure 3a). As a consequence, each protein monomer in the
MtOGT::E1X-dsDNA complex appears more compact than
the ligand-free protein (Figure 3b). These conformational changes
are accompanied by the side-chain repositioning of a number of
residues of both protein domains (Figure 3c). It is interesting that,
in the MtOGT::E1X-dsDNA structure, the segment encompassing
residues 29–35 moves away from the three-stranded β-sheet that
builds up the core of the N-terminal domain, and gets closer to
the DNA-binding surface of the C-terminal domain, behaving as
a flap that sees Arg37 as its pivotal point.
We underline that this analysis was mainly conducted by
inspecting the conformation adopted by chains B and C, because,
different from chain A, their α-carbon backbone at the level of the
flap is fully defined. However, given the minimal average RMSD
resulting from superimposing the three protein chains building
up the MtOGT::E1X-dsDNA crystal structure, and taking into
account that the B and C monomers host a nitrogenous base in their
active site (Figure 2d), we propose that an equivalent structural
repositioning of the flap might also occur in the MtOGT subunit
binding the modified base.
The Arg37-containing random coil could participate in the
co-operative assembly of protein clusters on to the dsDNA
substrate
The analysis of the MtOGT::E1X-dsDNA crystal structure seems
to exclude direct participation of Arg37 in DNA binding, because
the protein residue and the sugar-phosphate backbone of the
E1X-dsDNA substrate are observed at a distance of >16 Å
(Figure 3a). Instead, we propose that Arg37 could function as
a hinge limiting the conformational plasticity at the C-side of the
flap, by participating to keep it in contact with the bulk core of
the N-terminal domain, and also on the formation of the protein–
DNA complex (Figure 3c). In principle, the absence of such
an anchoring site, as exemplified by the MtOGT-R37L variant
characterizing a number of frequently isolated M. tuberculosis
strains, could affect the capability of the flap to undergo discrete
movements. In turn, the resulting unrestrained flexibility of the
N-terminal domain random coil could hamper the correct
assembly of MtOGT clusters at the damaged DNA sites.
To test this hypothesis, we expressed and purified two new
mutated versions of MtOGT (MtOGT-R37K and MtOGT-R37E),
and analysed their dsDNAmet-repairing activity, by adopting the
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Figure 3 The conformation adopted by discrete protein regions differs in the ligand-free and DNA-bound MtOGT structures
(a) Structural superposition of MtOGT in its apo form (PDB code 4BHB, green coloured) and complexed with E1X-dsDNA (PDB code 4WX9), highlighting the main structural rearrangements
characterizing the DNA-bound chain A (in white) and chain C (in violet). (b) Surface representation of a MtOGT monomer in ligand-free and DNA-bound states; the arrows indicate the direction of
the movements of the flap (1), the active site loop (2) and the tail (3) of the protein on DNA binding. (c) close-up views of selected residues, with a side-chain conformation that differs between the
superimposed structures of ligand-free (upper panel) and E1X-dsDNA-bound (lower panel) MtOGT.
same VG-based assay [32] previously used to characterize the
wild-type protein and the MtOGT-R37L variant [21]. Our data
(see Supplementary Table S2) show that the MtOGT-R37E
mutant exhibits a 5-fold lower affinity for the methylated duplex
(KDNAmetR37E = 1.14+−0.15 µM) with respect to MtOGT (KDNAmetwt= 0.24+−0.11 µM [21]), whereas the more conservative Arg37-to-
Lys substitution produces a more limited effect on the dsDNAmet-
binding constant (KDNAmetR37K = 0.38+−0.2 µM).
In parallel, we performed direct EMSA-based experiments
(Figure 4a), using a (carboxy)tetramethylrhodamine (TAMRA)-
labelled, non-alkylated dsDNA probe (see Supplementary Table
S1). It is interesting that the MtOGT-R37E protein reaches a
plateau in band-shift activity at a DNA/protein molar ratio of
1:600 (KDNA-R37E = 41.4+−1.1 µM), whereas both the wild-type
MtOGT and the MtOGT-R37K variant induce a complete shift
at a DNA/protein molar ratio in the range of 1:150 (KDNA-wt =
7.2+−0.2 µM [21], KDNA-R37K = 13.2+−0.7 µM). The results of the
EMSA-based analysis match well with those obtained from the
VG-based competitive assays, and are consistent with previously
published data showing that the recombinant MtOGT-R37L
variant displays a 10-fold lower affinity towards the dsDNAmet
substrate compared with the wild-type MtOGT, although the co-
operativity of DNA binding is maintained [21]. Taken together,
our previous study [21] and the present study confirm that the
Arg37 residue, although not being directly involved in substrate
binding, plays an active role during catalysis, a role that can
be performed almost equally well by the positively charged
lysine residue. By contrast, the presence of a hydrophobic or
negatively charged side chain at position 37 of the MtOGT protein,
which characterizes the MtOGT-R37L and MtOGT-R37E proteins
respectively, translates into less efficient DNA binding and repair.
By analysing the crystal structure of the MtOGT-R37K variant
(Figure 4b and Table 1), we noticed that the lysine residue
could partially substitute for arginine, in terms of charge and
size, inside the peculiar network of contacts established between
the second β-strand and the facing random coiled region of the
N-terminal domain. In the structure of the loss-of-function
MtOGT-R37L protein, the presence of leucine at position 37
destroys this bonding scheme [21]. However, in both of these
ligand-free structures, no relevant changes of the local fold
are observable. Given the requirement of a positively charged
group at position 37 of the protein for a fully efficient catalysis,
we speculate that Arg37 could play a role in co-ordinating the
repositioning of the flap during proper DNA recognition and
binding, thus optimizing molecular contacts between adjacent
monomers assembled on to the damaged DNA, as observed in the
MtOGT::E1X-dsDNA structure.
The intrinsic flexibility of the MtOGT active site loop
As mentioned above, the active-site loop and the C-terminal
tail of MtOGT adopt different conformations, depending on the
association of the protein with the DNA substrate (Figure 3).
Different from what has been reported for all OGTs for which
the crystal structure has so far been solved [22–25,34–36], but
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Figure 4 A positively charged residue at MtOGT position 37 is required for
optimal dsDNA binding
(a) Upper image: EMSA-based analysis of wild-type MtOGT (WT) [21], and of the indicated
point-mutated proteins, performed by using 1 pmol of TAMRA-labelled dsDNA (Table 1) as the
probe (DNA); lanes 2–9: increasing amounts of protein (P) incubated in the presence of the
probe at the indicated DNA/protein molar ratio; in each panel the open arrowheads point to
the shifted DNA probe. Lower image: plot of the DNA-bound protein fraction at each DNA/protein
molar ratio tested by EMSA (upper image); [P], protein concentration (M); K , dissociation
constant (µM). (b) Close-up of the N-terminal domain and part of the of the active site of the
ligand-free MtOGT (PDB code 4BHB) [21] and MtOGT-R37K (PDB code 4WXD), on optimal
structural superimposition; residues mentioned in the text appear as sticks; secondary structure
elements are labelled in italic.
reminiscent of what was observed in the OGT structure of
Methanococcus jannaschii in solution [37], the C-side region
of the active-site loop (residues 136–141) of the ligand-free
structures of MtOGT and its mutated variants is invariably
oriented towards the bulk solvent. This conformation is stabilized
by contacts established between the conserved Tyr139 of the active-
site loop and the stretched-out C-terminal tail of the closest
symmetry mate within the crystal lattice [21] (and the present
study). On the contrary, the C-side of the active-site loop of each
protein chain that builds up the MtOGT::E1X-dsDNA structure
is bent inwards towards the catalytic pocket, where it participates
in making the ligand-binding cavity fit the flipped-out base
(Figure 5a). These observations raise the possibility that the
Figure 5 Tyr139 could help the active-site loop movements during DNA
binding
(a) Close-up view of the active site of MtOGT (PDB code 4BHB) [21] and MtOGT-Y139F (PDB
code 4WXC), both crystallized in ligand-free form, and of the A, B and C chains building up
the MtOGT::E1X-dsDNA complex (PDB code 4WX9), resulting from optimal superimposition of
the corresponding structures (colour codes for protein/chain identification appear on the right);
residues mentioned in the text appear as sticks; secondary structure elements are labelled in
italic. (b) Upper image: EMSA-based analysis of MtOGT (WT) [21] and its Y139F mutated
variant, performed as detailed in Figure 4. Lower image: plot of the DNA-bound protein fraction
at each DNA/protein molar ratio tested by EMSA (upper image); [P], protein concentration (M);
K , dissociation constant (µM).
active site of MtOGT could exist in two alternative conformations
(‘ligand-free/active-site loop out’ or ‘DNA-bound/active-site loop
in’) also in a physiological context, displaying a degree of
structural plasticity higher than that characterizing the equivalent
region of hAGT.
However, if Tyr139 of the active-site loop of MtOGT performed
exactly the same molecular tasks highlighted for the equivalent
residue of the human protein (Tyr158), namely narrowing of the
ligand-binding pocket and providing an aromatic environment
for the alkyl adduct [24,25], then the replacement of Tyr139 by a
phenylalanine should have little effect on catalysis.
Data from VG-based assays (see Supplementary Table
S2) reveal that a MtOGT-Y139F variant displays a 10-fold
lower affinity for dsDNAmet compared with wild-type MtOGT
c⃝ 2016 Authors; published by Portland Press Limited
130 R. Miggiano and others
Figure 6 Structure-based model of MtOGT clustering on to a DNA duplex
(a) The possible negative effect of the presence of a MtOGT monomer (‘B sym. mate’), which is bound to the complementary strand opposing the lesion, on the growth of the protein cluster towards
the 5′-end of the damaged strand. (b) Structure-based model of five co-oriented MtOGT monomers assembled on to the same dsDNA molecule; the close-up images show the interchain contacts
observed at the chain 2/chain 3 (left) and chain 1/chain 5 (right) interfaces; the colour codes for protein domain and DNA strand identification appear at the top of the panel. In (a) and (b), the protein
chains are rendered as on the surface and the DNA appears as a cartoon. (c) Schematic representations of the protein–DNA assemblies depicted in (a) and (b), viewed perpendicular to the dsDNA
axis; the MtOGT monomers that bind bases of the damaged or intact strand are depicted as red or green ovals, respectively; the dashed ovals represent the MtOGT subunit that would come into
collision with pre-assembled monomers.
(KDNAmetY139F = 2.19+−0.5 µM; KDNAmetwt = 0.24+−0.11 µM [21]),
confirming the MtOGT requirement of a tyrosine residue at
position 139 for optimal repair of an O6-methylated guanine in
dsDNA. Instead, the ability of MtOGT to bind unmodified dsDNA
appears less affected by the Tyr139-to-Phe substitution; in fact,
when analysed in EMSA, both proteins reach a plateau in band-
shift activity at a DNA/protein molar ratio of approximately 1:150,
displaying an affinity towards the unmodified probe that differs
3-fold (KDNA-wt = 7.2+−0.2 µM [21], KDNA-Y139F = 20.5+−3.2 µM;
Figure 5b). Therefore, we speculate that Tyr139 could play a role
not only in properly fixing the base inside the protein active
site on DNA binding, as proposed for hAGT Tyr158 [24,25,38–
40], but also in making MtOGT able to discriminate between
intact and alkylated dsDNA molecules, albeit through a molecular
mechanism that will need further study for elucidation.
The MtOGT::E1X-dsDNA crystal structure provides insights into
co-operative DNA binding
The architecture of MtOGT in a stable complex with the E1X-
dsDNA substrate could be regarded as a snapshot of a potential
reaction step at which the modified base has already been
recognized and bound by one monomer (chain A), whereas two
other subunits (the chain B and C symmetry mates) occlude
available binding sites on both strands of the dsDNA substrate,
at the highest possible density allowed in the close proximity
of the lesion, by housing unmodified nucleobases in their
active site (Figure 1). From this standpoint, the supramolecular
assembly revealed by our structure could represent a model
of the MtOGT clustering on a monoalkylated dsDNA
molecule.
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Figure 7 Preliminary model of MtOGT-mediated direct alkylated DNA repair
Schematic diagrams of possible modes of DNA binding, protein cluster assembly and protein–DNA complex dismantling in M. tuberculosis emerging from crystallographic studies. The single steps
are described in the Discussion.
However, we cannot rule out the possibility that longer more
physiological DNA substrates might sustain the nucleation of
MtOGT protein clusters larger in size than the one characterizing
the MtOGT::E1X-dsDNA crystal structure. To verify this
hypothesis, we tried to model further DNA-bound MtOGT
monomers towards the 5′-end of the modified strand, starting
from the experimental ‘C sym. mate’ (monomer ‘2’ in Figure 6),
and using the ‘chain A/C sym. mate’ dimer as the moving unit
(monomers ‘1’ and ‘2’ in Figure 6).
It is of interest that the unprecedented association of a MtOGT
monomer with the region of the intact DNA strand facing the
alkylated base (i.e. the ‘B sym. mate’-binding dA18) would hamper
the recruitment of additional protein subunits at the 5′-side of the
damaged base (Figure 6a).
On the other hand, the MtOGT::E1X-dsDNA crystal structure
itself does not provide any indication regarding the dynamics
of the alkylated-DNA damage reversal performed by MtOGT.
Therefore, we can also assume that the binding of co-oriented
MtOGT monomers on to the modified strand could be favoured
on assembly of protein clusters with components that display
unbiased binding to both strands. To visualize the former situation,
we reiterate the superimposition procedure mentioned above,
by omitting the chain B symmetry mate. We obtained a model
of MtOGT protein clusters (Figure 6b) that proves to be more
compact compared with the one proposed for hAGT [45,46],
possibly due to the structural plasticity of MtOGT, which could
allow more crowded protein assembling on to DNA. It is
interesting that the DNA binding-associated repositioning of the
flap (Figure 3) enables additional contacts between adjacent
subunits. In particular, residues 32–34 of chain 2 are clamped
between the active site entrance of the same chain, and the turn
element of the HTH motif of adjacent chain 3 (residues 100–105)
(Figure 6b, inset on the left), thus strengthening our hypothesis
of a possible direct contribution of the flap to co-operative DNA
binding. Moreover, by considering chains 1 and 5 in our model
(Figure 6b, inset on the right) we noticed that the N-terminal
domain random-coiled region of chain 1 collides with the tail of
chain 5.
This analysis suggests that both short- and long-range steric
hindrance phenomena could play a role in regulating MtOGT–
DNA association and dissociation, resulting in protein clusters
that are capable of self-limiting their size, similar to what has been
experimentally determined by direct atomic force microscopy
(AFM)-based studies of hAGT [47].
DISCUSSION
The architecture of the protein–DNA complexes revealed by
the MtOGT::E1X-dsDNA crystal structure could provide a
potential solution to an inconsistency present in the literature
concerning the DNA-binding mechanism of O6-alkylguanine-
DNA alkyltransferases. Indeed, in spite of the fact that previous
X-ray crystallography-based studies revealed a 1:1 pro-
tein/modified DNA stoichiometry [24,25,34]: (i) the co-operative
binding of DNA has been demonstrated as a bona fide activity
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of hAGT [41–46], (ii) structure-based models of hAGT/dsDNA
supramolecular complexes have been built and experimentally
tested in solution [45], and, more importantly, (iii) the protein
assembling into discrete clusters on physiological DNA substrates
was directly observed by AFM-based experiments [47].
Several authors have analysed the possible functional benefits
of performing alkylated-DNA direct repair in a co-operative
manner. It has been pointed out that co-operative assembly of
protein–DNA complexes might contribute to the efficiency
of lesion search and removal, by concentrating the repair activity
on the DNA substrate at a higher density than that expected in a
non-co-operative DNA-binding model [44]. Furthermore, a small
protein cluster size could allow tracking of a lesion wherever
short regions of free DNA were made available, i.e. during DNA
replication and transcription, on chromatin remodelling [48].
Moreover, an inherent capability of the protein of limiting its
own distribution on DNA could influence the rates of binding to
and dissociation from the target, and hence the kinetics of the
lesion search; in fact, the repositioning of a subunit placed in the
middle of a single long protein cluster should probably be slower
than the repositioning of subunits mapping at the ends of many
short clusters [44,47].
These arguments could work well with our results to outline
a preliminary model of alkylated-DNA recognition and repair
performed by MtOGT (Figure 7). In principle, to guarantee
efficient scouting of alkylated bases inside the genome, both
intact and damaged DNA molecules should represent a ligand
for MtOGT. However, the binding of the protein to an adduct-free
DNA region could be less efficient compared with the binding
to an alkylated substrate, or the protein could form suboptimal
protein clusters (Figure 7, step 1a), leading to a weaker assembly
(or an easier dissociation) of the protein–DNA complex. Our
structural studies show that the insertion of a modified base inside
the MtOGT active site triggers conformational modifications of
solvent-exposed regions of the protein which could act as a
signal that a lesion has been encountered (Figure 7, step 1b).
Additional protein subunits could now be tightly packed, also by
virtue of their peculiar structural flexibility, at the 5′-side of the
lesion, where they undergo the same structural rearrangements
to host extrahelical nucleobases in their active site. In this way,
the GC-rich mycobacterial DNA could be scanned, at a fixed
space interval, for the presence of other alkylated sites (Figure 7,
step 2).
Our results suggest that, although an O-alkylated guanine is a
potential substrate for the catalysis (leading to permanent protein
inactivation), both purine bases could behave as reversible protein
ligands; as a consequence, an unmodified guanine temporarily
occupying the MtOGT active site could be safely checked
for chemical modifications. This corroborates the concept that
identifies, in the alkylated DNA, direct damage reversal performed
by OGTs, a smart system to oversee genome quality [48].
Finally, the conformational changes induced in MtOGT by its
association with DNA appear to directionally bias protein–protein
interaction towards the 5′-end of the modified strand; however, the
harmful sequestration of MtOGT in the form of a continuous
coat on the DNA substrate could be limited either by steric
hindrance phenomena involving co-oriented monomers (Figure 7,
step 3a) or by the association of an MtOGT subunit with the
intact strand region opposing the alkylated base (Figure 7, step
3b), leading to the release of the unreacted monomers into the
free protein pool (Figure 7, step 4), ready to initiate a new
cycle.
Further experiments, using different DNA substrates and
crystallization-independent techniques, have been undertaken to
verify this model.
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Introduction
Labeling of proteins with synthetic probes in living cells 
is an important approach to study protein function (Grone-
meyer et al. 2006). However, radioactive and fluorescent 
probes need complex chemical modification and protein 
purification procedures, leading only in few cases to a spe-
cific labeling of proteins. The introduction of fusion poly-
peptides (tags), which allow to simplify and optimize puri-
fication methods (affinity tags) and/or detection procedures 
(by using specific antibodies) has been fundamental. Nev-
ertheless, most tags do not satisfy the need of the in vivo 
specific detection of proteins of interest. The discovery of 
autofluorescent proteins as the Aequorea victoria green 
fluorescent protein (GFP) made possible the expansion of 
the studies on fusion proteins in several applicative fields of 
cellular and molecular biology (Chalfie et al. 1994; Tsien 
1998). Despite their wide use in the last decades, GFP tag 
and its derivatives have some disadvantages and/or limi-
tations: (1) their relative big dimensions (ca. 230 amino 
acids) in some cases might affect the target protein’s func-
tion and localization; (2) the isolation of the natural fluoro-
phore in the active site makes GFPs and variants partially 
sensitive to environmental changes, as pH (Ashby et al. 
2004; Campbell and Choy 2000); (3) because the forma-
tion of the internal fluorophore is O2-dependent, GFPs are 
not suitable tags in applications requiring anaerobic con-
ditions (anaerobic organisms and tumor cells in particular 
stages); (4) the general use of most protein-tags is restricted 
to mesophiles and mild reaction conditions. Recently, ther-
mostable GFPs variants have been developed as tags for 
thermophilic microorganisms (Aliye et al. 2015; Cava et al. 
2008; Pédelacq et al. 2006); however, these tools, again, 
suffer from most of the same limitations listed above for 
their mesophilic counterparts.
Abstract In the last decade, a powerful biotechnologi-
cal tool for the in vivo and in vitro specific labeling of 
proteins (SNAP-tag™ technology) was proposed as a valid 
alternative to classical protein-tags (green fluorescent pro-
teins, GFPs). This was made possible by the discovery of 
the irreversible reaction of the human alkylguanine-DNA-
alkyl-transferase (hAGT) in the presence of benzyl-guanine 
derivatives. However, the mild reaction conditions and the 
general instability of the mesophilic SNAP-tag™ make this 
new approach not fully applicable to (hyper-)thermophilic 
and, in general, extremophilic organisms. Here, we intro-
duce an engineered variant of the thermostable alkylgua-
nine-DNA-alkyl-transferase from the Archaea Sulfolobus 
solfataricus (SsOGT-H5), which displays a catalytic effi-
ciency comparable to the SNAP-tag™ protein, but showing 
high intrinsic stability typical of proteins from this organ-
ism. The successful heterologous expression obtained in 
a thermophilic model organism makes SsOGT-H5 a valid 
candidate as protein-tag for organisms living in extreme 
environments.
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O6-alkylguanine-DNA-alkyl-transferases (AGTs or 
MGMTs, EC: 2.1.1.63) are ubiquitous proteins involved in 
the direct repair of alkylation damage in DNA. By a one-
step SN2 reaction mechanism, they specifically transfer the 
alkylic group from the damaged base (O6-alkylguanine or 
O4-alkylthymine) to a cysteine residue in their own active 
site (Daniels et al. 2000, 2004; Fang et al. 2005; Pegg 
2011; Tubbs et al. 2007; Yang et al. 2009) (Fig. 1a). AGTs 
are called suicide or kamikaze proteins because of the 1:1 
stoichiometry of their reaction, leading to an irreversible 
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Fig. 1  a Direct repair of alkylation DNA damage by AGTs: reac-
tion mechanism of the irreversible transfer of the alkyl group from 
the damaged guanine to a cysteine in the active site. b A variant of 
the human AGT (SNAP-tag™) can react in vitro and/or in vivo with 
BG-derivative substrates, leading to the labeling of a fused protein of 
interest (P) with a desired chemical group (L)
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inactivation and destabilization of the alkylated form of the 
protein (Fang et al. 2005; Yang et al. 2009). In 2003, the 
group of Kai Johnsson, studying the human AGT (hAGT), 
investigated the possibility to employ this protein as pro-
tein-tag, using benzyl-guanine-derivative substrates, also 
accepted by the active site of the protein (Keppler et al. 
2003). The covalent and irreversible nature of the alkylated 
form of hAGT and its small size (ca. 20.0 kDa) allowed 
new biotechnological approaches, making it an interest-
ing tool for in vivo and in vitro specific labeling of pro-
teins, when fused to a protein of interest (Gautier et al. 
2008; Keppler et al. 2003, 2004). A commercial variant of 
the hAGT (SNAP-tag™, New England Biolabs) is already 
available to be covalently labelled with a large number of 
chemical groups conjugated with O6-benzyl-guanine (BG-
derivative) (Fig. 1b).
However, no thermophilic AGTs have been developed 
as biotechnological tools to date, making the SNAP-tag™ 
technology suitable only for mesophilic organisms and 
mild reaction conditions. Hence, a thermostable version of 
AGT could be useful for the development of protein-tags 
for organisms growing under harsh reaction conditions. 
We previously characterized an AGT from the thermoaci-
dophilic archaeon Sulfolobus solfataricus (SsOGT), which 
has the same catalytic efficiency of hAGT with fluorescent 
BG-derivatives, but displays a marked stability over a wide 
range of temperature, pH, ionic strength and to common 
denaturing agents (Perugino et al. 2012). Here, we present 
the use of an engineered variant of the thermostable SsOGT 
protein, which lacks DNA binding activity (Perugino et al. 
2012), as a protein-tag for extremophilic organisms.
Materials and methods
Reagents
All chemicals were purchased from Sigma-Aldrich, 
SNAP-Vista Green™ and CLIP-FI™ fluorescent substrates 
(referred to BG-FL and BC-FL throughout, respectively) 
were from New England Biolabs (Ipswich, MA). Syn-
thetic oligonucleotides were from Primm (Milan, Italy) and 
listed in Table 1, Pfu DNA polymerase were from Strata-
gene (La Jolla, CA), as well as Escherichia coli ABLE C 
strain. Thermus thermophilus HB27EC strain is a derivative 
of DSM 7039 with enhanced natural competence because 
of a knockout mutation in the argonaute protein (Swarts 
et al. 2014). Protein concentration was determined by the 
BioRad protein assay kit (Bio-Rad Pacific), using BSA as 
standard.
DNA constructs
The DNA fragment of the beta-glycosidase from S. solfa-
taricus gene (lacS) was PCR-amplified using the pGEX-
K-Gly construct as template (Moracci et al. 1996), and 
by using the LacS-fwd and LacS-rev oligonucleotides 
(Table 1), which possess an internal Pst I site. This allowed 
the ligation of this gene downstream and in frame with 
the ogtH5 gene in the pQE-ogtH5 construct (Perugino 
et al. 2012), and leading to the pQE-ogtH5-lacS plasmid 
for the heterologous expression of the SsOGT-H5-Ssβgly 
fusion protein. pMK-ogtH5 for the heterologous and con-
stitutively expression in T. thermophilus of the SsOGT-H5 
mutant (referred to H5 throughout) was obtained by mul-
tiple rounds of PCR amplification: the PlspA-fwd/OP-rev 
and PO-fwd/Ogt3′ oligonucleotides pairs were first used 
to amplify the PlspA promoter and the ogtH5 gene DNA 
fragments, respectively. In a final round of PCR, the former 
two DNA fragments were fused to each other by the com-
plementary nature of the PO-fwd and OP-rev oligonucleo-
tides (Table 1), and amplified by using the external PlspA-
fwd/Ogt3′ oligonucleotides pair. Finally, the obtained 
DNA fragment was ligated in the multi-cloning site of 
the pMK184 (Cava et al. 2007) vector by using the EcoR 
I/Hind III sites. For all the obtained constructs, regions 
encoding the cloned genes were verified by DNA sequenc-
ing (Primm, Milan, Italy).
Table 1  List of oligonucleotides used in this study
Name Sequence Notes
LacS-fwd 5′-CCAGAACTGCAGATGTACTCATTTCCAAATAGC-3′ Pst I site underlined
LacS-rev 5′-CCAGAACTGCAGTTAGTGCCTTAATGGCTTTACTGG-3′ Pst I site underlined
OP-rev 5′-GGTGATGGTGATGGTGAGATCCTCTCATatgcctcacacctccttaaggg-3′ PlspA promoter sequence in lowercase; ogt gene 
sequence in uppercase; Nde I site underlined
PlspA-fwd 5′-aatggagaattcggggatcgatccccggg-3′ EcoR I site underlined
PO-fwd 5′-cccttaaggaggtgtgaggcatATGAGAGGATCTCACCATCACCATCACC-3′ PlspA promoter sequence in lowercase; ogt gene 
sequence in uppercase; Nde I site underlined
Ogt-3′ 5′-TATTAAGCTTTTATTCTGGTATTTTGACTCCCTCTAGT-3′ Perugino et al. (2012); Hind III site underlined
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Protein expression and purification
H5 and H5-Ssβgly were expressed in E. coli ABLE C 
and purified by His6-tag affinity chromatography, as 
described (Perugino et al. 2012, 2015), with the excep-
tion of a further purification step for the fusion protein: 
briefly, to remove E. coli contaminants, the pool of the 
eluted fractions from the affinity chromatography was 
incubated for 20 min at 70 °C, and centrifuged for 30 min 
at 30,000g. The soluble fraction was dialysed against 
PBS 1× buffer (phosphate buffer 20 mM, NaCl 150 mM, 
pH 7.3) and aliquots stored at −20 °C. To assess the 
purity of the protein samples and determine their concen-
trations, SDS-PAGE and Bio-Rad protein assay were per-
formed, respectively.
In vitro and in vivo alkyl-transferase assay
The activity of the purified proteins wild-type SsOGT 
and H5, alone or in fusion with Ssβgly, was measured by 
a fluorescent-based assay using BG-FL and BC-FL sub-
strates in standard conditions, as previously described 
(Miggiano et al. 2013; Perugino et al. 2012, 2015). 
Briefly, in a total volume of 10 µL, 5.0 µM of protein 
(0.1 mg mL−1) was incubated with 20 µM of the sub-
strate in 1× Fluo Reaction Buffer (50 mM phosphate, 
0.1 M NaCl, 1.0 mM DTT, pH 6.5) at different tempera-
tures and times, as indicated. Reactions were stopped by 
denaturing and loading samples on SDS-PAGE, followed 
by fluorescence imaging analysis on a VersaDoc 4000™ 
system (Bio-Rad) by applying as excitation/emission 
parameters a blue LED/530 bandpass filter, respectively. 
For the determination of the second-order rate constants, 
assuming the irreversible mechanism with 1:1 substrate/
enzyme binding, fluorescence intensity data were cor-
rected for the amount of loaded protein (by coomas-
sie staining analysis), in order to estimate the relative 
amount of covalently modified protein in time-course 
experiments. (Gautier et al. 2008; Miggiano et al. 2013; 
Perugino et al. 2012, 2015). For the in vivo assay, trans-
formed cells of T. thermophilus HB27EC strain with the 
pMK184 and pMK-ogtH5 plasmids were grown at 60 °C 
in TB selective medium (tryptone 8 g L−1, yeast extract 
4 g L−1, NaCl 3 g L−1, kanamycin 30 mg L−1; in min-
eral water, pH 7.5) as late as stationary phase (O.D.600 nm 
>1.5) (Cava et al. 2009). Cell pellets from an appropriate 
volume (typically 1.0 mL) were resuspended in 0.1 mL 
of TB medium in the presence of 3.0 µM of BG-FL and 
incubated at several temperatures for different times, 
as indicated. After the reaction, cells were first washed 
twice with 1.0 mL of TB medium, then denatured for 
10 min at 110 °C in O’Farrell 1× buffer supplemented 
with EDTA 10 mM, and finally loaded on SDS-PAGE for 
the analysis as described above.
Protein stability analysis
The stability of the wild-type and H5 was determined by 
Differential Scan Fluorimetry (DSF), following an adap-
tation of a protocol previously described (Niesen et al. 
2007; Perugino et al. 2015): samples containing 25 µM 
of each protein (0.5 mg mL−1) in PBS 1× buffer and 
SYPRO Orange dye 1× were subjected to a tempera-
ture scanning from 20 to 95 °C at 0.2 °C min−1 (5 min 
per cycle with an increase of 1 °C per cycle) in a Real-
Time Light Cycler™ (Bio-Rad). Relative fluorescence 
data were normalized to the maximum fluorescence value 
within each scan. Finally, plots of fluorescence intensity 
as a function of temperature showed increasing fluores-
cence sigmoidal curves (which described a two-state 
transition), leading to the determination of the inflection 
points, indicating Tm values, as described by the Boltz-
mann equation (Niesen et al. 2007). Stability was also 
tested by protease attack resistance and by in vivo protein 
degradation in T. thermophilus cells. In the first analy-
sis, in a total volume of 10 µL, 1.0 µM of each protein 
(0.02 mg mL−1) was incubated for 2 h at 25 °C in the 
presence of trypsin protease at different substrate/enzyme 
weight ratio, as indicated. Reactions were then denatured 
for 5 min at 100 °C in O’Farrell 1× buffer and immedi-
ately loaded on SDS-PAGE (0.2 µg per lane). Gels were 
subjected to Western Blotting analysis by using an anti-
SsOGT antibody, as previously described (Perugino et al. 
2012). For the preparation of the fluoresceinated form 
of the wild-type and H5, before the trypsin treatment, a 
reaction with BG-FL for 2.0 h at 25 °C was performed, 
followed by a gel fluorescence imaging to assess the 
complete labeling. To determine the stability of alkylated 
SsOGT in T. thermophilus HB27EC strain, we followed 
the same procedure described above to assay the protein 
activity; after incubation with BG-FL and washing, cells 
were incubated at 70 °C for different times, followed 
by denaturation, SDS-PAGE and fluorescence imaging 
analysis.
Beta-glycosidase assay
Glycoside hydrolytic activity of H5-Ssβgly was detected 
in vivo on LB Agar selective medium in the presence of 
the chromogenic substrate X-gal (Sambrook et al. 1989), 
as well as by calculating the steady-state kinetic constants 
with 4-nitrophenyl-β-D-galactopyranoside (4Np-gal) and 
4-nitrophenyl-β-D-glucopyranoside (4Np-glc), by using 
a Cary E1 spectrophotometer (Varian) and following the 
5Extremophiles (2016) 20:1–13 
1 3
a
b
Nter
Cter
connecting
loop
HTH
motif
active site
loop
C119
cognate
cytosine
DNA
minor
groove
O6-MG
R102
M106
K110
S100
G105
C119
Fig. 2  3D structure of: a free SsOGT (PDB ID: 4ZYE) and b the methylated DNA::SsOGT-C119A complex (PDB ID: 4ZYD)
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same procedure used for the Ssβgly enzyme (Moracci et al. 
1996, 1998).
Data analysis and softwares
Analysis of the solved 3D structures of the wild-type and 
the methylated DNA::SsOGT-C119A complex, as well as 
the modeling of the methylated DNA::H5 complex, were 
performed by using the MacPyMOL freeware (DeLano 
Scientific FCC). Data from activity and stability assays 
were fitted to appropriate equations by using the Prism 
Software Package (GraphPad Software) and GraFit 5.0 
Data Analysis Software (Erithacus Software).
Results
Mutations at the HTH motif affect the DNA-binding 
by SsOGT
The 3D structure of SsOGT, recently solved by X-ray crys-
tallography, is overall very similar to that of all other AGTs 
and consists of two domains connected by a loop (Perugino 
et al. 2015) (Fig. 2a). The role of the Nter domain of these 
proteins is not completely understood and is likely involved 
in the protein overall stability (Perugino et al. 2015) as 
well as activity (Miggiano et al. 2013), whereas the highly 
conserved Cter domain contains all the elements for the 
SsOGT SsOGT-H5 
K110 
A119 
E110 
A119 
O6-MG 
cognate cytosine 
R102 
G105 
O6-MG 
cognate cytosine 
A102 
K105 
G105 K105 
Fig. 3  Comparison of the crystal structure of methylated-
DNA::SsOGT-C119A complex of the SsOGT-C119A (gray) with a 
3D model of the same DNA molecule in complex with the H5 mutant 
(cyan): DNA, O6-MG and residues involved in the mutagenesis are 
represented as ball and sticks. A spheric representation in transpar-
ency in the SsOGT-C119A and H5 for the five residues involved in 
the mutagenesis is also shown. Atoms are colored by the CPK con-
vention, whereas O6-MG and the unpaired cytosine are colored in yel-
low and cyan, respectively
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Fig. 4  a Time-course of wild-type (Perugino et al. 2012) and H5 
under standard conditions with 20 µM of SNAP-Vista Green™ (BG-
FL) at 25 °C. Analysis and quantification of protein activity, as well 
as second-order rate constant values determination were performed 
as previously described (Perugino et al. 2012), and shown in Table 2. 
b Stability of H5 in comparison with the wild-type protein by DSF 
analysis, as described in “Materials and methods”. Tm values were 
obtained by measuring the relative fluorescence intensity of each pro-
tein from three independent experiments, as a function of tempera-
ture. c Resistance to protease attack of the wild-type SsOGT and H5: 
proteins (ca. 0.2 µg per lane) were incubated for 2 h at 25 °C in the 
presence of different amounts of trypsin, as indicated. After SDS-
PAGE, gels were analyzed by fluorescence imaging and then sub-
jected to western blot analysis using a polyclonal anti-SsOGT anti-
body (Perugino et al. 2012). Fluorescein-labelled forms of wild-type 
and H5 are indicated as wt-FL and H5-FL, respectively. d In vivo 
stability of fluoresceinated H5: after protein labeling procedure with 
BG-FL (see “Materials and methods”), intact T. thermophilus cells 
were incubated at 70 °C for different times as indicated. Acrylamide 
gel was analyzed by fluorescence imaging and coomassie staining (to 
correct fluorescence for the amount of loaded proteins)
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recognition and the repair of the damaged guanine. In 
contrast to most DNA binding proteins, AGTs contact the 
DNA via the minor groove through their helix turn helix 
(HTH) motif (Daniels et al. 2004) (Fig. 2b).
We previously prepared a mutant version of SsOGT 
(H5), whose mutations in five conserved residues of the 
HTH motif (S100A, R102A, G105K, M106T, K110E; 
zoom in Fig. 2b) impair dramatically the DNA binding 
capacity of the protein (Perugino et al. 2012). The availa-
bility of the crystal structure of the methylated DNA bound 
SsOGT (Perugino et al. 2015) allowed us to obtain a reli-
able model of the H5-DNA complex 3D structure (Fig. 3), 
which showed that: i) the substitution of the positively 
charged K110 with a glutamic acid residue could result 
in repulsive effects toward DNA phosphate backbone; ii) 
the replacement of the arginine finger R102 by an alanine 
residue might hamper the stabilization of the transiently 
unpaired cytosine opposite the methylated G (Kanugula 
et al. 1995; Liu et al. 2007; Perugino et al. 2012; Zang et al. 
2005); iii) the lysine in place of the G105 residue could 
produce a dramatic steric hindrance and collide with the 
phosphate backbone of the DNA strand close to the O6-
MG. This analysis provided a structural explanation of the 
complete inability of H5 to bind DNA, which is an impor-
tant pre-requisite for its application as a protein-tag.
Activity and stability of H5
Previous biochemical analysis suggested that H5 might 
be a good candidate thermostable protein-tag because: i) 
it retained the catalytic activity on the fluorescent BG-FL 
substrate, and, like SsOGT, showed significant activity 
over a broad range of reaction conditions (Perugino et al. 
2012); ii) the absence of any structural Zn2+ ion in the 
SsOGT structure (Perugino et al. 2015), makes it insen-
sitive to the presence of chelating agents (EDTA up to 
10 mM; Perugino et al. 2012). Furthermore, H5 displays 
a significant increase of the activity at any temperature 
tested, if compared to the wild-type SsOGT (Perugino et al. 
2012): the second-order rate constant value at 25 °C on a 
BG-derivative substrate was one order of magnitude higher 
than the wild-type (Fig. 4a; Table 2). This result suggests 
that the replaced residues in the HTH motif mutated in H5 
play a role in the overall flexibility of the protein during the 
protein-substrate complex formation. 
The substrate specificity of the wild-type and H5 proteins 
was evaluated by reactions in the presence of a benzyl-
cytosine-derivative substrate (BC-FL): the failure of com-
plete labeling hampered the determination of second-order 
rate constants (data not shown), confirming that alkylated 
cytosines are poor substrates for natural AGTs.
Previous experiments showed that H5 was only margin-
ally less stable than the wild-type (Perugino et al. 2012). To 
compare the stability of the H5 protein with that of the SNAP-
tag™, we performed quantitative analysis by DSF. We first 
followed the protocol used for SNAP-tag™ (ramping of 1 %: 
1 min per cycle with an increase of 1 °C per cycle; Mollwitz 
et al. 2012), leading to a Tm value for the SNAP-tag
™ pro-
tein of ca. 67 °C. However, these conditions were not suffi-
cient to induce the H5 protein denaturation, since no fluores-
cence change was obtained up to 95 °C, as also observed for 
the wild-type protein (data not shown). Melting temperature 
values were achieved only increasing the incubation times by 
heating samples from 20 to 95 °C with a ramping of 0.2 % 
(5 min per cycle with an increase of 1 °C per cycle). Under 
these conditions, we calculate a Tm value of 75 °C (Fig. 4b; 
Perugino et al. 2015). Although this value is comparable to 
that obtained for SNAP-tag™ (67 °C; Mollwitz et al. 2012), 
the stronger conditions used in the DSF analysis for H5 clearly 
indicate that this protein is more stable than its mesophilic 
counterpart. Stability was also analyzed by the intrinsical 
resistance to protease attack of free and labelled form of both 
wild-type and H5. An incubation for 2 h at 25 °C in the pres-
ence of different amounts of trypsin protease was performed 
(Fig. 4c). Due to their intrinsically stability, both proteins were 
unaffected by the action of the trypsin in most of the condi-
tions tested (from 1:16 to 1:2 E:S ratio), notably higher that 
Table 2  Second order rate constant values of wild-type and H5 under 
standard conditions on the BG-FL substrate
Incubation temperatures are indicated
T (°C) k (s−1 M−1) References
Wild-type
 70 5.33 × 104 Perugino et al. (2012)
 25 2.80 × 103 Perugino et al. (2012)
H5
 70 3.78 × 104 Perugino et al. (2012)
 25 1.60 × 104 This study
Fig. 5  a E. coli ABLE C strain was transformed by using pQE-ogtH5 
(Perugino et al. 2012) and the pQE-ogtH5-lacS plasmids. Trans-
formed cells were plated on LB agar in the presence of ampicillin 
and the X-gal chromogenic substrate. b SDS-PAGE of the expression 
and purification by His6-tag affinity chromatography of the H
5-Ssβgly 
fusion protein: 1 cell free extract of E. coli ABLE C/pQE-ogtH5-lacS; 
2 protein molecular weight marker; 3 2.0 µg of H5 protein; 4 pool of 
fractions eluted by imidazole; 5 soluble fraction of the sample of lane 
4, after thermal treatment (see “Materials and methods”); 6 whole E. 
coli ABLE C cells transformed with the pQE31™ empty vector (Qia-
gen). All samples, except for the protein marker, were incubated with 
the BG-FL substrate under standard conditions, and loaded on SDS-
PAGE. After, the gel was exposed for the fluorescence imaging analy-
sis (left) and then stained by coomassie blue (right), as described in 
“Materials and Methods”. The high molecular weight band marked 
by an asterisk correspond to a partially denatured form of the fusion 
protein, which is particularly resistant to denaturation, as previously 
shown for the tetrameric Ssβgly (Moracci et al. 1996, 1998)
▸
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those used for hAGT (Kanugula et al. 1998; Mollwitz et al. 
2012). To observe a reasonable reduction of the western blot 
signals, a very high amount of protease was needed (1:1 and 
2:1 E:S ratio): as expected, alkylated (fluoresceinated) forms 
of both proteins were less stable than their unlabelled counter-
parts. Again, a slight difference between the wild-type and H5 
proteins was found at high E:S ratios; overall data confirmed 
the general stability and resistance to protease attack of these 
thermostable AGTs.
Application of H5 as protein-tag
In order to test the possibility to use H5 as a protein-tag, 
we used as a model the S. solfataricus lacS gene coding 
for a thermophilic β-glycosidase (Ssβgly; Moracci et al. 
1996); previous studies demonstrated that tags linked 
at the N-terminus of Ssβgly (such as a GST-tag) did not 
affect the overall folding of the latter (Moracci et al. 1996, 
1998). The lacS gene was fused downstream to and in 
frame with the ogtH5 gene, for the expression of the H5-
Ssβgly fusion protein in the E. coli ABLE C lac(−) strain. 
Blue colonies on X-gal LB agar solid medium appeared, 
indicating the presence of a hexogenous β-galactosidase 
activity, and confirming that Ssβgly is active also as fusion 
protein even at mesophilic temperatures (Fig. 5a). Puri-
fication of the fusion protein by affinity chromatography 
through a nickel column was performed, exploiting the 
presence of a His6-tag at the N-terminus of the H
5 moiety. 
Interestingly, the presence of Ssβgly did not interfere with 
the H5 activity, making it possible to follow all purifica-
tion steps by SDS-PAGE and fluorescence imaging of the 
samples, previously incubated with the BG-FL substrate. 
Finally, we were able to calculate the kinetic constants of 
the hydrolytic activity of H5-Ssβgly at high temperatures, 
which were comparable to those previously described 
for the Ssβgly enzyme (Table 3) (Moracci et al. 1996). 
Importantly, the utilization of the thermostable protein-tag 
enabled us to proceed with a thermoprecipitation treatment 
to further purify the pool of affinity chromatography eluted 
fractions (Fig. 5b, lane 5), and to perform kinetic analysis 
on a thermophilic enzyme at high temperatures without the 
need to remove the tag. 
Heterologous expression of H5 in T. thermophilus
Thermus thermophilus HB27EC was chosen as model ther-
mophilic cell host to test our protein-tag because it is a 
naturally agt(−) strain, thus lacking any endogenous DNA-
alkyl-transferase activity. It encodes a single AGT-like pro-
tein (ATL), which is inactive in DNA repair, but involved 
in the recruiting of nucleotide excision repair (NER) pro-
teins (Morita et al. 2008). The ogtH5 gene was cloned in 
the pMK184 plasmid (Fig. 6a) (Cava et al. 2007), a shuttle 
vector containing: i) both E. coli and T. thermophilus HB27 
replication origins; ii) the kat gene for growth in kanamycin 
selective medium; iii) a multi-cloning site (MCS) upstream 
of the α-lacZ gene, allowing E. coli white/blue colony 
screening on X-gal containing plates. As in E. coli cells 
(Perugino et al. 2012), it was possible to check the in vivo 
activity of H5, by directly incubating intact cells in the TB 
medium supplemented with the BG-FL substrate. To test 
the permeability of T. thermophilus (a bacterium with a 
complex cell envelope, including an outer membrane) to 
this substrate, we incubated at different temperatures and 
also in the presence of non-toxic organic solvents, such as 
DMSO, to improve cell permeabilization. Figure 6b shows 
fluorescent signals at the same molecular weight of the 
purified H5 protein in whole cell extracts from TthHB27/
pMK-ogtH5 transformants, whereas no signals were seen 
in cells transformed with the empty plasmid (TthHB27/
pMK184), confirming the lack of any endogenous alkyl-
transferase activity. The maximal activity was obtained 
at 60 and 70 °C, likely due to the higher permeability of 
the cells at their physiological temperatures concomitant 
with an increase of activity of the thermophilic H5 protein 
(Fig. 6, lanes 5, 6 and 9). The presence of organic solvents 
impaired the protein activity and/or the substrate perme-
ability, as suggested by the absence of the unreacted sub-
strate at the bottom of the gel at the highest concentration 
of DMSO (lane 8 in Fig. 6). As for most of model organ-
isms used, BG-FL molecule resulted non-toxic for T. ther-
mophilus HB27EC cells, as indicated by a TB agar plate 
(“spot”) assay (data not shown) (Wilkinson et al. 2012).
Moreover, the fluoresceinated form of H5 was reason-
ably stable in vivo in T. thermophilus cells, showing a slow 
fluorescence signal decay: ca. 50 % of the protein was still 
detectable after 24 h at high temperatures (Fig. 4d), a time 
span compatible with most of the experiments performed 
by using the SNAP-tag™ technology in vivo.
Table 3  Steady state kinetic constants of Ssβgly and the H5-Ssβgly 
fusion protein for the hydrolysis of chromogenic substrates at 65 °C 
in 50 mM phosphate buffer pH 6.5
Substrate KM (mM) kcat (s
−1) kcat/KM 
(s−1 mM−1)
References
Ssβgly
 4Np-gal 1.17 ± 0.06 275.0 ± 4.0 235.0 Moracci et al. 
(1996)
 4Np-glc 0.30 ± 0.04 240.0 ± 7.0 800.0 Moracci et al. 
(1996)
H5-Ssβgly
 4Np-gal 2.13 ± 0.50 205.2 ± 14.4 96.5 This study
 4Np-glc 0.04 ± 0.02 88.5 ± 7.1 2328.2 This study
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Discussion
SNAP-tag™ technology is rising as a powerful alternative 
approach to GFP-tags for the in vivo labeling of protein of 
interest. Despite the need to introduce an external substrate 
for the labeling, this method offers a lot of advantages, 
mainly the specificity of the reaction and the possibility to 
label a protein with an infinite number of chemical groups, 
b
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Fig. 6  a pMK-ogtH5 plasmid used to transform T. thermophilus 
HB27EC strain. b Whole transformed cells were incubated in TB 
medium in the presence of 3.0 µM of BG-FL, at temperatures, times 
and DMSO concentration as indicated. Entry 1: 1.0 µg of purified H5 
protein. All samples were treated as described in Fig. 5
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if conjugated to a benzyl-guanine, a classical inhibitor of 
hAGT and a suitable substrate of its commercially available 
variant (Hinner and Johnsson 2010).
The discovery of a BG-sensitive thermostable OGT from 
the thermoacidophilic Archaea S. solfataricus opened the 
possibility to widen the SNAP-tag™ technology to organ-
isms which thrive in extreme environments. Because of the 
intrinsic nature of proteins from hyperthermophiles, SsOGT 
displayed a strong stability under several harsh conditions, 
as extremes of pH, ionic strength, temperatures, presence 
of organic solvents (Perugino et al. 2012), and protease 
treatments. Mutagenesis at the expense of the HTH motif 
allowed the construction of a variant of this enzyme (H5), 
which retained most of the advantages of the native protein 
in terms of stability, and showed even enhanced activity at 
lower temperatures. We showed that H5 is correctly folded, 
expressed, functionally active and stable in both mesophilic 
E. coli and thermophilic T. thermophilus hosts. In order to 
obtain a smaller version of SsOGT, a preliminary attempt to 
reduce the wt protein by limited proteolysis was performed, 
obtaining a truncated polypeptide (ca. 14.0 kDa) which was 
still active in the presence of BG-FL substrate. Gel purifi-
cation and N-terminal sequence analysis revealed the loss 
of the first 36 aminoacids. However, this “mini SsOGT” 
protein could not be obtained by heterologous expression 
in E. coli (data not shown), suggesting that the first 36 ami-
noacids are important for the correct folding of the pro-
tein during translation. Interestingly, inspection of the 3D 
structure revealed the presence of a disulfide bond at the 
Nter (C
29-C31), which is important for the protein stability 
(Perugino et al. 2015).
The analysis of the H5-Ssβgly fusion protein demon-
strated that it is possible to study both mesophilic and ther-
mophilic proteins/enzymes fused to H5 under their own 
physiological conditions, without the need to remove the 
tag. These properties, together with the complete abolition 
of binding to DNA, make H5 a robust alternative as pro-
tein-tag for the application of the SNAP-tag™ technology 
for in vivo (protein–protein interaction, in situ localization, 
FRET experiment in combination with thermostable GFP 
variants, etc.) and in vitro studies (heterologous expres-
sion and purification of proteins of interest in extremophilic 
organisms). Finally, the high substrate specificity toward 
BG-derivatives makes H5 an interesting starting point to 
be modified by molecular evolution in order to obtain a 
thermostable variant active on BC-derivative substrates 
(like the commercial CLIP-tag™): this orthogonal substrate 
specificity will allow simultaneously and specifically the 
labeling of different molecular targets in living cells (Gau-
tier et al. 2008).
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In this study, the in vivo analysis of the AGT of the hermaphrodite nematode Caenorhabditis 
elegans is reported. This worm encodes two genes, CeAGT-1 and CeAGT-2: the first seems to be 
similar to the classical AGT at the primary structure level; the second is an AGT, harbouring only 
the catalytic C-terminal domain, fused to a histone-like domain. Due to the peculiar primary 
structure of CeAGT-2, I tried to analyse its role in vivo. C. elegans is a suitable model organism to 
investigate and dissect each component of the various DNA repair pathways in response to DNA 
damage, but also to study the role of DNA repair in different developmental stages. In particular, to 
understand the possible role of the protein, I have characterized the phenotypes of CeAGT-2 mutant 
strain by subjecting it to various experimental procedures e.g. testing the susceptibility of the 
CeAGT-2 strain to the alkylating agent treatment. Furthermore, C. elegans offers the possibility to 
observe multiple phenotypes related to the embryonic/larval development of the nematode, by 
analysing living features. In this latter case, the embryonic lethality and the aberrant phenotypes 
observed are associated with mutations in genes involved in meiosis and in the formation and/or 
production of gametes, so I analysed the role of CeAGT-2 during gametogenesis. Overall results 
show a key role of CeAGT-2 in metabolic pathways related to DNA repair and meiotic 
development. 
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Introduction 
Caenorhabditis elegans as a model organism 
 
Integrity of genetic information is essential to both individual health and reproductive capacity. 
The Caenorhabditis elegans model system provides an opportunity not only to investigate the 
components of the various repair pathways and the pathway interactions, but also to study the role 
of repair in different developmental stages. As an animal system provides a useful model to more 
fully understand the integration of the types of repair that occur in response to DNA damage. 
Sydney Brenner in 1963 introduces for the first time Caenorhabditis elegans as model system. It is 
a member of the Nematode phylum, belonging to the Rhabditidae family. It is a small animal, about 
1 mm long when adult. Its normal habitat is in soil, surviving on bacteria and fungi. C. elegans 
exists either as hermaphrodite or as male, characterized by clear different structures when adult. The 
number of sexual chromosomes determines the worm’s sex. Six chromosomes are present: five 
pairs of autosomes (chromosomes I, II, III, IV, and V) and one pair of sex chromosomes X. 
Hermaphrodites have two X chromosomes (designated XX), while males have one X chromosome 
(designated XO), the hemizygous state [Brenner, 1974]. Spontaneous males appear in the wild type 
population with a very low frequency (0.2%), due to the loss of one sexual chromosome for non-
disjunction. Males can cross-fertilize hermaphrodites and give a mixed progeny of 50% males and 
50% hermaphrodites. The phenotype in which the frequency of males is higher than the wild type is 
named Him phenotype (high incidence of males) indicating segregation defects of sexual 
chromosomes [Hodgkin et al., 1979].  
C. elegans genome has been the first multicellular eukaryote genome to be sequenced in 1998 
(The C. elegans Sequencing Consortium). Its genome is 97 Mb and codify for more than 19.000 
proteins, sharing an high degree of gene homology with other superior eukaryotes. About 60% of 
genes have an orthologue in mouse and human. Many physiological pathways and damage/stress 
response pathways are conserved [Lai et al., 2000]. All this features makes C. elegans a competitive 
model system to study biological processes in a multicellular organism compared to longer cell 
cycle organisms with a lower progeny. In the next figure is reported the life cycle of C. elegans, in 
which embryonic and larval development is schematized. 
 
 
Germline in C. elegans 
 
Over the past twenty years, C. elegans has emerged as a major model organism for investigating 
meiotic mechanisms. Several features of C. elegans biology have contributed to facilitate this kind 
of studies. The worm germ line is especially amenable to high-resolution cytological analysis of 
chromosome and nuclear organization in the context of whole mount preparations that preserve 3D 
nuclear architecture. Importantly, each germ line contains a complete time course of meiosis, with 
nuclei organized in a temporal/spatial gradient corresponding to the stages of meiotic prophase 
[Crittenden et al., 1994]. In the distal region, named mitotic zone, nuclei undergoes the mitotic S 
phase [Hirsh et al., 1976]. From the mitotic zone to the proximal region it is possible to observe the 
different prophase stages I. In transition zone chromosomes acquires crescent-shaped form and 
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nuclei undergoing Leptotene and Zygotene. At this stage chromosomes pairs and recombination 
starts with cuts due to SPO-11 topoisomerase [Dernburg, 1998]. The number of Spo11-induced 
DSBs in meiosis is regulated: there are twelve cuts per nucleus [Mets et al., 2009]. The crescent-
shaped form of the nuclei is needed to approach the chromosomes, in C. elegans only one 
chromosomal end bound the nuclear membrane [Goldstein, 1982]. The chromosomal pairing start at 
the “Pairing Center” (PC), a region mapped at the chromosomal ends. The PC have many repeated 
sequences recognized from Zinc finger proteins, ZIM-1, ZIM-2, ZIM-3 e HIM-8 [Villeneuve, 
1994]. The synapsis starts from the PC to the other chromosomal end [MacQueen et al., 2005]. The 
synaptonemal complex (SC) formation is necessary for recombination using the homologous 
chromosome as a repair template [Colaiacovo et al., 2003; MacQueen et al., 2002].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: C. elegans life cycle at 20° C (from [Altun and Hall 2009; Wormatlas]) 
 
 
In C. elegans, unlike yeast, plants and mammals, the SC can be assembled without DSBs formation 
[Dernburg, 1998]. The key factor in the meiotic step of strand invasion, Dmc1, is missing in C. 
elegans, and RAD-51 is the only RecA-like enzyme present at this step. In WT C. elegans, RAD-51 
foci representing nascent meiotic DSBs arise during zygotene and early/middle pachytene stages, 
and then decrease in number during the late pachytene stage as meiotic DSB repair progresses 
[Colaiacovo et al., 2003]. Increase and/or persistence of such foci are indicative of DNA repair 
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defects. At early pachytene, after SC formation chromosomes are distributed at nuclear periphery. 
Most DSBs are repaired in early pachytene. The meiotic machinery ensures that each chromosome 
receives at least and just one crossing-over (CO). The sites of the maturing crossover become 
visible in diakinesis [Colaiacovo et al., 2003]. By the end of pachytene, about half of the oocytes in 
the C. elegans germ line undergo physiological cell death [Gumienny et al., 1999]. Among the end 
of pachytene and diplotene stages the SC disassemble and chromosomes assuming a cruciform 
structure [MacQueen et al., 2002]. The SC disassembly in a non-symmetric way involving pro-
crossover protein, ZHP-3 [Nabeshima et al., 2005]. The chiasmata is the physical display of CO 
between homologues at the end of recombination and produces the right tension to allowed correct 
chromosomal segregation to the pole. During diakinesis stage, meiocytes leave the syncytium and 
cellularize. At diakinesis stage is possible to observe six pairs of bivalent held together by 
chiasmata [Villeneuve, 1994]. Defects in homologous pairing, SC assembly or CO formation leads 
to twelve separated univalents and an improper segregation in meiosis. In the proximal part of the 
gonad, the oocytes arrest until the end of their maturation, that is a fundamental step for their 
fertilization [Gumienny et al., 1999]. In the next figure is reported a cartoon rappresentation of 
organozation of female germline in C. elegans. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Organization of the female germ line in C. elegans 
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Apoptotic Pathway in C. elegans 
 
During the embryonic development, in the hermaphrodite worms it is possible to notice that 
always the same 131 cells, out of the 1090 generated, are doomed to die by apoptosis [Sulston et al., 
1983]. This process has been deeply characterized in C. elegans, leading to the identification of the 
main genes, which drive apoptosis pathway: ced-3 (C. elegans abnormal death 3), ced-4 
(hortologous to mammalian Apaf1), ced-9 (hortologous to mammalian Bcl2), egl-1 (egg laying 
defective 1). The ced-3, ced-4 and egl-1 genes are pro-apoptotic factors, and their knockout leads to 
the survival of the 131 somatic cells that normally die [Ellis et al., 1986]. The ced-9 gene has 
instead an anti-apoptotic function, so a gain of function mutation causes a block of apoptosis, while 
a loss of function mutation determines a precocious death during early development, due to the the 
miss-regulation of the apoptotic pathway [Hengartner et al., 1992]. In order to elucidate the 
interaction existing among the “deathgenes”, epistasis studies have been performed, highlithing the 
mechanism at the base of the apoptotic mechanism execution. When death signals trigger the 
activation of the apoptotic program, the caspases belonging protein CED-3 is switched from an 
inactive state (procaspase) to an active state (caspase) by the CED-4 protein. The sequestration of 
CED-4 by CED-9 maintains the state of CED-3 inactive. Under normal conditions, when no death 
signals are present, CED-4 cannot activate CED-3, since it is associated in an inactive state with 
CED-9, but when apoptosis is triggered, another factor plays its role, EGL-1. EGL-1 binds CED-9, 
which this way is unable to block CED-4, and therefore CED-4 can associate and activate CED-3, 
achieving the apoptotic program. The identification of these key genes regulating cell death 
program in C. elegans that are conserved in humans has represented a significant advance in the 
knowledge about apoptosis. At critical times when cells progress from one stage to the next, the 
quality of the DNA is assessed by cell cycle checkpoints. If the chromosomes don't pass quality 
control, the checkpoint may generate a ‘Wait’ signal. In the germ-line, damage can lead to apoptosis 
(non programmed cell death), cell cycle arrest, or heritable mutation. The C. elegans ortholog of the 
transcription factor P53, CEP-1, which is a key regulator of the DNA damage checkpoint, is 
required for DNA damage-induced apoptosis in the C. elegans germ-line, but not for programmed 
cell death occurring during worm development nor physiological (radiation-independent) germ cell 
death [Gartner et al., 2008]. 
 
 
 
The AGT protein in Caenorhabditis elegans 
 
Alkylation at the O6-position of guanine and the O4-position of thymine in DNA makes these 
bases highly mutagenic, causing GC to AT and AT to GC transitions [Singer et al., 1976]. Many 
organisms have developed an effective mechanism to repair these mutagenic lesions through the 
action of the ubiquitous AGTs. All these proteins contain a -PCHRV- consensus sequence in the 
active site and repair the alkylation damage to DNA by transferring the alkyl group from the O6-
position of guanine to the active site cysteine residue in this sequence, thus restoring the DNA to its 
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unmodified form in a single step. The AGT contain a helix-turn-helix DNA binding domain and 
that the target substrate base is flipped out of the DNA helix into a binding pocket that contains the 
cysteine acceptor residue [Pegg et al., 2011].  
The process of identifying specific genes of a particular function in a species has changed 
drastically with rapidly emerging complete analysis of genomes from many different organisms. 
The presence of an AGT gene has been confirmed in almost all the organisms with the -PCHRV- 
motif providing a key recognition point. The search of the C. elegans genome database [C. elegans 
Sequencing Consortium, 1999] for any AGT protein identified a clone Y62E10A.5 containing the 
consensus sequence and many other features common to AGT, and is termed CeAGT-1 [Kanugula 
et al., 2001]. A detailed examination of the C. elegans genome database also revealed the presence 
of a hypothetical protein, clone F09E5.13, which has some similarities to AGT. This sequence 
codes for a 274 amino acid protein. In particular, it has some similarities to known AGT in the 
region from residues 62 to 96 (corresponding to residues 137-172 in hAGT), where a cysteine 
acceptor site within the -PCHRV- motif was identified: it is therefore termed CeAGT-2 [Kanugula 
et al., 2001]. Although in several bacteria, including E. coli, are known to express two AGT 
proteins, where one of them is highly inducible in response to exposure to alkylating agents 
[Samson, 1992; Sekiguchi et al., 1996], this is the first time that the presence of two AGTs in a 
eukaryote were identified. The cDNA of CeAGT-2 was present in a mixed-stage expression library 
and the mRNA corresponding to this gene product was detected at all stages, especially at the egg 
and adult stages of the organism in a comprehensive analysis of gene expression [Kanugula et al., 
2001]. 
The CeAGT-2 shows a number of highly novel features: i) the primary sequence displayed that, 
among known AGTS, the presumed active site cysteine is located much closer to the amino-
terminus of the protein. The available 3D structures of AGT show that the protein is made up of a 
two-domain structure, where all residues that have been identified as part of the active site and 
DNA binding region are in the C-terminal domain. The N-terminal domains have a roughly similar 
structure but virtually not amino acid homology between species [Daniels et al., 2000]. This N-
terminal domain is totally absent in CeAGT-2; ii) CeAGT-2 has a much longer C-terminal 
sequence, no similar to any known AGT, rather this region shows about 25% sequence homology 
with human histone 1C. This region is very rich in proline and basic amino acids and there are 
several sequences with similarity to known nuclear location signals (figure 3). These may be needed 
to allow nuclear uptake of the 274 amino acid protein, which is much larger than other eukaryotic 
AGT [Kanugula et al., 2001]; iii) although CeAGT-2 has several of the highly conserved residues 
in the active-site (including Pro-144, Cys-145, His-146, Val-148, an aromatic residue at position 
158, Leu-168, Leu-169, and Glu-172), several other conserved residues are not present: residues 
Asn-137 and Arg-147, which are totally conserved in all other known AGTs, are replaced by Gln 
and Pro, respectively; iv) the amino acid sequence of the presumed DNA binding domain of 
CeAGT-2 is strikingly different from known AGTs. Few of the residues in the helix-turn- helix 
motif made up of residues 113 to 136 in hAGT that form this domain [Daniels et al., 2000; Wibley 
et al., 2000] are identical to those in CeAGT-2. Moreover, the fully conserved residues Tyr-114 and 
Arg-128, which are clearly involved in AGT reaction, are replaced by the conservative substitutions 
Phe and Lys, respectively [Kanugula et al., 2001]. 
Previously, the CeAGT-2 gene was cloned and expressed as truncated form lacking the Histone-
like domain, termed CeAGT-2tr, and show that it does possess DNA repair AGT activity despite 
not canonical structural features [Kanugula et al., 2001]. The CeAGT-2tr is able to remove methyl 
groups from both O6-methylguanine and O4-methylthymine.  The good activity toward the later 
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substrate indicates that it is more nearly similar in its repair capabilities to the E. coli Ogt (which 
repairs O4-methylthymine efficiently) than to mammalian AGTs, which have a very poor ability to 
repair this minor methylation product [Samson et al., 1997]. 
 
 
 
 
 
 
 
 
Figure 3:	 Schematic representation of the AGT domains: A) Scheme of the peculiar primary 
structure of the N and C-terminal domains of AGTs; B) Scheme of the primary structure of the N 
and C-terminal domains of CeAGT-1; C) Scheme of the primary structure of the N and C-terminal 
domains of CeAGT-2; D) Schematic portion of the N-terminal domain characterized [Kanugula et 
al., 2001]. Typical N-terminal domain, C-teminal domain and histone-like domain are represented 
in blue, green and gray rectangle, respectively.  
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Purpose 
 
C. elegans encodes two distinct orthologs of AGTs, known as CeAGT-1 and CeAGT-2. 
Whereas no information is available about the former, the CeAGT-2 protein was shown to have 
DNA alkyltransferase activity in vitro and in bacterial cells [Kanugula et al., 2001]. Interestingly, 
CeAGT-2 has a peculiar structure, if compared with other AGT: in this protein the domain 
containing the DNA binding region and active site is fused to a domain resembling histone 1C, the 
function of this domain has not been established (figure 3). For this peculiar primary structure, it 
has drawn our attention for its possible role in vivo. 
The presence of two AGT may indicate a genomic duplication phenomenon resulting in 
functional divergence of the two genes. So the non-canonical structure of the second AGT could 
indicate the acquisition of additional functions. In C. elegans, high-resolution microscopy combined 
with genetic tools provides a unique opportunity for the detailed analysis of DNA repair pathways 
on an organismal level and in true tissues. In particular, the C. elegans gonad is an extremely 
powerful toolkit for the study of these processes, because the spatiotemporal organization of germ 
cells allows following their progress in specific stages of gametogenesis, from mitotic divisions up 
to the end of meiosis. In C. elegans no ceagt-1 mutant and ceagt-1/ceagt-2 double mutant be found 
in C. elegans banks, whereas a null ceagt-2 mutant was available (tm 6462), although no 
information has been reported on it. 
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Results 
 
The sensitivity of the CeAGT-2 mutant to alkylating agents 
 
Because of the absence of one of the two AGTs in the CeAGT-2 null mutant, this was first 
analysed in terms of drug sensitivity to alkylating agents: young adult worms were treated with the 
appropriate drug, in this case 300 uM final concentration of methyl-methane-sulfonate (MMS) in 
for 16 h in liquid culture. Then the worms were isolated and the laid eggs were scored for 42h. For 
all multiple independent replicas and for data analysis and significance, the Student Test was 
applied. The progeny was also scored for embryonic lethality (unhatched eggs). In every 
experiment, untreated controls were screened at the same time points. Preliminary results indicated 
that the CeAGT-2 mutant strain was more sensitive to alkylating agents than the WT strain, as was 
appreciable from the chart in figure 4. It suggested that CeAGT-2 is involved in repairing alkylation 
damage, indicating a enancher interaction with CeAGT-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Embryonic survival at different time points after treatment with 300uM MMS (methyl 
methane sulfonate) for the indicated genotype.  
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Defect in CeAGT-2 lineage 
 
The second step of this analysis was to investigate about the type of defects observed in the 
CeAGT-2 homozygous mutant population (Figure 5). Phenotypic screenings consist of young adult 
worms individually cloned on freshly untreated seeded plates. Each worm was transferred to a fresh 
plate every 24 h, and the eggs laid after 48 and 72 h will be scored. The progeny was scored for 
embryonic lethality (unhatched eggs), percentage of males, developmental defects and larval arrests 
after 24, 48 and 72 h. We observed a significantly higher frequency of embryonic lethality, 
developmental defects and larval arrests in CeAGT-2 mutant compared to wild type control.  The 
developmental defects and larval arrest observed in mutant CeAGT-2 especially fall in the 
alterations of cell lineage. These phenotypes are caused by alteration of post-embryonic lineages, 
suggesting that meiotic or somatic mutations in genes that regulate these lineages cause the 
formation of aberrant phenotypes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Main phenotypic characteristics of CeAGT-2 strain compared with N2 strain 
 
 
The embryonic lethality in the CeAGT-2 strain may be caused by mutations in meiotic genes 
that regulate cell lineage or alterations in cell time division and fate during embryonic development. 
Both these results indicated that the lacking of this AGT protein hampers the correct germline 
 N2 CeAGT-2 
Parental 20 28 
Laid Eggs 5341 5769 
Dead Embryos 27 70 
Hatched Eggs 5314 5699 
Males 3 2 
Brood Size 267 206 
% Dead Embryos 0,5% 1,2% 
% Males 0,06% 0,04% 
Larval Arrest 0 54 
% Larval Arrest 0% 0,9% 
Develop. Defects 2 48 
% Develop. Defects 0,04% 0,8% 
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progression. This result is the starting point for a question: can CeAGT-2 be involved in the 
physiological repair processes needed to properly perform meiosis and hence for a proper 
maturation of gametocytes? So, we had to focus our attention on the body responsible for these 
processes: the gonad of C. elegans contains germ cells, whose physical location corresponds to a 
particular stage in meiotic progression. This facilitates the study of the effect of gene depletions at 
various stages of meiotic prophase. 
 
 
 
Immunolocalization of RAD-51 in the gonad 
 
The C. elegans germline also offers an excellent system to study the kinetics of formation and 
repair of double strand breaks (DSB) that occur in all cells after certain types of DNA damage, but 
they are physiologically generate by the topoisomerase-like protein SPO-11 during meiosis and are 
essential for the correct execution of meiosis [Colaiacovo M. et al. 2003; MacQueen et al. 2002]. 
Meiotic DSB are preferentially repaired by RAD-51 recombinase, through homologous 
recombination, by using a parental homolog to form inter-homolog crossovers that are essential for 
accurate chromosome segregation at the first meiotic division [Colaiacovo et al., 2003]. In WT C. 
elegans, foci formed at meiotic DSB arise during the early and middle pachytene stages, and then 
rapidly decrease in number during late pachytene stage, as meiotic DSB repair progresses 
[Colaiacovo et al., 2003]. So, by following RAD-51 recombinase foci by immunolocalization, it is 
possible monitoring the proper continuation of meiotic processes in the CeAGT-2 gonad, 
establishing if the protein is involved and maturation of gametocytes. 
Rad-51 foci had a different localization pattern in CeAGT-2, when compared with the WT: in 
the latter, the Rad-51 foci number in the nuclei increase in early pachytene stage but decreasing in 
middle pachytene; finally they disappear in late pachytene stage. In the CeAGT-2 mutant we noted, 
however, not only an increase in the number of foci per nucleus, but also a major persistence. This 
is highlighted by a high number of foci still present in late pachytene stage: in the figure 6, photos 
of immunolocalizations performed on the WT and mutant and the relative graph obtained by 
quantification of the number of foci per nucleus are shown. Once again, we got indications of the 
possible involvement of CeAGT-2 in the physiological repair processes needed to perform a correct 
meiosis. 
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Figure 6: A) Representative images of gonade zones nuclei (indicated by circles) stained with 
anti-RAD-51 antibodies (red) and DAPI (blue). B) Quantification of RAD-51 foci in germlines of 
the WT. C) Quantification of RAD-51 foci in germlines of the CeAGT-2. D) Statistical analyses. 
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Number of apoptotic nuclei in the gonad 
 
Finally, we evaluated the apoptosis levels in the CeAGT-2 mutant strain. It has been widely 
demonstrated that in C. elegans under physiological conditions, a physiological number of germ 
cells undergo the apoptotic process, gererally an average of three for gonad [Gartner et al., 2008]. 
We measured an increase in the germline apoptotic level, probably caused by the persistence of 
DNA lesions in the CeAGT-2 mutant germline, which triggers the DNA damage checkpoint and 
inducing apoptosis. As shown in the figure 7, the number of apoptotic bodies in the CeAGT-2 strain 
was significantly more than the WT. So, CeAGT-2 mutant worms show elevated basal levels of 
apoptosis of late pachytene nuclei, suggesting a possible defect in meiotic processes or defect in the 
selection of cells destined for apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: A) Representative image of a WT and CeAGT-2 mutant apoptotic corps in the 
germline stained with viable dye Syto-12. B) Graph of the average of apoptotic corpses for gonad 
arm in the indicated strains. 
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Materials and methods 
 
Solutions 
Nematode Growth Medium (NGM) plates: NaCl 0.3%, Peptone 0.25%, and Agar 2%. After 
sterilization add: cholesterol (5mg/ml), CaCl2 (1mM), MgSO4 (1mM), and NaKPO4 (25mM pH6). 
Lysogeny Broth (LB) solution: NaCl 1%, Yeast extract 0.5%, Bacto tryptone 1%. 
M9 1X solution: 0.3% H2PO4, 0.6% Na2HPO4, 0.5% NaCl and 1mM MgSO4. 
Bleaching solution: NaOH 1.6M, NaClO 0.6% 
TAE solution: 40mM Tris HCl pH8, 20mM Acetic Acid and 1mM EDTA pH 8. 
Lysis buffer: 20000U/ml proteinase K in 10 mM Tris pH 8.2, 50 mM KCl, 2.5 mM MgC12, 
0.45% Tween 20. 
Ab buffer: 1% BSA, 0.1% Tween20, 0.05% sodium azide in 1x PBS 
 
 
Maintaining of the strains 
Worms are grown at 20°C on NGM plates containing Escherichia coli (E. coli) OP50, a uracil-
requirement mutant to prevent overgrowth of the bacterial layer. OP50 bacteria are grown in an LB 
solution at room temperature overnight. The maintaining of the worms was carried out as described 
by Sulston and Hodgkin in 1988. 
 
 
Worms synchronization with Alkaline Hypochlorite solution (bleaching) 
Worms are sensitive to bleach while the egg shell protects embryos from it. After treatment with 
alkaline hypochlorite solution, only embryos are able to hatch and they will grow synchronous. 
1. Grow worms until adult stage. 
2. Recover gravid adults in 15 ml tubes by washing plates with NaCl 0.1M. 
3. Pellet worms by centrifuging for 2’ at 1500 rpm at 4C° and discard supernatant. 
4. Perform 3 washes with NaCl 0.1M until the buffer appears clear of bacteria. 
5. Add some volume of bleaching solution and agitate for 10’. 
6. Stop reaction by adding NaCl 0.1M to fill the tube. 
7. Quickly centrifuge (since treatment may still be active) for 1’ at 1500 rpm at 4C° and discard 
supernatant. 
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8. Wash pellet 3 times by filling the tube with NaCl 0.1M. 
9. Place the eggs to seeded NGM plates with OP50. 
 
 
Phenotypically Screening  
Each strain worm are cloned during the L4 larval state on single Petri plates and keep at 20°C, 
producing and laying eggs for 4 days. 
Transfer every 12 hours the laying worms onto fresh plates until the deposition of non-fertilized 
oocytes. 
Monitor each plate for 24/72 hours to analyze three different parameters: embryonic lethality, 
the presence of males and aberrant phenotypes among the progeny. 
The value of embryonic lethality is calculated as the ratio of unviable eggs to laid eggs. The 
percentage of males and of aberrant phenotypes is calculated as the ratio of males/aberrant 
phenotype on the hatched eggs.  
Aberrant phenotypes are scored until the progeny reached the adulthood. 
Aberrant phenotypes are classified as: 
dpy: Dumpy, short and fat worms; 
unc: Uncoordinated, worms that have problems in movement; 
vul: Vulvaless sterile worms with no vulva; 
no gonad: Worms with no gonadal arms; 
bag: Bag of worms, worms defective in laying eggs and the embryos hatch inside the mother 
who soon dies; 
sma: Small, these animals tend to be more proportional in shape than dpy animals; 
rol: Roller, worms that tragically twist in place about their long axis; 
long: Worms that have the body length half longer than WT; 
lin: Cell lineage defects 
no tail: Tailless worms; 
larval arrest: Worms that do not reach adulthood. 
 
 
Treatment with genotoxic agents (MMS) 
Prepare NGM plates with MMS 300 µM.  
Store at 4°C at dark for maximum 7 days. 
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Plates are seeded with fresh OP50 before use. 
Treat young adult worms for 24 hours, adding fresh OP50 every 12 hours. 
Transfer laying worms onto fresh MMS plates each 12 hours up to 72 hours. 
Monitor the plates for 24/72 hours to analyze embryonic lethality. 
The value of embryonic lethality is calculated as the ratio of unviable eggs to laid eggs at 24-36 
and 36-72 hours after treatment. 
 
 
Quantitative analysis of DAPI-stained bodies at diakinesis stage 
Adult hermaphrodites were picked out for quantitative analysis of DAPI-staining bodies in 
diakinesis nuclei. 
1. Transfer the worms in 15µl M9 1X solution on glass slides. Sacrifice 20 worms per strain to 
observed nuclei from both gonadal arms. 
2. Permeabilize the samples and fix through 15µl of EtOH 100% two times. 
3. Add 15µl of the 4', 6'-diamidino-2-phenylindole hydrochloride (DAPI) (2ng/µl) diluted in M9 
1X to visualize the DNA in the fixed animals. 
Perform quantitative analysis on z series of images acquired using a Leica DM6 fluorescence 
microscope, Leica DFC365 FX Digital camera under the control of Leica LAS X software. Optical 
sections were collected at 0.50µm increments. 
 
 
Apoptosis assay 
Staining is performed with the syto-12, a vital dye, that directly permits the recognizing of cells 
that undergo apoptosis [Gumienny et al., 1999]. 
1. Suspend adult worms in M9 1x solution. 
2. Incubating with 33 µM of syto-12 for 1 hours and half at 20 °C in the dark. 
3. Transfer the worms to seeded plates to allow stained bacteria to be purged from the gut for 
30’ in the dark. 
4. Mount the worms on 2% agarose pads in levamisole 2mM. 
The quantitative analysis was performed on z series of images acquired using a Leica DM6 
fluorescence microscope, Hamamatsu camera under the control of Leica LAS AF 6000 software. 
The estimation of apoptotic levels was calculated as the average number of apoptotic nuclei per arm 
screened for each genotype. 
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Immuno-staining of meiotic nuclei 
1. Dissect adult hermaphrodites in 15µl M9 1X solution on poly-lysin coated glass slides. Add 
siloconized coverslips and put the slides on liquid nitrogen for 30’’. Lift the sicilonized coverslips 
from the glass slide. 
2. Permeabilize the sample and fix through 3 steps at -20°C in methanol, methanol/acetone 
(1:1), and acetone respectively 5’. 
3. Wash 3 times for 5’ in 1x PBS. 
4. Block fixation with 50µl of 3% BSA (BSA 10mg/ml) in PBS 1X under a parafilm coverslip 
for 30’ at 37°C in a humid chamber. 
5. Rinse off the coverslip in PBS 1x. 
6. Dilute primary antibody in Ab buffer: abRAD-51 in rabbit 1:200.  
7. Incubate slides with 60µl the primary Ab under a parafilm coverslip for 90’ at room 
temperature in a humid chamber. 
8. Rinse off coverslips in PBS 1x. 
9. Wash 3 times for 5’ in 1x PBS. 
10. Dilute secondary antibody in Ab buffer. 
11. Incubate with 60µl Ab Texas red for 60’ at room temperature DARK 
12. Wash 3 times for 5’ in 1x PBST. 
13. Mount with 6µl Prolong Gold Antifade reagent with DAPI (life technologies). 
Quantitative analysis of RAD-51 foci was performed on z series of images acquired using a 
Leica DM6 fluorescence microscope, L camera under the Leica DFC365 FX Digital camera control 
of LASX software. Optical sections were collected at 0.18 µm increments. The quantitative 
analyses of RAD-51 were performed by dividing the germ line into 7 zones (mitotic tip, mitotic 
zone, transition zone, early pachytene, middle pachytene, late pachytene and diplotene), in 
accordance with their cytological features. 
 
Statistical tools 
Statistical analyses of DAPI stained bodies in diakinesis nuclei, apoptosis levels and RAD-51 
foci patterns were computed through t-Student test for independent samples using the VassarStats 
software (http://faculty.vassar.edu/lowry/VassarStats.html). 
The level comparison of embryonic lethality and percentage of aberrant phenotypes of the 
different genotypes were computed through chi-square test using the VassarStats software 
(http://faculty.vassar.edu/lowry/VassarStats.html). 
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Discussion 
 
In this chapter we focused on the in vivo study of one of two AGTs of the nematode C. elegans. 
To date, this is the first in vivo analysis of CeAGT-2, since only a little biochemical characterization 
is present in literature. 
The C. elegans offers the opportunity not only to investigate the components of the various 
repair pathways and pathways interactions in response to DNA damage, but also to study the role of 
DNA repair at different stages of development. Its genome shares a high degree of homology with 
other complex eukaryotes: about 60% of the genes have an orthologous in the mouse and human. 
Many physiological pathways and damage/stress response pathways are conserved [Lai et al., 
2000]. In C. elegans, genetic screening together with high-resolution microscopy offers an 
opportunity to also observe numerous progeny and multiple phenotypes of the progeny. All of these 
features make it a good system to study biological pathway in a multicellular organism. 
C. elegans has two genes coding for CeAGT-1 and CeAGT-2, the first seems to be similar to the 
classical AGTs at the primary structure level. CeAGT-2 shows three fundamental differences 
[Kanugula et al., 2001]: i) the predicted active site is located much nearer to the N-terminus respect 
any other known AGTs. The canonical N-terminal domain is totally absent in CeAGT-2; ii) 
CeAGT-2 has a much longer C-terminal sequence for which there is no equivalent in any known 
AGTs, and this region shows a primary sequence histone-like (figure 3). Previously, the ceagt-2 
gene was expressed as a truncated form of this gene without the histone-like moiety, termed 
CeAGT-2tr: the relative protein still possesses DNA repair AGT activity on both O6methylguanine 
and O4methylthymine [Kanugula et al., 2001]. 
The peculiar primary structure of CeAGT-2 capture our attention asking its in vivo role. In C. 
elegans the ceagt-1 single mutant is not available, whereas only a null ceagt-2 mutant is present in 
the worm banks, although no information has been reported on this strain. So, we characterized the 
CeAGT-2 deleted strain, taking into account the presence of the CeAGT-1. 
This mutant is more sensitive to the alkylating agent than the WT, showing a higher embryonic 
lethality correlated to a greater number of unhatched eggs. This confirmed that CeAGT-2 could 
plays a key role in the response to DNA damage to alkylating agents as already noted for other 
different organisms. Surprisingly, exploiting the phenotypic analysis on the CeAGT-2 strain in 
physiological condition, I observed other significantly alterations respect to the WT strain, that are 
often associated with genes involved in meiosis and in the formation and/or production of gametes. 
So, we analyzed the role of AGT during the maturation of gametocytes, performing the 
immunolocalization of RAD-51 foci in the gonad of CeAGT-2 mutant, because the RAD-51 
recombinase is a suitable marker for following the optimal continuation of meiotic processes. We 
found an increase of number and increase of persistence of RAD-51 foci, suggesting meiotic defects 
during the formation of germ line in CeAGT-2. Furthermore, we found also an increased number of 
apoptotic bodies in the CeAGT-2 strain respect to the WT, probably because the persistence of 
DNA lesions in the C. elegans germline activates the DNA damage checkpoint and induces increase 
in the germline apoptotic level. These results show a possible in vivo role of CeAGT-2 in pathways 
related to DNA repair and meiotic development. In order to assert with certainty the involvement of 
the protein in the above described pathways are needed additional experiments, mainly achieving 
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double and triple mutants of the CeAGT-2 strain with genes involved in the development of the 
worm. 
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8. Final Conclusions 
 
SsOGT resulted a convenient model to unravel structure-function relationships of AGTs. Taken 
as a whole, structural, biochemical and molecular dynamics studies of the enzyme and relative 
mutants at every stage of the DNA repair activity, suggested a model for the in vivo function and 
degradation of this class of proteins. Although the architecture of the free and DNA-bound AGT, as 
well as details of its reaction mechanisms, is conserved among the class, the peculiar stability of this 
archaeal AGT allowed us to obtain 3D structural information in the post reaction form, overcoming 
the severe limitations of extreme instability of the alkylated forms of the human homolog [Daniels 
et al., 2000b].  
The architecture of the DNA-protein complexes highlighted by the X-ray crystallography and 
biochemical approaches (new fluorescent assay), provided a potential solution to a few information 
present in the literature about the DNA-binding mechanism. In particular, we determined the O6-
mG position dependent-efficiency of DNA repair by SsOGT, requiring for its optimal activity at 
least three bases at both sides of the lesion. These results are in coherence with the observed 
contacts between the protein and both DNA strands in 3D structure. Furthermore, contacts formed 
with the DNA strand at the both sides of the lesion are important for SsOGT, whereas those formed 
at the 3’ side are more crucial for hAGT. The explanation for this difference could be that SsOGT 
needs to form more and stronger contacts on the DNA to assist stabilization of the DNA-protein 
complex at higher temperatures, preventing thermal denaturation and facilitating lesion removal 
[Perugino et al., 2015].  
Alkylation-induced instability of hAGTs is a well-known process whose molecular mechanism 
is, however, poorly understood, mainly due to the failure in the purification of alkylated hAGT and 
its C145F and C145L mutants [Daniels et al., 2000b]. Again, the stability of SsOGT enabled us to 
purify it in the methylated form, as well as the C119L and C119F mutants at mild temperatures. We 
acquire direct and quantitative data on the protein stability in correlation with the active site 
occupancy and, for the first time, we could observe structural modifications occurring upon 
methylation in solution, whereas small structural rearrangements concerning hAGT upon alkylation 
were obtained in not optimal physiological conditions [Daniels et al., 2000b]. Our data are also 
coherent with the observation that alkylated SsOGT undergoes degradation after treatment of S. 
solfataricus cells with alkylating agents [Perugino et al., 2012], highlighting that at the 
physiological growth temperature (80 °C) alkylated SsOGT behaves as hAGT, being target the of 
degradation pathways in vivo [Perugino et al., 2015]. 
By combined structural, biochemical, mutational and molecular dynamics analysis we 
demonstrated that the two main interactions contribute to maintain the correct folding of SsOGT: 
the D27-R133 pair and the K48-network. Before DNA-binding, then post-reaction alkylation 
induced a perturbation of these interactions: based on our data, we proposed a model for the 
conformational changes and fate of the SsOGT upon alkylation [Morrone et al., 2017]. The optimal 
activity and stability of SsOGT require coordination between the N-terminal and C-terminal 
domains of the protein. The two clusters of interactions identified play an important role in protein 
stability and in communication the state of active site. We proposed that these cluster act as “locks”: 
in the ligand-free protein, both locks are in their “closed state”, ensuring the correct folding of the 
protein for its optimal stability and optimal activity. The protein binding to DNA and recognition of 
the damaged guanine leads to opening of the first lock only (the K48-network), destabilizing the 
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link between the N-terminal domain and the connecting loop. We presume that this modification is 
reversible until the active site remains unmodified: in this way, if the protein dissociates from DNA 
without any repair activity, the integrity of the K48-network is restored and the structural stability of 
the protein preserved. However, once the DNA repair reaction is completed, irreversible alkylation 
of the catalytic site induces irreversible conformational changes, switching the second lock (formed 
by the D27-R133 ion pair) in its “open state”. The loss of coordination between the N-terminal and 
C-terminal domains starts the SsOGT destabilization and its degradation [Perugino et al., 2015]. 
By superimposition analysis of the available 3D structures, we noted that the region 
corresponding to the K48-network in SsOGT, is characterized by the presence of hydrophobic 
residues that stabilize contacts between the N-terminal and C- terminal domain in hAGT [Daniels et 
al., 2000b]. Although this hypothesis could not be tested directly, we think that these hydrophobic 
interactions might play a similar role in hAGT. So, our model might be extended to other AGTs, 
assuming that interdomain communication and coordination plays a key role in maintaining folding 
and respond to alkylation triggering destabilization and degradation [Perugino et al., 2015; Morrone 
et al., 2017]. 
 
Regarding the mode of lesion recognition, several authors have analysed the possible functional 
advantages of performing the direct repair in a co-operative manner. It was underlined that co-
operative assembly of protein complexes on the DNA might contribute to the efficiency of lesion 
search and removal [Melikishvili et al., 2008]. The co-operative binding of hAGT on DNA was 
directly observed by AFM experiments and demonstrated the protein assembling into discrete 
clusters on DNA substrates [Tessmer et al., 2014]. These arguments are not in contrast with our 
results, aimed to describe a model of lesion recognition and repair performed by MtOGT. In 
principle, to guarantee efficient recognition of alkylated bases, both intact and damaged DNA 
strand should represent a ligand for MtOGT [Miggiano et al., 2016]. The insertion of a modified 
base inside the MtOGT active site allows conformational modifications of some regions of the 
protein, which could act as a signal, that a lesion has been encountered. Additional protein subunits 
could now be added, also thanks to of their structural flexibility, at the 5’ side of the lesion, where 
they undergo the same structural rearrangements to host extrahelical nucleobases in their active site. 
In this way, the DNA could be scanned, at a fixed space interval, for the presence of other alkylated 
sites [Miggiano et al., 2016]. 
 
The discovery that SsOGT is sensitive to BG-derivates, opened the possibility to expand the 
SNAP-tag™ technology, limited to mild reactions and environments. Because of the intrinsic nature 
of this thermostable protein, it displays a strong stability under several hard conditions, as extremes 
of pH, ionic strength, temperatures and presence of organic solvents [Perugino et al., 2012]. 
Mutagenesis on the HTH motif abolished the bonding ability, allowed the construction of a variant 
of this enzyme (SsOGT-H5), which conserves most of the advantages of the native protein in terms 
of stability, but showing major activity at lower temperatures, as the commercial SNAP-tag™. We 
successfully express and purify SsOGT-H5 in both mesophilic E. coli and thermophilic T. 
thermophilus hosts. We demonstrated that it is possible manipulate a thermostable protein/enzyme 
fused to the SsOGT-H5 in harsh conditions (as the H5-Ssβgly fusion protein; [Vettone et al., 2016]) 
without the need to remove the tag. These properties make SsOGT-H5 a valid alternative as protein-
tag for all the in vivo and in vitro applications of the SNAP-tag™ technology where extreme 
conditions are required. 
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Finally, we analyse the CeAGT-2 in the nematode C. elegans. This protein shows a particular 
feature: the predicted active site is located much nearer to the N-terminus of the protein respect of 
the other AGTs. The canonical N-terminal domain is totally absent in CeAGT-2, whereas the C-
terminal domain behaves to a histon-like domain [Kanugula et al., 2001]. The peculiar primary 
structure of CeAGT-2 attracts our attention, asking on the possible role of this AGT in vivo. To this 
aim, we characterized a mutant strain of CeAGT-2 by genetics and high-resolution microscopy, 
providing a unique opportunity for the detailed analysis of DNA repair pathways at organismal 
level and in true tissues. As already noted for other organisms, we confirmed a major sensitivity to 
alkylating agent treatment of this mutant respect to the WT strain. However, by phenotypic analysis 
on the CeAGT-2 strain, I observed significant alterations of other phenotypes (embryonic lethality 
and aberrant phenotypes), which are often associated with mutations in genes involved in meiosis 
and in the formation and/or production of gametes. So, we analysed the role of CeAGT-2 during the 
maturation of gametocytes, taking advantage that nematode gonad is an extremely powerful toolkit 
for the study of these processes, because the spatio-temporal organization of germ cells allows 
following their progress in specific stages of gametogenesis, from mitotic divisions up to the end of 
meiosis. In particular, we performed a immunolocalization on nematode gonad nuclei following the 
RAD-51 recombinase foci, which localize on DNA cuttings during meiotic recombination, 
generated by the topoisomerase-like protein SPO-11 during meiosis, essential for the correct 
execution of crossing-over [Colaiacovo et al., 2003]. In WT nematode, the RAD-51 foci formed at 
meiotic DSB: they appear during the early step of pachytene stage and then rapidly repaired during 
last step of pachytene stage [Colaiacovo et al., 2003]. In the gonad of CeAGT-2 mutant, we found 
not only an increase of number of RAD-51 foci/nucleus in first steps of pachytene stages, but also 
an increase of persistence in late pachytene stage, suggesting meiotic defects during the formation 
of germ line. This statement requires further experiments to understand if the CeAGT-2 is really 
involved in maturation of gametocytes. Another aspect of this study was the evaluation of apoptosis 
levels in the CeAGT-2 strain. It is important to say that in C. elegans WT strain, under 
physiological conditions, a certain number of germ cell suffer the apoptotic process, leading to a 
physiological number of apoptotic bodies (an average of 3/gonad arm) [Gartner et al., 2008]. A 
defect in genes involved in apoptotic process or involved in repair pathway, which hampers a 
correct resolution of meiotic DSB, it is cause of a variation of the number of apoptotic bodies. In 
particular, the persistence of DNA lesions in the C. elegans germline triggers the DNA damage 
checkpoint and induces increase in the germline apoptotic level. This was the case for the CeAGT-2 
strain, in which the above-mentioned number was significantly higher than the WT (an average of 
5/gonad arm). Although is premature to assert with certainty the involvement of the CeAGT-2 in 
the pathways above described (additional experiments on several double mutants strains are 
needed), these result suggest a possible role of the protein in meiotic processes and in metabolic 
pathways related to DNA repair during the meiotic development.  
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